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 The prospect of treating debilitating and even fatal diseases by way of genetic-
based interventions has been the long-standing goal of gene therapy.  However, its 
widespread clinical use has been severely limited due to a dearth of effective gene 
delivery systems.   Further stalling the development of viable vectors is the lack of 
clear mechanistic understanding of the barriers that vectors must overcome for 
successful transfection.  
 The goal of this research is to better understand the structure-function 
relationships that govern polymer-mediated transfection to serve as guiding principles 
for the rational design of safer and more efficient polymeric vectors.  To achieve this 
goal, we developed a simple and robust synthetic protocol to synthesize combinatorial 
libraries of polymeric gene vector candidates.  We evaluated three combinatorial 
libraries of polymeric vectors formulated from single and serially-incremented binary 
combinations of seven cationic, pH-sensitive, and hydrophobic pendant groups at 
three different molecular weights (10kDa, 30kDa, 50kDa).  High levels of transfection 
correlated with increasing molecular weights and were achieved by polymers co-
functionalized with primary amino and imidazole groups.   These high-transfecting 
polymers appeared to harness the superior charge neutralizing and size condensing 
capacity of primary amino groups while benefiting from imidazole’s polyplex-
stabilizing ability.  Imidazole groups were found to effectively bind with DNA via 
non-electrostatic interactions, resulting in polyplexes that were more resistant to 
premature polyplex dissociation, which ultimately led to more efficient delivery to 
cells. 
 The effects on transfection of the polydispersity index (PDI) of polymeric 
vectors were also evaluated by comparing two identically-formulated libraries, each 
representing a different PDI (1.3 and 2.0).  Within the higher PDI library, we 
identified several polymer formulations that achieved transfection levels superior to 
branched-PEI (25kDa), while maintaining superb cell viability.  Biophysical 
characterization of these high-performing polymers revealed a greater degree of 
polyplex stability compared to their lower PDI, low-transfecting counterparts.    
 The results from this research have provided a deeper understanding of how 
several widely used polymeric structures influence gene delivery.  The polymeric 
system and the approach presented herein serves as the foundation upon which future 
nucleic acid-based therapies (e.g., RNAi therapy) may be based in the move towards 
safer and more efficient delivery systems.   
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 CHAPTER 1 
 
INTRODUCTION 
 
 The lack of safe and efficient gene delivery systems represents the single 
biggest challenge facing gene therapy today.  Despite innovative strategies that have 
created more effective delivery systems, the current technology has fallen short in 
transforming gene therapy into a clinical reality.  Perhaps one of the most active areas 
of vector research is the design of polymer-based delivery systems.  By virtue of their 
synthetic versatility and amenability to diverse chemical modification, polymers offer 
an attractive platform upon which sophisticated delivery systems can be based.   
However, polymer vector research currently suffers from an opaque understanding of 
the structure-function relationships that govern polymer-mediated gene delivery.  
Without a clear understanding of how polymeric structures and features influence the 
transfection capacity of polymeric vectors, rationally designing safer and more 
effective vectors will continue to be an extremely challenging task.   
 This thesis aims to address this gap in knowledge through the iterative 
synthesis of combinatorial libraries of polymeric gene vector candidates.    Chapter 2 
provides a review of the prolific research into polymer-based delivery systems, and the 
wealth of knowledge that has been generated over the past two decades, with a focus 
on recent developments within the past three years.  Chapter 3 details the synthetic 
approach that was developed to streamline the synthesis of large and diverse polymer 
libraries.  Chapter 4 discusses the evaluation of three combinatorial libraries of 
cationic and hydrophobic polymers and the structure-function relationships deduced 
from this library.  In Chapter 5, we evaluated the polydispersity of polymeric vectors 
and its effects on gene delivery.   
 1
   The final two chapters discuss two additional methods that were formulated to 
support the synthesis of combinatorial libraries for future structure-function studies.  
In Chapter 5 we devised a high throughput equilibrium dialysis system designed to 
purify and isolate polymeric compounds from 96 well plates.  Finally, Chapter 6 
details a stochastic Monte Carlo (MC) model that was developed to facilitate the 
design and iterative redesign of richer and more focused combinatorial libraries.   The 
utility of MC methods for library design was established based on an experimental 
data set of over five thousand combinatorially-assembled buffer formulations for 
refolding denatured protein into its functional conformation.  The protein refolding 
experimental platform may initially seem unrelated from the polymeric vector 
research.  However, the combinatorial nature of the polymeric vector library in the 
gene vector study is akin to the buffer formulation library and is therefore amenable to 
the use of MC methods that were demonstrated on the combinatorial library in the MC 
study.   
 
 
 2
 CHAPTER 2 
 
2 POLYMER SYSTEMS FOR GENE DELIVERY – PAST, PRESENT, 
AND FUTURE 1 
 
2.1. ABSTRACT 
 Gene therapy has long sought to treat disease by delivering therapeutic genes 
to diseased cells.  However, its widespread clinical use has faltered in the face of 
several challenges, most notably in the area of delivery.  Efforts to understand the 
biological barriers that prevent the effective delivery of therapeutic genes to targeted 
tissues, and developing safe and efficient vectors that can overcome the barriers, stand 
at the heart of current gene delivery research.  The first part of this review provides a 
comprehensive discussion of the current understanding of these biological barriers and 
the rich collection of polymers and design strategies that have accumulated from 
nearly two decades of research aimed at overcoming these hurdles.  The second part 
highlights the challenges that remain and several innovative approaches and methods 
that have recently been developed representing, in part, the future directions of gene 
delivery research. 
 
2.2. INTRODUCTION 
Long heralded by some as the next revolution in modern medicine, gene 
therapy has the potential to profoundly shift the way human disease is managed and 
treated [1].  The concept is simple - deliver exogenous, therapeutic genes to the body 
to treat genetic-based diseases.  The results could be substantial - diseases once 
                                                 
1  Reproduced with permission from Wong, S., Pelet, J., Putnam, D., Polymer systems for gene 
delivery-past, present, and future, Progress in Polymer Science, 32, 8-9, 799-837 (2007).  Copyright 
[2007]  Elsevier. 
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 considered incurable may be treated or even prevented, for instance, with DNA 
vaccines that inoculate against infectious diseases [2].  Thanks to advances in 
molecular biology and genomic research, numerous diseases (e.g., sickle cell anemia, 
HIV, Parkinson’s disease, Huntington’s disease, Alzheimer’s disease) have been given 
a genetic identity for which gene therapy may be a possible prescription [3-6].  
 However, the promise of gene therapy has yet to be fulfilled due to challenges 
associated with cell targeting specificity, gene transfer efficiency, gene expression 
regulation, and vector safety.  Engineered viruses were the first delivery agents 
employed to meet these challenges.  Using viruses that were either genetically 
rendered to be replication defective or gutted of their genetic material and replaced 
with therapeutic genes, some of the earliest clinical trials produced promising results 
leading many to believe that viral vectors were poised to achieve the goal of gene 
therapy [7-10].  It was not long after these initial reports of successful clinical 
implementation, however, that the severe side effects possible with viral-based gene 
therapy were made strikingly evident.  The concern that viral vectors could induce 
cancer via insertional mutagenesis – random transgenic insertion into the host 
chromosome disrupting the normal expression of a critical gene that ordinarily 
regulates cell growth and division – was realized when three clinical trial participants 
developed leukemia-like complications post retroviral-based gene therapy [11-13].  
Moreover, the viral vectors themselves can initiate an immunogenic response which, 
in at least one reported incident, has led to a fatal outcome [14].  
 Although these safety issues do not necessarily preclude the use of viruses as 
gene vectors, they have motivated the exploration for safer, less pathogenic and 
immunogenic gene delivery alternatives including lipid-based vectors, chemically 
modified viruses, inorganic materials, and polymer-based gene delivery systems.  In 
addition to the potential safety benefits, such non-viral systems offer greater structural 
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 and chemical versatility for manipulating physicochemical properties, vector stability 
upon storage and reconstitution, and a larger gene capacity compared to their viral 
counterparts.  Lipid-based vectors, chemically modified viruses, and inorganic 
materials are the subject of several reviews to which the reader is referred [7, 15, 16].  
The scope of this review aims to highlight the progress that has been made toward 
developing polymer-based gene delivery systems with an emphasis on recent progress 
reported within the past three years.   
 The first part of this review discusses the current understanding of the various 
biological barriers that face efficient gene delivery (Figure 2-1) and the rich collection 
of polymers and design strategies that have accumulated from nearly two decades of 
intense and prolific research aimed at overcoming these barriers.  The second part of 
this report highlights the challenges that remain and several innovative approaches and 
methods that have been recently developed representing, in part, the future directions 
of gene delivery research. 
 
Figure  2-1.  Barriers to Gene Delivery - Design requirements for gene delivery 
systems include the ability to I) package therapeutic genes; II) gain entry into cells; 
III) escape the endo-lysosomal pathway; IV) effect DNA/vector release; V) traffic 
through the cytoplasm and into the nucleus; VI) enable gene expression; and VII) 
remain biocompatible. 
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 2.3. GENE PACKAGING 
 The fundamental design criteria for any synthetic gene delivery system 
includes the ability to 1) neutralize the negatively charged phosphate backbone of 
DNA to prevent charge repulsion against the anionic cell surface; 2) condense the 
bulky structure of DNA to appropriate length scales for cellular internalization (i.e., 
nanometers for receptor-mediated endocytosis; micrometers for macropinocytosis or 
phagocytosis); and 3) to protect the DNA from both extracellar and intracellular 
nuclease degradation [17-19].  To meet these requirements, researchers have relied on 
three main packaging strategies: electrostatic interaction, encapsulation, and 
adsorption (Figure 2-2). 
 
Figure  2-2.  Gene Packaging – The three main strategies employed to package DNA 
are via 1) electrostatic interaction, 2) encapsulation within or 3) adsorption onto 
biodegradable nano- or microspheres. 
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 2.3.1. Electrostatic interaction 
 Many of the polymeric vectors developed to date have exploited the anionic 
nature of DNA to drive complexation via electrostatic interaction.  Table 2-1 identifies 
several commonly used polycations that have been used in such a capacity.  All of 
these polymers possess amino groups, at least a portion of which are protonated at 
neutral pH, to enable electrostatically-driven self assembly with DNA.  At a sufficient 
nitrogen to phosphate (N:P) charge ratio, the polymer can condense DNA to sizes 
compatible with cellular uptake while providing steric protection from nuclease 
degradation [20]. 
 Although the presence of the positive-charge carrying moieties forms the basis 
for this method of DNA packaging, it is the cationic charge that appears to correlate 
with the high degree of cytotoxicity typically associated with polycations.  Moreover, 
a strong electrostatic charge, though conducive for DNA packaging and protection, 
may lead to difficulties of DNA release once the polyplex arrives at the site of action.  
For these reasons, researchers have developed biodegradable polycations as well as 
alternative methods of DNA packaging, namely via encapsulation and adsorption. 
 
2.3.2. Encapsulation 
 An alternative to electrostatic condensation of DNA is its encapsulation within 
biodegradable spherical structures.  The vast majority of biodegradable polymers that 
have been used for nano- or microspherical encapsulation are shown in Table 2-1.  
Owing to the ester linkages along their backbones, all of these polymers (i.e., 
polyesters) can be hydrolytically degraded to shorter oligomeric and monomeric 
components that are more readily cleared from the body.  Furthermore, degradation 
kinetics can be modulated by various factors including polymer properties and 
composition thereby enabling control over DNA release [21-23].  Similar to their 
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 polycation counterparts, these DNA-encapsulating agents protect the incorporated 
genes from enzymatic degradation.  The size of the DNA-encapsulated complex, 
however, is determined by the method of particle formulation, which can be tailored to 
range from the nanometer to micrometer length scale [24].  The current methods 
available for encapsulation represent one of the main limitations of this packaging 
method, as it often involves high shear stresses and exposure to organic solvents and 
extreme temperatures that can degrade the genetic cargo [25].  Other limitations 
include low encapsulation efficiency, potential DNA degradation due to a low pH 
microenvironment within the hydrolyzing polyester, and low DNA bioavailability due 
to incomplete release from the polymer [26-28]. 
 
2.3.3. Adsorption 
 In response to the limitations posed by current encapsulation methods, 
adsorption techniques were developed as a DNA packaging alternative.  DNA 
adsorption represents a marriage of the two above-mentioned approaches in that it 
involves adsorbing or conjugating cationic moieties (e.g., cationic surfactants, 
PDMAEMA, PEI) to the surface of biodegradable particles to which DNA can 
electrostatically bind [59, 81-83].  This approach offers the benefit of enhancing the 
amount of DNA available for immediate release while reducing its exposure to harsh 
encapsulation conditions. However, surface presentation of the nucleic acids can 
render them susceptible to enzymatic degradation although this may be mitigated by 
the type of polycation employed and the resultant degree of electrostatic interaction 
with the adsorbed DNA [59, 64].      
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 Table  2-1.  Structures of some widely used gene-packaging polymers. 
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 Table 2-1. (continued) 
 
Biodegradable polymers
Polycations (continued)
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 Table 2-1.  (continued) 
 
eferences:  L-PEI and b-PEI [29, 30]; PDMAEMA [31-35]; PAMAM [20, 36-38]; PPI [39, 40]; PLL 
1-45]; chitosan [46-50]; spermine [51-53]; cyclodextrin-containing polycations [54]; 
Biodegradable polymers (continued)
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R
[4
poly(phoshphoester) [55, 56]; poly(phosphazene) [57, 58]; PLA [59, 60]; PLGA [61-64]; 
poly(orthoester) [65, 66]; poly(β-amino ester) [67-70]; h-PAE [71, 72]; n-PAE [73, 74]; PAGA [75-77]; 
PHP-ester [78-80] 
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  The polymers highlighted in Table 2-1 represent various molecular backbones 
.4. CELLULAR ENTRY 
e first obstacle encountered by the polymer/DNA 
mple
and delivery platforms upon which synthetic vector designs are based.  The versatility 
of polymer chemistry allows these polymers to be functionalized, copolymerized, or 
structurally modified (e.g., into various architectures) to impart physicochemical 
properties upon the vector to overcome the barriers of gene delivery.  Using both 
traditional and more recently developed polymers and synthetic techniques, 
researchers have created an extensive collection of polymer tools that can be drawn 
upon for subsequent vector designs. The following discussion highlights the diverse 
assortment of polymer tools and strategies that have been developed to overcome the 
barriers to safe and efficient gene delivery.   
 
2
 On a cellular level, th
co x, or “polyplex”, is the plasma membrane.  To gain entry into the cell, passive 
diffusion is typically not afforded to polyplexes due to size restrictions of 
transmembrane pores and channels and low partition coefficients into lipid bilayers.  
Many of the strategies developed to surmount this physical barrier have taken 
advantage of the process by which cells naturally use to internalize macromolecules 
(e.g., nutrients, bacteria) from the extracellular space, namely endocytosis.  As with 
most physiological processes responsible for sustaining the livelihood of the cell, 
cellular entry must be tightly regulated lest the uptake of undesirable or unnecessary 
particles and macromolecules should occur.  As such, endocytic uptake occurs by at 
least five known pathways to afford a diverse, yet regulated mechanism of controlling 
cellular entry – phagocytosis, macropinocytosis, clathrin-mediated endocytosis, 
caveolae-mediated endocytosis, and clathrin- and caveolae-independent endocytosis 
[84].  In terms of polymer-mediated gene delivery, all share a common uptake mode 
 12
 of enclosing the internalized polyplexes within transport vesicles derived from the 
plasma membrane.  Differences arise, however, in the subsequent intracellular 
processing and routing of internalized polyplexes, which consequently affects the 
extent to which the polyplexes can deliver their genetic cargo efficiently.  The factors 
that determine the pathway though which polyplexes will be internalized remain 
unclear and are briefly discussed in the next section.  Discussed below are several of 
the strategies that have been developed to induce endocytosis, referred to generally in 
this section unless distinguished otherwise, of polymer-based gene delivery systems 
(Figure 2-3). 
 
 
 
F
m
igure  2-3.  Cellular Entry – Polyplexes may gain entry into cells through I) receptor-
ediated endocytosis; II) phagocytosis via size exclusion; III) non-specific ionic 
interactions with membrane-bound proteoglycans; IV) non-specific lipophilic 
interactions with phospholipid components of the cell membrane; or V) cell 
penetrating peptide (CPP)-mediated uptake, the mechanism of which remains unclear.   
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 2.4.1. Targeted uptake 
2.4.1.1. Receptor – mediated targeting and endocytosis 
 Numerous polyplexes have been designed to gain cellular entry via receptor-
mediated endocytosis.  Vectors that bear targeting ligands, which induce endocytosis 
upon binding to their cognate surface receptors, have been used to mediate 
internalization in a cell-specific manner.   Indeed, for most diseased conditions where 
the therapeutic genes must be delivered to a certain cell type, targeting receptors that 
are present only on certain cell populations has provided a useful tool in gene delivery.   
 A panoply of targeting ligands have been investigated including proteins, 
carbohydrates, peptide sequences, biomolecules, and antibodies. Table 2-2 lists several 
examples of the most commonly used ligands that have provided selective targeting to 
various cell types displaying the appropriate receptor protein.  
 
Table  2-2.  Ligands used to promote cellular uptake 
 Ref. 
Endogenous Ligands  
Transferrin [86-89] 
TGF-α [90] 
Folate [91, 92] 
FGF [87, 93] 
EGF [94, 95] 
VEGF [87] 
Asialoorosomucoid [96, 97] 
RGD peptide [98-101] 
  
Carbohydrates  
Galactose [102, 103] 
Mannose [104-106] 
Lactose [105, 107] 
  
Antibodies  
antiCD3 [88, 108] 
antiEGF [109] 
antiHER2 [110, 111] 
antiIgR [112] 
antiJL-1 [113] 
  
Cell penetrating peptides  
HIV Tat [101, 114, 115] 
Penetratin [116, 117] 
Transportan [117, 118] 
Polyarginine [119]  
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  Selection of the appropriate targeting ligand can be influenced by a myriad of 
factors.  Endogenous ligands, such as folate and transferrin, are the most widely used 
class of targeting moieties based on their biocompatibility and fairly well studied 
receptor distribution [85].  However, their inherent circulation in the body can also 
lead to competitive interference with those attached as targeting moieties.  In contrast, 
exogenous ligands, such as the peptide- and antibody-based targeting agents may 
avoid these problems although their foreign nature renders them susceptible to an 
immune response, which could limit their utility [85]. 
 
2.4.1.2. Size exclusion and phagocytosis 
 Targeting and subsequent cellular uptake can also be mediated via size 
exclusion.  It has been shown that DNA-encapsulated microspheres with diameters 
between 1-10 μm are preferentially internalized by phagocytic cells such as antigen-
presenting cells (APCs) of the immune system [120].  As such, this strategy has been 
widely adopted for DNA vaccine applications where APCs are the target cells [66, 82]. 
 
2.4.2. Non-specific uptake 
2.4.2.1. Ionic interactions with membrane – bound proteoglycans and en
Cellula
docytosis 
 r entry can also be gained in the absence of targeting strategies.  A 
mber
 
nu  of polyplexes have been able to induce cellular uptake through charge-
mediated interactions with proteoglycans that are present on the cell surface [121]. 
Proteoglycans are composed of a membrane-associated core protein from which a 
chain of sulfated or carboxylated glycosaminoglycans (GAGs) extends into the 
extracellular space [122].  These highly anionic GAG units determine much of the 
interactions between the cell surface and extracellular macromolecules and are 
responsible for the overall negative charge of the plasma membrane [123]. Although 
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 the exact mechanism by which these membrane-bound molecules mediate cellular 
internalization remains unclear, they are believed to play a central role in the 
endocytic uptake of many non-targeted, positively-charged gene delivery systems [121, 
124].  It is important to consider, however, that differences in proteoglycan 
distribution between cell types can lead to varying degrees of internalization from one 
cell type to another.  Additionally, the non-specificity of this mode of interaction can 
lead to indiscriminate uptake and undesirable gene expression by unanticipiated cell 
populations. 
 
2.4.2.2. Lipophilic interaction with phospholipid membrane and endocytosis 
 etween 
2.4.2.3. Cell penetrating peptide – mediated uptake 
M een extensively investigated for 
An alternative opportunity for cellular uptake relies on the interaction b
vector-bound lipophilic residues and the phospholipid layers that comprise the cellular 
membrane [125].   Through a series of rationally incremented chemical modifications 
to branched PEI, Thomas and Klibanov demonstrated the potential ability of long, 
lipophilic alkyl chains (i.e., dodecane, hexadecane) to induce endocytosis through 
interactions with the cell membrane resulting in increased transfection efficiencies 
[126].  Moreover, their results revealed that the position of lipophilic substitution (i.e., 
primary vs. tertiary amines of PEI) can have profound effects on the extent of this 
interaction and thus transfection efficiencies [126]. 
 
ore recently, cell penetrating peptides (CPP) have b
their ability to facilitate membrane translocation (Table 2-2).  Originally derived from 
viral proteins, these peptides are typically 5-40 amino acids in length, positively 
charged, and amphipathic in nature.  By virtue of their net positive charge, some CPPs 
have served as both the DNA-binding and the cell penetrating component [114, 115, 
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 127].  Although the mechanism by which CPPs facilitate cellular uptake remains 
controversial, the prevailing hypotheses of CPP-mediated uptake include 1) formation 
of peptide-lined pores within the membrane; 2) direct penetration through the 
membrane and into the cytoplasm; 3) transient uptake into a membrane-bound 
micellar structure that inverts to release the CPP and its genetic cargo inside the 
cytosol; and 4) the induction of endocytosis [128]  (Figure 2-4). As with any peptide 
or protein-based component, incorporation into vector designs should not be pursued 
without caution due to potential immunogenicity concerns.  Furthermore, it is believed 
that peptide conformation may play a critical role in membrane penetration and 
therefore the method of incorporation must be careful not to disrupt peptide activity. 
 
 
igure  2-4. Cell Penetrating Peptide (CPP)-Mediated Uptake – Hypothesized F
mechanisms of CPP-mediated entry include I) formation of peptide-lined pores within 
the cell membrane; II) direct penetration through the membrane and into the 
cytoplasm; III) transient uptake into a membrane-bound micellar structure that inverts 
to release the CPP and its genetic cargo inside the cytosol; and IV) induction of 
endocytosis.  (Adapted from [128, 129]) 
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 2.5. ENDO-LYSOSOMAL ESCAPE 
cytosis, subsequent intracellular routing of 
pathway, polyplexes can be 
 If cellular entry is gained by endo
vesicle-bound polyplexes can include recycling back to the cell surface, sorting to 
acidic, degradative vesicles (e.g., lysosome, phagosome), or delivery to an 
intracellular organelle (e.g., Golgi apparatus, endoplasmic reticulum) [130].  The 
intracellular itinerary that the endocytic vesicles follow depends upon the pathway by 
which they were internalized (i.e., phagocytosis, macropinocytosis, clathrin-mediated 
endocytosis, caveolae-mediated endocytosis, and clathrin- and caveolae-independent 
endocytosis).  Currently, clathrin-mediated endocytosis is the most characterized 
pathway and has served as the route for which synthetic gene delivery systems have 
been designed.  It is important to consider, however, the emerging evidence suggesting 
that the uptake pathway, and thus intracellular routing and consequently transfection 
efficiency, is dependent upon a number of factors including cell line, polyplex type, 
and the conditions under which the polyplex is formulated [131, 132].  Thus, 
elucidating the mechanistic details of the other internalization routes will be important 
for the design of more optimized synthetic vectors.   
 Within the clathrin-mediated endocytic 
sequestered within endosomal vesicles and shuttled through the endo-lysosomal 
pathway.  Release from these vesicles is paramount to avoiding enzymatic degradation 
within the lysosomal compartment (Figure 2-5). Because these vesicles acidify (pH 
decreases from ~6 to ~5) as they mature from endosomes to lysosomes, escape 
mechanisms have attempted to harness the influx of protons through the use of pH-
responsive moieties (Table 2-3). 
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Figure  2-5.   Endo-lysosomal Escape – Polyplexes that are internalized via 
endocytosis can be sequestered within endosomal vesicles and trafficked to the 
lysosome to be enzymatically degraded.  Vesicles acidify (pH reduces from ~6 to ~5), 
through the action of vesicle-bound proton pumps, as they mature along the endo-
lysosomal pathway.  Strategies to escape lysosomal degradation have exploited the 
influx of protons by incorporating pH-sensitive moieties into vector designs.   
 
2.5.1. Protonable amines 
 The most commonly used pH-sensitive excipients are protonatable amino 
groups with 5 < pKa < 7 (e.g., 2° and 3° amines, imidazole).  As the vesicle acidifies, 
these amino groups are thought to become protonated thus preventing the vesicle from 
attaining the desired pH.   As a result of this endosome buffering activity, commonly 
referred to as the “proton sponge” effect, the endo-lysosomal vesicle osmotically 
swells, ruptures, and releases its contents into the cytosol [133, 134]. 
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 Table  2-3.  Ligands used to promote endo-lysosomal escape 
 
 Ref. 
Protonable amines  
Imadazole groups 
 
 
 
 
 
 
[44, 140-144] 
L-PEI [29, 30] 
b-PEI [29, 30] 
PDMAEMA [31-35] 
PAMAM [20, 36-38] 
  
Endosomal release peptides  
Viral derived  
Melittin [145] 
Influenze virus hemalgglutinin HA-2 [146, 147] 
Diptheria toxin [148] 
  
Synthetic peptides  
GALA [37] 
KALA [149, 150] 
JTS-1 [151] 
  
Alyklated carboxylic acids  
 
 
 
 
 
 
[46, 139] 
  
  
  
  
  
N
N
R
N
HN
R
OH
O
n
poly
(propylacrylic acid)
poly 
(ethylacrylic
acid)
OH
O
n
poly (ethylacrylate-
co-acrylic acid)
O
O
n
OH
O
m
 
 
 
 
 20
 2.5.2. Endosomal release peptides 
 Endosomal release peptides have also been used to promote translocation 
through the endosomal membrane.  These peptides differ slightly from CPPs in that 
they undergo a structural transformation from a random coil at neutral pH to an α-
helical conformation at lower pH environments.  Triggering of the α-helical 
conformation is believed to induce membrane interaction and disruption leading to 
subsequent release of the endosomal contents into the cytosol [135]. 
 
2.5.3. Alkylated carboxylic acid 
 Inspired by the membrane-disruptive abilities of the endosomal release 
peptides, but concerned with their potential immunogenicity and high manufacturing 
costs, an alternative class of synthetic, pH-sensitive polymers was developed.   These 
polymers were designed to contain the same functional groups, namely alkyl and 
carboxyl groups, that are presumably responsible for the membrane-disruptive 
properties of the α-helical endosomal release peptides [136].   The carboxyl 
component functions as the protonatable species while the hydrophobic alkyl groups 
interact with the endosomal membrane to collectively enhance vesicle escape.  
Through a series of structure-function experiments, it was determined that pH-induced 
membrane lytic ability can be modulated by the carboxylic acid to alkyl group ratio 
with poly(propylacrylic acid) exhibiting the most promising utility in gene vector 
design [136-139]. 
 
2.6. CYTOSOLIC TRANSPORT AND NUCLEAR IMPORT 
 Polyplexes that enter the cytosol, either directly upon cellular internalization or 
upon escaping the endo-lysosomal pathway, are immediately faced with a physically 
and metabolically hostile environment (Figure 2-6).  
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Figure  2-6.  Cytosolic Transport and Nuclear Import –Polyplexes entering into the 
cytosol are faced with nucleolytic enzymes interspersed amongst the filamentous 
network of the cytoskeleton.  Strategies to minimize residence time within the cytosol 
and promote transport toward and into the nucleus include incorporating nuclear 
localization signals (NLS), NLS-containing proteins, and carbohydrates into vector 
designs. 
 
Within the cytosolic milieu, nucleolytic enzymes ready to degrade unprotected nucleic 
acids are interspersed amongst microtubules, intermediate filaments, and 
microfilaments that are organized into a dense network to form the cytoskeleton [152]. 
These filaments provide an internal structure to the cell and function in cell motility 
and intracellular transport of vesicles, chromosomes, and macromolecules. It has been 
shown that the mesh-like structure of the cytoskeleton, and more specifically cross-
linked actin filaments, can severely impede the diffusion of naked DNA greater than 
250 bp in size with an extended linear length of approximately 85 nm [153, 154].  
Thus, free diffusion of polyplexes that are typically on the order of 150-200 nm is not 
likely to be the main mode of cytosolic transport.   
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  In order to minimize residence time within the cytosol and promote transport 
toward and into the nucleus, researchers have recruited natural endogenous cytosolic 
factors and their associated cellular pathways to facilitate the shuttling of either 
polyplexes or DNA itself (Table 2-4). 
 
Table  2-4.  Ligands used to promote cytosolic transport and nuclear import. 
 
 Ref. 
Nuclear localization signals (NLS)  
Human T cell leukemia virus type 1 (HTLV) [155] 
M9 [156] 
HIV Type – 1 viral protein R (Vpr)  [157, 158] 
SV40 Large T antigen [155, 159, 160] 
  
NLS – containing proteins  
Protamine [161, 162] 
Histone [89, 163] 
High mobility group proteins [164, 165] 
   
Carbohydrates  
Lactose [166] 
Mannose [167] 
N – acetylglucosamine [168] 
  
 
2.6.1. Nuclear localization signal (NLS) 
 The nuclear import machinery, naturally utilized by cells to transport large 
proteins into the nucleus, has motivated the application of nuclear localization signals 
(NLS) in gene vector design.  Proteins less than 40 kDa in MW or 9 nm in diameter 
can passively diffuse through channels, known as nuclear pore complexes (NPC), that 
perforate the nuclear envelope [169].  Proteins greater in size, however, require the 
assistance of import proteins (e.g., importins) to actively shuttle them through the 
NPCs.  Cytosolic proteins destined for the nucleus contain a distinct amino acid 
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 sequence, known as the NLS, that are recognized by import proteins which direct their 
subsequent transport into the nucleus.   
 Significant effort has been devoted to exploit this highly sophisticated and 
efficient trafficking pathway to mediate intracellular transport of both exogenous and 
vectorized DNA [170].  Since most NLSs are short, cationic peptide sequences, they 
can be used to electrostatically interact and condense DNA thus abrogating the need 
for a distinct polycation condensing agent [157].  Alternatively, NLSs can be attached 
to a polymer vector that is subsequently complexed with its genetic cargo [160, 171].  
Despite their promising fitness for gene delivery, the extent to which NLSs can 
enhance cytosolic trafficking and nuclear uptake may be limited by the size and type 
of DNA used (i.e., linear, plasmid), the method of NLS incorporation (i.e., covalent 
conjugation to DNA, electrostatic complexation with DNA, or conjugation to a 
polymer vector), type of NLS peptide employed, the number of NLSs incorporated, 
and the type of polymer vector used (e.g., liposomes, PEI) [155, 172]. 
 
2.6.2. NLS – containing proteins 
 In addition to using NLS sequences for nuclear targeting, researchers have also 
explored the possibility of using various natural or recombinant nuclear proteins from 
which NLS sequences were derived. The large majority of nuclear proteins examined 
for gene delivery applications fall into two broad categories – histones and non-
histone proteins.   Histones are a subset of nuclear proteins involved with DNA 
binding and condensation as well as regulating transcription and cell cycle progression 
[173, 174].  Non-histone proteins, such as the high mobility group proteins, function 
similarly and support various DNA-related activities including transcription, 
replication, and recombination [174].  Both groups of nuclear proteins typically carry 
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 a net positive charge and contain natural NLS sequences thus making them readily 
amenable to participate in both a DNA-packaging and nuclear targeting capacity.   
 Recently, greater resolution of the NLS-mediated trafficking pathway has been 
reported.  By binding the NLS-bearing nuclear protein, p50, to plasmid DNA and 
microinjecting the complex into the cytoplasm, Mesika et al. demonstrated that 
importins can recognize and bind to the p50-bound DNA, subsequently migrating 
along microtubules driven by dynein motor proteins.  The importin and its conjoined 
cargo travel toward the microtubule organizing center located adjacent to the nucleus.  
Upon arrival near the nucleus, the importins dock onto the NPC and shuttle the p50-
bound DNA into the nucleus [175].   
 These results and other recent reports have shed light on the potential role of 
microtubules in the cytosolic trafficking of both NLS-bearing plasmids and 
endosomally-enclosed polyplexes [176, 177].   Coupled with the possibility that 
dynein motor proteins are the drivers of such transport, an exciting opportunity exists 
in exploiting these cellular entities directly (i.e., in the absence of NLSs and import 
proteins) to facilitate cytosolic transport and ultimately improve transfection 
efficiencies.  
 
2.6.3. Carbohydrates 
 Carbohydrate-binding receptors, known as lectins, that reside intracellularly 
have offered researchers an opportunity to use sugars to direct the cytonuclear 
transport of synthetic gene delivery systems [178, 179].  Although carbohydrate-
mediated transport shares some common features with NLS-based transport – both are 
energy- and signal-dependent processes that import their cargo into the nucleus 
through nuclear pores- the former appears to translocate through the nuclear pores 
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 along a distinct pathway that does not require the presence of cytosolic factors to 
facilitate import [180, 181].  
 The identification of specific carbohydrates and their respective intracellular 
lectins that can be used in this capacity remains an active area of research.  It appears 
that certain carbohydrates used to target cell surface lectins to facilitate cellular 
targeting and uptake may not necessarily facilitate subsequent intracellular trafficking 
due to a difference in carbohydrate specificity by intracellular lectins [178, 182].  
There have also been conflicting reports about the involvement of certain sugars in 
mediating cytonuclear transport of polyplexes that will require further scrutiny to 
resolve [166, 183, 184]. Nevertheless, the relative ease of synthesis, inherent 
biocompatibility, and reduced immunogenic concerns associated with carbohydrate-
based moieties have contributed to its advantageous utility in gene vector design. 
 
2.6.4. Cell mitosis 
 If dividing cells are targeted, polyplexes may also gain nuclear entry upon 
nuclear reformation during mitosis.  It has been shown that reporter gene expression 
may be considerably enhanced if transfection occurs shortly before cell division 
presumably due to the temporary breakdown of the nuclear envelope which allows 
inclusion of DNA within the nuclear space [185].  However, this behavior appears to 
be vector type-dependent and may be clinically limited as most cells in the body are 
postmitotic [185]. 
 
2.7. GENE EXPRESSION 
 Upon arrival into the nucleus, exogenous genes must recruit methods to 
express their encoded therapeutic proteins (Figure 2-7).   
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Figure  2-7.  Gene Expression – Subsequent to DNA/vector dissociation in the I) 
cytosol or II) nucleus, released genes must be transcribed and translated into the 
prescribed therapeutic proteins. 
 
Stable, long term expression is generally achieved through transgenic insertion into 
the host genome whereas transient, short term expression results from episomal 
transgene retention.  Attempts to direct genome insertion have primarily relied on 
incorporating DNA transposons within the delivery system.  Transposons are naturally 
occurring DNA sequences capable of enzymatically excising themselves, through the 
activity of a self-encoded transposase component, out of one chromosomal locus and 
re-inserting themselves into another locus [186]  (Figure 2-8a).  By incorporating the 
transposon sequence either on the same plasmid as the transgene or on a separate 
plasmid and co-delivering it with the transgenic plasmid, chromosomal insertion may 
be induced resulting in longer transgene expression [187-192]  (Figure 2-8b).  The 
Sleeping Beauty (SB) transposon is the most widely studied system for gene therapy 
applications.  Table 2-5 provides several other transposon systems that are receiving 
increasing attention. 
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Figure  2-8.  Schematic illustration of a) the transposition process – transposons 
partially encode for a transposase component that excises and subsequently ligates the 
transposon into target DNA (Adapted from [193]); b) transposon systems used in gene 
delivery - 1-component systems comprise the transposase and therapeutic gene 
sequences delivered on the same plasmid; 2-component systems comprise a 
transposase-encoding helper plasmid that is co-delivered with the plasmid containing 
the therapeutic gene of interest. (Adapted from [187, 194]) 
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 Table  2-5.  DNA elements used to direct gene expression. 
 
 Ref. 
Transposons  
Sleeping beauty [187, 189, 190, 
195] 
Tol2 [188] 
Piggybac [192] 
Himar 1 [191] 
  
Site – specific elements  
ΦC31 [196, 197] 
Gal4 DNA binding domain [192, 198, 199] 
Zinc finger DNA binding domain [200] 
   
Transcription – regulating promoters  
Mammalian and viral promoters [201] 
  
Stimuli – inducible promoters  
Tetracycline – induced [202] 
Rapamycin – induced [203] 
Hypoxia – induced [204] 
Glucose – starvation [205] 
  
 
An important limitation of transposon-mediated genome integration is the 
random insertion into the host genome that can lead to inadvertent gene disruption and 
consequently unwanted side effects such as disruption of essential or tumor-suppressor 
genes and oncogene activation. Thus targeted, site-specific integration capabilities 
have been explored with the use of integrase enzymes derived from bacteriophages 
(e.g., φC31 integrase) and the creation of engineered hybrid systems comprised of a 
transposable element and a DNA sequence recognition element (e.g. DNA binding 
domain).  Both systems provide a certain degree of site specificity through their ability 
to recognize and dock the transgenic plasmid to a known genome locus after which 
transgene insertion occurs.  However, both systems are not without their respective 
limitations.  A recent study showed that φC31-mediated gene insertion may be 
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 accompanied by small chromosomal deletions thus compromising the fidelity of 
transgenic integration.[206]  In the case of the hybrid systems, the methods involved 
in chimerically fusing a transposable element to a sequence recognition element can 
potentially disrupt the activity of one or both.    Indeed, Wu et al. recently probed such 
concerns by fusing the Gal4 DNA binding domain (DBD) to four different 
transposons, namely SB11 (a hyperactive version of SB), Tol2, piggybac, and Mos1 
[192].  The results from their evaluation in four different mammalian cell lines 
revealed that Gal4 DBD fusion essentially abolished the ability of the SB11- and Tol2-
based systems to mediate chromosomal integration thereby highlighting the potential 
detriments of these molecularly engineered systems [192].   
An additional layer of control currently under investigation is the ability to 
regulate transcription by introducing or withholding a stimulus.  Efforts in this 
direction have primarily focused on including stimuli-responsive promoter sequences 
upstream of the therapeutic gene sequence.  Both chemical and physical stimuli have 
been explored and are listed in Table 2-5. 
 
2.8. DNA/VECTOR DISSOCIATION 
 It has been posited that DNA dissociation from its vector is necessary in order 
for efficient gene expression to occur [207, 208].  Moreover, expression can be further 
enhanced if dissociation occurs within the nucleus so as to minimize the residence 
time of unprotected DNA within the nuclease-rich cytosol [209]  (Figure 2-7).  
Toward this goal, researchers have devised several strategies to effect the intracellular 
release of DNA, namely by incorporating thermoresponsive properties or 
hydrolytically degradable or reducible linkages within the polymeric vector (Table 2-
6). 
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 Table  2-6.  Strategies used to promote DNA/vector dissociation. 
 
 Ref. 
Thermoresponsive polymers  
Poly(N-isopropylacrylamide) [210-212] 
  
  
  
  
  
  
  
Disulfide bonds [44, 70, 213, 214] 
   
Ester bonds [215-217] 
  
NHO
n
 
2.8.1. Thermoresponsive polymers 
 Recent investigations of thermoresponsive polymers for gene delivery 
applications have attempted to regulate the degree of DNA condensation via 
temperature cues.  This class of polymers undergoes a reversible coil-to-globule phase 
transition in response to changes in temperature [218].  The coil phase is characterized 
by a relaxed, hydrophilic, extended-chain conformation whereas the globule phase 
represents a collapsed, hydrophobic, tightly coiled conformation [218].  The transition 
temperature, above which the globule phase exists and below which the coil phase 
exists, is often referred to as the Lower Critical Solution Temperature (LCST) [218].  
Poly(N-isopropylacrylamide) (NIPAM) is one of the most studied thermoresponsive 
polymers in gene vector design.  Its LCST of 32°C can be increased or decreased by 
copolymerization with hydrophilic or hydrophobic monomers, respectively, thus 
offering a modification method through which other functionalities may be 
incorporated while strategically tuning its thermoresponsive behavior [219].  
 In principle, thermoresponsive polymers with LCSTs below body temperature 
can be used to deliver tightly condensed DNA complexes to cells.  Once inside the 
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 cells, an externally applied temperature reduction to below the LCST induces the 
relaxed, extended-chain conformation to result in DNA release [211, 219] (Figure 2-9).   
 
 
 
Figure  2-9.  Schematic illustration of thermoresponsive polymers as gene vectors.  
Polymers with a lower critical solution temperature (LCST) below body temperature 
assume a collapsed conformation at T>LCST to form tightly condensed polyplexes, 
which promotes cellular uptake.  Upon reducing the temperature to T<LCST (e.g., 
from an externally applied source), the polymer assumes a relaxed, linear 
conformation to enable DNA/vector dissociation. 
 
Indeed, several groups have demonstrated the ability to enhance transfection 
efficiency in a temperature-dependent manner with the use of NIPAM-based vectors 
[210-212].  However, the evidence provided thus far has only indicated a modest level 
of transfection enhancement.   The extent to which thermoresponsive polymers can 
enhance transfection will depend on optimizing several important parameters 
including the time and temperature protocol for effective intracellular release, the 
balance of other functionalities to complement the thermoresponsive properties (e.g., 
cationic character, hydrophobicity, endosomal escape capabilities), and the LCST 
range to be suitable for in vivo applications.  The use of such polymers for gene 
delivery applications represents a nascent area of research with a potential that 
remains to be seen. 
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 2.8.2. Disulfide bonds 
 An alternative method of effecting DNA release makes use of the redox 
differential between the oxidizing extracellular space and the reducing intracellular 
compartment.  Upon entry into the cytosol, polymers containing disulfide bonds can 
be reduced and cleaved to two thiol groups (-SH) through the action of glutathione, 
one of the most abundant cytosolic peptides in mammalian cells [220].   
 Disulfide-bonds can be incorporated into gene delivery systems in a variety of 
ways.  Cationic ligands can be bound to a polymer backbone via a disulfide linkage to 
afford electrostatically-mediated DNA packaging extracellularly with the intention of 
bond cleavage and subsequent DNA release upon exposure to disulfide-reducing 
agents in the cytosol  [70, 221, 222] (Figure 2-10a).  Alternatively, thiol-containing 
pendent groups can be attached to linear polycations such that DNA packaging results 
from both electrostatic interaction with cationic ligands and encagement as thiol 
groups crosslink with other thiol-containing chains [223]  (Figure 2-10b).  Disulfide 
bonds can also be introduced along the backbone of a polymer, for instance, by 
integrating cysteine residues within the polymer chain [44, 213] (Figure 2-10c).  In 
this system, reduction of the backbone to its smaller molecular weight components 
aims to promote not only DNA release, but reduced cytotoxicity that is typically 
associated with lower MW polymers [44, 213, 214, 224]. 
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Figure  2-10.  Schematic illustration of disulfide bonds incorporated into polymer 
vectors to afford DNA/vector dissociation upon exposure to a reducing environment 
(e.g., cytosol).  Methods include a) binding cationic ligands to the polymer backbone 
via disulfide linkages; b) conjugating thiol-containing pendant groups to linear 
polycations that can crosslink with other thiol-containing chains; and c) introducing 
disulfide bonds along the polymer backbone. 
 
 It is important to consider, however, the presence of other disulfide reducing 
agents extracellularly and within other intracellular compartments (e.g., endosome, 
lysosome) that can result in premature release of disulfide-bound ligands [220].  
Regardless, the inherent reversibility of disulfide linkages and their relative stability in 
plasma have provided an attractive tool for conjugating a variety of ligands (e.g., 
targeting, endosomal release peptides, CPPs) that need to be released in the cytosol. 
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 2.8.3. Ester bonds 
 Hydrolytically-sensitive ester bonds can also be used to bring about DNA 
release in a temporally controlled manner.  Like disulfide bonds, ester bonds have 
been used as labile crosslinkers for higher ordered structures (e.g., branched, network), 
as linkages for cationic pendent groups to a polymer backbone, as well as along the 
backbone (e.g., biodegradable nano- and microspheres) so as to afford low MW 
degraded by-products [78, 215-217, 225].   In contrast to their disulfide counterparts, 
water molecules are the cleaving agents and as such, hydrolysis can occur upon first 
exposure to physiological environments.  Several studies have explored the parameters 
(e.g., MW, crosslinking density, cationic charge density) that potentially mediate 
degradation kinetics and thus DNA release; however the structural and chemical 
requirements for the controlled and sustained release have yet to be fully defined [78, 
226]. 
 
2.8.4. Charge reduction or modification 
 A more passive approach for effecting DNA release has been pursued by either 
reducing or modifying the cationic charge of the vector such that polymer/DNA 
interactions are weakened and DNA can dissociate more readily in the presence of 
anionic biological macromolecules (e.g., mRNA, heparin, proteoglycans).  Erbacher et 
al. and Gabrielson et al. partially substituted the cationic primary amines of PLL and 
PEI with gluconyl and acetyl groups, respectively, in order to reduce the cationic 
charge [227, 228]. Kimura et al. evaluated the effects of both reducing and modifying 
the cationic charge by chemically modifying poly(lysine) with hydroxyl and 
quarternary ammonium groups, respectively [229]  (Figure 2-11).  All three groups 
demonstrated the ability of charge reduction and/or modification to weaken the 
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 DNA/polymer interaction and attribute the resultant enhancement in transfection, at 
least partially, to the easier dissociation of DNA from its vector. 
 
 
 
 
Figure  2-11.  Structures of poly(L-lysine) (PLL) derivatives prepared by Kimura et al. 
to evaluate the effects of charge reduction and/or modification on DNA/vector 
dissociation behavior [229]. 
 
2.9. BIOCOMPATABILITY 
 One of the biggest challenges facing synthetic gene delivery systems, second 
to subtherapeutic transfection efficiencies, is the issue of biocompatibility.  The 
current biocompatibility design criteria for gene delivery systems require both 
systemic stability within the bloodstream as well as minimal induction of toxic effects 
at the cellular level. 
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 2.9.1. Systemic stability in the bloodstream 
 The clinical viability of any gene delivery system requires the unimpeded 
systemic delivery through the bloodstream and oftentimes to disseminated regions of 
the body.  It has been shown that cationic polyplexes can 1) interact with blood 
components (e.g., serum proteins, blood cells) to form large, aggregated, embolytic 
entities; 2) aggregate with other individual polyplexes due to exposure in varying 
physiological salt conditions; 3) activate the complement system; or 4)  become 
recognized and cleared by the reticuloendothelial system [230, 231]. The induction of 
any one of these events can lead to premature elimination of the polyplex preventing 
delivery of the genetic cargo to its final destination [230, 231]. By designing for 
sufficient serum stability to account for these clearance mechanisms, polyplexes may 
experience extended circulation times, in turn improving the chance for extravasation 
into the targeted tissue and increasing the opportunity for polyplex-cell interactions.
 The incorporation of poly(N-(2-hydroxypropyl)methacrylamide) (pHPMA), 
poly(ethylene glycol) (PEG), and various oligosaccharides into vector designs 
represents the most widely used strategy for improving stability within the 
bloodstream (Table 2-7).  By virtue of their hydrophilic, non-ionic nature, these 
materials have been shown to increase polyplex solubility and reduce the interactions 
between individual polyplexes as well as with serum components resulting in 
prolonged circulation times [232, 233]. 
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 Table  2-7.  Ligands used to stabilize polyplexes in bloodstream. 
 
 Ref. 
Non – ionic hydrophilic polymers [234-236] 
Poly(ethylene glycol) (PEG)  
  
  
  
Poly(N-(2-hydroxypropyl)methacrylamide) 
(pHPMA) [61, 237] 
  
  
  
  
  
  
  
Oligosaccharides  
Alginate [238] 
Dextran [239-241] 
Hyaluronic acid [242] 
Trehalose [243] 
Cyclodextrin [54] 
  
O n
O
NH
HO
n
 
 PEG and pHPMA are thought to stabilize the polyplex by creating a 
hydrophilic shell that effectively masks its serum-destabilizing properties (e.g., ionic, 
hydrophobic residues).  It is becoming clear that in order for the hydrophilic shell to 
provide steric stability (i.e., prevention of serum-induced aggregation) without 
compromising transfection efficiency, it must also provide lateral stability (i.e., it must 
not contribute to or allow disruption of the electrostatic interaction between the 
polycation and DNA) [244].  It has been shown that PEG or pHPMA moieties, when 
grafted to or copolymerized with the polycation, can indeed stabilize the polyplex in a 
serum-rich environment; yet, at the same time, it may interfere with DNA 
complexation resulting in poorly condensed polyplexes and reduced transfection 
efficiencies [239, 245]. To alleviate this problem, several methods of PEG or pHPMA 
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 incorporation have been developed to create an effective hydrophilic coat that 1) does 
not interfere with DNA/polycation complexation; 2) protects against penetration from 
competing anionic biomolecules that can disrupt polymer/DNA interaction; and 3) 
surrounds the polyplex to provide steric stability.  These methods include coating the 
surface of preformed polyplexes with monovalent or multivalent PEG or pHPMA 
chains that can bind to amino groups extending from the polyplex [233, 246-248] 
(Figurea 2-12a and 2-12b).  Multivalent chains have the ability to cooperatively bind 
with multiple amino groups per hydrophilic chain forming a covalently crosslinked 
coating that offers both steric and lateral stability [246-248] (Figure 2-12b).  
 Additional gene transfer-enhancing functionalities (e.g., targeting) can also be 
incorporated with heterobifunctional PEG or multivalent HPMA chains that bind to 
extended amino groups of the polyplex at one reactive site and additional functional 
groups at other reactive sites along the same chain [87, 94, 95, 234] (Figure 2-12c).  
Alternatively, serum-stabilizing chains can be bound to the vector via degradable 
bonds (e.g., acid-labile hydrazone or acetal bonds, reducible disulfide bonds) that can 
be cleaved upon exposure to the appropriate intracellular environment thereby 
shedding the hydrophilic coating to reveal its underlying  functionalities (e.g., 
endosomal escape) [61, 249, 250] (Figure 2-12d).  
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Figure  2-12.  Schematic illustration of poly(ethylene glycol) (PEG) and poly(N-(2-
hydroxypropyl)methacrylamide) (pHPMA) attachment to polymeric gene delivery 
systems to improve polyplex stability in the bloodstream.  Methods include a) coating 
preformed polyplexes with monovalent PEG/pHPMA chains; b) coating preformed 
polyplexes with multivalent PEG/pHPMA chains to form a crosslinked hydrophilic 
shell; c) coating preformed polyplexes with heterobifunctional PEG or multivalent 
pHPMA chains that can attach additional functional groups at remaining reactive sites; 
and d) binding PEG/pHPMA chains via disulfide bonds to effect subsequent cytosolic 
release of the hydrophilic coat.   
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  Due to their inherent solubility, biocompatibility, biodegradability, and 
potential targeting capacity, oligosaccharides have also been considered as an 
attractive alternative to synthetic stabilizers.  Table 2-7 lists a few such compounds 
that have been employed in a serum-stabilizing capacity.  Of the oligosaccharides 
shown, cyclodextrin (CD) is distinct in its ability to accommodate hydrophobic 
molecules within the hydrophobic interior of its cup-shaped structure while remaining 
readily soluble by virtue of the hydrophilic shell that surrounds its exterior.  As a 
result of its functional flexibility, CDs have been incorporated in gene vector designs 
in various creative capacities [251, 252]. 
 The aforementioned serum-stabilizing agents have all demonstrated the ability 
for hydrophilic, non-ionic polymers to reduce polyplex aggregation, increase solubility, 
reduce surface charge, and prolong circulation in the bloodstream.  The extent to 
which these hydrophilic moieties are able to stabilize the polyplex, however, is 
dependent on a number of factors including the chain length of the hydrophilic moiety 
or the polycation vector, polycation type, grafting density, and identity and density of 
co-functionalized ligands and should be appropriately considered for the specific gene 
delivery application [253, 254]. 
 
2.9.2. Cytotoxicity 
 For gene therapy to be successful, the cells that are targeted must remain viable 
to sustain transcription and translation to the prescribed proteins.   In this regard, the 
cytotoxic effects of both the polyplex and the free vector, derived from any 
uncomplexed vector remaining after polyplex formation or upon intracellular release 
of the DNA, must be considered [255, 256].  Although the mechanisms that govern the 
cytotoxic effects of certain polyplex and vector properties remain uncertain, the 
prevailing hypothesis suggests that cytotoxicity is mediated by ionic interactions 
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 between anionic domains on the cell surface and cationic moieties present on the 
vector [257].  The ionic interaction is thought to result in polyplex aggregation and 
accumulation at the cell surface which can severely impair membrane function and 
ultimately lead to cell death [258].  Moreover, structural parameters that might 
promote such interactions can further exacerbate the cytotoxic effect.  Such 
parameters include the following vector and polyplex properties - MW, structure (e.g., 
linear, branched), degree of branching, cationic charge density, type of cationic 
functionality, polyplex size, polyplex surface charge, three-dimensional conformation, 
and polyplex flexibility [259-261].  
 Of these properties, MW has been shown in numerous studies to be directly 
proportional to both cell toxicity and transfection efficiency.  This apparent dichotomy 
poses a challenge to gene vector design, since low cytotoxicity and high transfection 
efficiency are two fundamental design criteria for all gene delivery systems, and has 
inspired investigators to seek creative approaches to overcome the challenge.  Most of 
the strategies employed have attempted to exploit both the low cytotoxic effects 
typically correlated with lower MW (≤ 2 kDa) vectors and the enhanced transfection 
efficiencies typically associated with high MW (≥ 25 kDa) vectors.  Such efforts 
coincide with the strategies used to facilitate DNA release where low MW polymers 
are crosslinked or linearly linked together by degradable linkages (e.g., disulfide 
bonds, ester bonds) to form a high MW polymer that can eventually degrade to its 
lower MW components [78, 213, 214, 262-265].  These lower MW components can 
then be cleared either via renal elimination for MWs less than 30 kDa (e.g., 1.8 kDa 
PEI) or through natural metabolic pathways for low MW polymers that are 
endogenous metabolites (e.g., poly(4-hydroxyl-L-proline ester)) [78, 79, 142]. 
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 2.10. STRUCTURAL AND PROCESSING CONSIDERATIONS 
 The synthetic versatility that is afforded by polymer chemistry has enabled the 
creation of a diverse array of polymers ranging in size, architecture, and chemical 
composition.  Polymers spanning in MW from 102 to 106 Da in a linear, branched, 
crosslinked, or dendritic structure with various physicochemical properties have been 
developed as potential gene vector candidates.  In contrast to the chemical entities that 
have been developed to fulfill specific vector criteria (e.g., pHPMA for serum stability, 
polycations for DNA packaging), the role that structural features (e.g., MW, 
architecture, side chain distribution) play in gene transfer is less straightforward.  They 
appear to play a more supporting role that act synergistically with chemical entities to 
modulate their gene transfer functionality.   
 Numerous studies have shown that structural features such as MW, 
architecture, side chain termini composition, side chain density, and side chain length 
can greatly influence the transfection potential of a gene vector [43, 266-269].  Even 
minor structural differences such as the stereochemistry of a single side chain group 
can significantly affect transfection [270, 271].   
 Adding to the growing list of chemical and structural properties that impact 
transfection are the experimental conditions under which polyplexes are formulated 
and evaluated.  Parameters such as polymer compound purity, the ionic environment 
in which polyplexes are formed, the presence of free polycations in solution during 
transfection, DNA concentration, N:P ratio, cell seeding densities, and incubation 
times can affect a vector’s ability to successfully mediate gene delivery [30, 39, 255, 
256, 272]. 
 These parameters, from chemical properties to structural dimensions to 
experimental parameters, have been highlighted to serve as points of consideration in 
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 both the design of safe and efficient vectors as well as the interpretation of transfection 
results. 
 
2.11. CHALLENGES AND FUTURE DIRECTION 
 Although research has produced a robust arsenal of polymer tools and design 
strategies to date, the challenge still remains in creatively integrating the different 
functionalities into a single multifaceted vector.  Several strategies have emerged to 
offer new and interesting perspectives on meeting this challenge.  One approach seeks 
to develop alternative gene delivery platforms through the use of higher ordered 
macromolecular structures such as interlocked, multi-component supramolecules or 2-
D and 3-D scaffolds.  Another approach seeks to enhance existing vector platforms 
(i.e., covalent functionalization of polymer chains) by adopting combinatorial 
strategies and high throughput technology as a way to systematically evaluate the vast 
parameter space of vector design and accelerate vector discovery. 
 Gene delivery research will also see the development of more sophisticated 
analytical methods to quantify the various aspects of gene delivery.  Methods that can 
more accurately characterize the physicochemical characteristics of multifaceted 
vectors, evalulate the specific delivery-enhancing effects of various physicochemical 
vector features, and quantify the behavior of polyplexes within the cellular 
environment will offer researchers invaluable tools for probing the mechanisms that 
govern gene transfer.   
 Another important area of gene delivery research is the continued effort toward 
resolving the biological landscape through which gene delivery systems must traverse.  
Several groups have recently identified the involvement of previously unsuspected 
intracellular entities and pathways in gene delivery, underscoring the complexity of 
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 the cellular environment that still remains obscure.  Resolving the biological landscape 
and its implication in gene delivery will be critical toward improving vector designs. 
 
2.11.1. Multi – component supramolecules 
2.11.1.1. Polyrotaxanes 
 Polyrotaxanes are a specialized class of supramolecular structures composed of 
one or more ring-like molecules that are non-covalently threaded over a linear 
polymer chain with bulky end groups capping each chain termini to prevent 
dethreading of the ring molecules [273].  Recently, Ooya et al. demonstrated the 
utility of such polymers in gene delivery applications by threading cationically-
rendered α-cyclodextrin (α-CD) molecules over a PEG chain (Mn=4 kDa) and capping 
both ends with benzyloxycarbonyl tyrosine groups via disulfide bonds [251]  (Figure 
2-13).   
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Figure  2-13.  a) Schematic representation of biocleavable polyrotaxane-based vector 
designed by Ooya et al.  Polyrotaxanes are composed of one or more ring-like 
molecules that are non-covalently threaded over a linear polymer chain.  Bulky end 
groups cap each chain termini to prevent dethreading of the ring molecules.  b) DNA 
can be condensed to <200 nm polyplexes and subsequently released upon disulfide 
bond cleavage (Adapted from [251]). 
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  The assemblage of dimethylaminoethyl (DMAE)-modified α-CDs imparted 
upon each polyrotaxane unit a cationic charge capable of condensing DNA to <200 
nm-sized polyplexes and neutralizing its negative charge at N:P ratios of 0.5.  The 
DMAE functional groups also appeared to mediate endo-lysosomal escape by acting 
presumably in a buffering capacity resulting in greater nuclear accumulation of the 
liberated polyplexes compared to PEI-based polyplexes.  Moreover, disulfide bond 
cleavage facilitated both the release of DNA in the presence of competing polyanions 
and the breakdown of the supramolecular vector to its non-toxic, lower MW 
components as evidenced by the >90% cell viability at N:P ratios up to 10.   
 In comparison to linear PEI (22 kDa), a commercially available polymer often 
considered to be the gold standard for polymer-based vectors, polyplexes formed at an 
N:P of 0.5 were unable to form tightly packed polyplexes and possessed a negatively 
charged surface.  At higher N:P ratios, where PEI was able to form tightly condensed 
polyplexes with DNA, transfection efficiencies and cell viability profiles were 
comparable for both polyrotaxane-and PEI-based polyplexes at N:P=2.  As N:P ratios 
were increased to 5 and 10, however, polyrotaxane-mediated transfection efficiencies 
remained the same with no apparent reduction in cell viability; whereas, PEI-based 
polyplexes mediated greater transfection efficiencies, but with an accompanying 
increase in cytotoxicity.  These preliminary data suggest such multi-functional 
supramolecules to be viable gene delivery platforms and warrants further investigation 
to optimize their transfection potential.  Indeed, there have been several polymers 
relevant to gene delivery systems that have already been incorporated into 
polyrotaxane structures including PEI, PLL, polyesters, and poly(lactic acids) [274].  
Of the handful of ring-like molecules explored to date, CDs have been the most 
extensively studied and lend themselves readily to polyrotaxane-based gene delivery 
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 systems based on the substantial precedents within the literature of their utility in 
vector design [54, 275-277]. 
 
2.11.1.2. Substrate-mediated delivery 
 The past several years have seen a steady growth in interest in releasing naked 
DNA or polyplexes from surface-erodible substrates or biodegradable 2-D and 3-D 
scaffolds.  Such substrate-mediated delivery typically requires implantation of the 
DNA-loaded substrate or scaffold proximate to target cells as a means of overcoming 
serum instability and clearance from the bloodstream that is often associated with in 
vivo systemic injection [278].  Localized substrate placement exposes targeted cell 
populations to a microenvironment with higher transgene concentrations compared to 
a systemically delivered bolus injection, which can become diluted upon circulation.  
As a result, gene delivery via implantable substrates requires less DNA or polyplex 
loading,  and therefore a lower risk of cytotoxic side effects, to achieve comparable 
transfection levels as systemic delivery [279].  Moreover, DNA or polyplex release 
profiles can be regulated by the degradation kinetics of the engineered systems to 
afford a controlled and sustained release rate and ultimately prolonged gene 
expression. 
 
2.11.1.3. DNA – eluting films 
 Substrate-mediated gene delivery has seen significant progress recently with 
the development of layer-by-layer (LBL) film deposition technology.  LBL fabrication 
entails the alternating, stepwise adsorption of multivalent layers to produce finely 
structured, dimensionally controlled, self-organized films that conform readily to 
topologically complex surfaces, in a variety of patterns, and for a range of materials 
(e.g., polymers, metals) [280-282].  Owing to its ease and versatility, LBL methods 
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 have been used to fabricate submicron-thick polyelectrolyte films loaded with DNA 
onto planar substrates that can mediate gene transfer to an overlaid monolayer of 
cultured cells [283-285]. 
 Recently Jessel et al. demonstrated the ability to further control the sequence 
of release of multiple DNA constructs to three different model cell types [286].  By 
embedding two distinct DNA constructs at different levels within a poly(L-lysine) 
(PLL) and poly(L-glutamic acid) (PGA) multilayered film, they showed that the onset 
of protein expression was dependent upon the depth at which the DNA was embedded 
within the film.  Furthermore, they showed that transfection required the assistance of 
a cationic chaperone (pyridyl-β-cyclodextrin) and speculated that enzymatic 
degradation of the PLL and PGA matrix, as opposed to the passive diffusion of DNA 
out of the matrix, was likely the mechanism by which cells obtained access to the 
embedded DNA.   
 In another study, Jewell et al. demonstrated the conformability of LBL-
fabricated films to complex surface topologies by depositing a homogenous, 120 nm 
thick, physically robust multilayered film on stainless steel intravascular stents [281].  
The film, composed of a hydrolytically degradable polyamine interdigitated with DNA, 
was able to erode in an aqueous environment to effect the release of the embedded 
DNA and transfect cells in serum-containing media.  Furthermore, the integrity of the 
film remained largely intact upon exposing the coated stent to mechanical stresses 
representative of those experienced during stent delivery and deployment. 
 
2.11.1.4.  2 – D and 3 – D scaffolds 
 Another form of substrate-mediated delivery seeds or adsorbs naked DNA or 
polyplexes within or onto the surface of porous, biodegradable matrices that 
encourage both cell ingrowth within the scaffold and temporally controlled release of 
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 the embedded DNA or polyplexes.  Such systems have been used primarily in tissue 
engineering applications where the scaffold serves as both a physical support for cell 
adhesion and subsequent tissue formation as well as a depot from which naked or 
condensed DNA are eluted.  The majority of scaffolds that serve in this capacity are 
fabricated from synthetic polyesters such as poly(lactide-co-glycolide) (PLGA) and 
poly(lactic acid) or natural polymers such as collagen, hyaluronan, and alginate.   
 DNA-loaded scaffolds can be constructed from nanofibers interlocked together 
to form a mesh-like network that mimics the natural fibrillar architecture of the 
extracellular matrix.  Using specialized polymer processing techniques (e.g., 
electrospinning, interfacial complexation fiber drawing), several groups have 
demonstrated the ability to incorporate DNA or polyplexes into the structural unit of 
each fiber without compromising the transfection competence of the impregnated 
DNA upon release from the fibers [287-289].  Such scaffolds have been shown to 
support cell adhesion and growth while eluting DNA or polyplexes to adhered cells for 
up to three weeks. 
 Scaffolds can also be fabricated into porous, sponge-like plugs that provide the 
same tissue-inductive guidance as fibrous scaffolds.  DNA and polyplexes have been 
incorporated into such scaffolds through a variety of techniques including non-specific 
surface adsorption, specific surface interactions (e.g., biotin-avidin interaction), 
covalent attachment, and encapsulation within the matrix [279, 290-292].  Mooney 
and co-workers and Shea and co-workers have demonstrated the in vivo efficacy of 
such 3-D matrices to sustain DNA or polyplex release on the order of months to cells 
located within and around the implanted scaffold [291, 293, 294].  Interestingly, 
Mooney and co-workers showed that polyplexes incorporated into PLGA scaffolds 
afforded longer and greater levels of gene expression compared to both bolus injection 
of polyplexes and scaffolds embedded with uncondensed DNA.  These comparisons 
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 underscore the systemic advantage of localized, implant-mediated delivery as well as 
the benefits of DNA condensation, presumably for overcoming intracellular barriers, 
to result in greater transfection efficiencies [291].   
 Efforts to further guide the spatial delivery of DNA have included orienting the 
adhesion of and subsequent delivery to cells along topographical features that are 
patterned into the scaffold [292].  The opportunity for even finer spatial resolution and 
architectural complexity may be achieved with nanofabrication techniques, an 
application that could make significant contributions to substrate-mediated gene 
delivery. 
 
2.11.2. Combinatorial strategies 
2.11.2.1. Combinatorial libraries and high throughput screening 
 Optimal transfection hinges upon a critical balance between the various 
structural and chemical properties endowed upon a vector.  Properties designed to 
overcome one barrier can directly hinder the ability to overcome other barriers.  For 
example, polyplexes with a positive surface charge may interact favorably with cell 
surface proteoglycans while excess positive charge may result in serum instability or 
cytotoxicity.  Moreover, some features require a minimum threshold be met to exert 
their intended transfection functionality.  For instance, it has been shown that certain 
sugars used as targeting moieties may require a minimum number of sugar residues 
represented on the polyplex to achieve sufficient avidity with their cell surface lectin 
to induce binding and subsequent uptake [178].  Unfortunately, rationally designing 
synthetic vectors with optimally balanced physicochemical properties remains 
extremely difficult since the biological barriers that must be overcome are still 
mechanistically ill-defined.  
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 Within the last decade, combinatorial chemistry has emerged as a promising, 
complementary tool to overcome the challenges that limit the rational design of 
polymeric vectors.  In principle, combinatorial chemistry entails the parallel synthesis 
of compounds that share common properties (e.g., molecular backbone, molecular 
weight) in addition to other structural features (e.g., functional groups) that are 
incrementally varied over an appropriate and relevant range [295].  The incremental 
variation of features offers a systematic approach to ascertain the critical balance 
required between different physicochemical properties.  Upon screening each 
compound, one can identify both hits - specific compounds that possess desirable 
properties - and trends that demonstrate how an incrementally varied feature affects 
the measured output.  In the context of polymeric vector design, hits are desired 
because they identify polymers that possess the desired biophysical and chemical 
properties (e.g., high transfection efficiency, low cytotoxicity).  Equally important are 
the trends that are observed between polymers that share an incrementally varied 
feature.  These trends may provide information about the functional effects of a 
particular structural feature (i.e., structure-function relationship) and ultimately shed 
light on the underlying biochemical and physical landscape and mechanisms that 
govern these structure-function relationships and, in turn, gene transfer [295].   
  Combinatorial libraries that span a large and diverse property range enable 
exploration of a broad chemical and structural parameter space.  Furthermore, the 
information gleaned from screening these libraries can guide subsequent syntheses of 
more focused libraries allowing investigators to probe the depth of this parameter 
space for a more optimized vector design.    
 Anderson et al. recently demonstrated the feasibility of such an approach in 
vector design by employing automated fluid-handling systems to facilitate the one-
step synthesis and cell-based screening of over two thousand unique gene vector 
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 candidates [296]. The synthesis of all pairwise combinations of 94 amino monomers 
and 25 diacrylate monomers at an equimolar ratio yielded 2,350 compositionally 
unique yet related polymers.  Subsequent screening of each compound revealed 46 hits, 
that is, polymers with greater transfection efficiencies than the control vector, PEI.  
Additionally, the authors were able to identify common features with possible 
transfection-enhancing effects amongst the top performing polymers, namely a 
hydrophobic component, mono- or dialcohol side groups, and linear, bis(secondary 
amines). 
 With these results, the authors subsequently created a more focused library of 
polymers, using 18 of the amino and 12 of the acrylate monomers from the initial 
library [67].  To optimize vector design, amino to acrylate monomer ratios were varied 
(from 0.6-1.4) for each pairwise combination as a way to introduce two additional 
features to the combinatorial library - 1) chain end group composition (amine or 
acrylate) and 2) MW (1000 to 61,000 Da) [297].  To probe the underlying structure-
function relationships, all polymers were initially screened for transfection efficiency 
at various N:P ratios and top performing polymers were subsequently evaluated for 
particle size and surface charge to explore their roles in gene transfer.  The results of 
this second-generation study identified a different set of polymers that brought about 
greater transfection efficiencies than the top performing polymers from the initial 
library.  The three most effective polymers contained hydrophobic and alcohol groups 
thus confirming the compositional trends observed previously.  These polymers were 
also all greater than 10 kDa in MW and able to condense DNA into polyplexes of less 
than 100 nm in diameter with a surface charge greater than 10 mV.  Interestingly, as 
the amine to acrylate monomer ratio was increased, maximum transfection efficiency 
occurred at intermediate ratios.  This result further highlights the benefits of utilizing 
combinatorial approaches to probe the effects of incremental variations in vector 
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 properties in order to discover polymers that possess an optimal balance in their 
physicochemical properties.  Attempts have been made to further optimize vector 
performance, based on monomers from the second-generation library, by adding cell 
targeting sequences and disulfide linkages to promote cytosolic DNA release and have 
recently been reported [70].   
 The benefits of combinatorial strategies cannot be fully realized unless the 
technical hurdles associated with high volume compound synthesis, characterization, 
and screening are sufficiently resolved: synthetic schemes should ideally be simple 
with a minimal number of steps required from chemical reaction to compound 
purification and isolation; characterization techniques must be accurate to derive true 
structure-function relationships; and screening assays should be amenable for rapid 
and high throughput platforms to facilitate evaluation of extensive libraries of 
compounds. 
 
2.11.2.2. Computational methods 
 Recent advances in high throughput technology have made possible the ability 
to rapidly polymerize, characterize (e.g., gel permeation chromatography, MALDI-
TOF mass spectrometry) and screen (e.g., transfection assay) libraries of compounds 
using high-speed instrumentation and automated fluid-handling systems [296, 298].  
Additionally, computational modeling techniques can be used to facilitate library 
design and compound discovery.  This idea is predicated on the notion that 
computational methods can be used to model and predict the biological response of 
each compound in a combinatorial library thereby abrogating the need to exhaustively 
synthesize and evaluate every compound.  
 Smith et al. demonstrated this concept by using an artificial neural network 
(ANN) model to predict the extent to which individual polymers, each belonging to a 
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 combinatorial library of related biomaterials, promote fibrinogen adsorption [299, 
300].  The model was configured based on the fibrinogen adsorption data of a pre-
existing combinatorial library of 112 polymeric biomaterials [295].  A randomly 
selected half of the experimental data set was used to “train” the ANN model.  The 
remaining half of the data set was used to validate its prediction accuracy by 
comparing the experimentally-determined versus predicted values.   A critical 
aspect of model development is the identification of common polymer parameters that 
can accurately represent the extent to which each polymer can support fibrinogen 
adsorption.  These molecular descriptors (MD), as they are called, may be 
experimentally measured (e.g. glass transition temperature, air-water contact angle) or 
mathematically derived (e.g., log of the octanol/water partition coefficient, total 
flexibility index).  Each polymer is quantitatively represented by a set of such MDs to 
be used as input variables into the ANN model for adsorption prediction.  Smith et al. 
identified three out of 106 MDs that were computationally determined to be the most 
highly correlative with fibrinogen adsorption – glass transition temperature, number of 
hydrogen atoms in the molecule, and log of the octanol/water partition coefficient 
calculated from a linear atom type model.  
 The results from their study demonstrated the ability of their semi-empirical 
model to predict 70% of the data to within experimental error, which the authors 
propose to be a sufficient level of accuracy for materials evaluation [299, 300].  The 
model was also able to distinguish between the highest and lowest fibrinogen 
adsorbing polymers which, upon closer analysis, identified distinct structural 
differences between the two as well as exclusive similarities within each group.  
Moreover, sorting out each compound based on the degree of fibrinogen adsorption 
can then be used to guide the actual laboratory synthesis of only the most promising 
candidate polymers. Interestingly, the outcome of their study bears striking 
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 resemblance to Anderson et al.’s results with one salient difference being the time and 
cost savings associated with virtual synthesis versus actual laboratory synthesis. 
 It is important to consider that the degree to which the model can accurately 
predict the biological response relies heavily on both the quantity and quality of 
molecular descriptors selected to represent each compound.   If the MDs chosen are 
experimentally measured (e.g., glass transition temperature), each compound must still 
be synthesized in order to measure its MD value.  Although costly and arduous in vitro 
assays (e.g., fibrinogen adsorption) can be avoided, a model that can predict the 
biological response of a compound entirely in silico without the need to synthesize it 
may be more desirable.  Therefore, Smith et al. modified their original model so as to 
predict fibrinogen adsorption affinity based solely on mathematically-derived 
structural MDs – molecular density, number of hydrogen atoms in the molecule, and 
log of the octanol/water partition coefficient calculated from a linear atom type model.  
The redesigned model was able to predict adsorption affinity as accurately as their 
original model without the use of experimentally measured MDs [301].    
 To our knowledge, computational models developed to facilitate the design of 
polymeric vector libraries have yet to be reported.  In light of the similarities between 
Smith et al.’s biomaterials library and Anderson et al.’s vector libraries, with regard to 
the polymeric constitution of the combinatorial library, the biological nature of the 
measured output, and the subsequent data analyses, the above-mentioned 
computational approach appears particularly well suited and readily amenable for the 
design and screening of vector libraries.  As combinatorial strategies gain a greater 
presence in vector development, the parameter space in which investigators desire to 
explore will inevitably expand.  Computational modeling will become increasingly 
relevant and perhaps an imperative approach to building, screening, and mining 
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 through vast combinatorial libraries that may otherwise be too large to exhaustively 
explore. 
 
2.11.3. Analytical methods 
 Along with innovative approaches for integrating the diverse collection of 
polymer tools and technologies, the future of gene delivery research rests on the 
continual development of robust analytical methods that can 1) accurately characterize 
the physicochemical characteristics of multifaceted vectors; 2) elucidate the 
mechanisms by which certain physicochemical features facilitate gene transfer; and 3) 
quantify the behavior of polyplexes within the cellular environment in order to gain 
mechanistic understanding of the intracellular barriers and rate-limiting steps that 
impede efficient gene delivery.    The creation of such methods will enable more 
accurate assessments of how polymers mediate gene delivery and in turn, better design 
principles can be established to guide the design of improved gene delivery systems.    
 Hennink and colleagues recently reported a more reliable, aqueous-based, size 
exclusion chromatography (SEC) protocol for determining the absolute molar mass 
and distribution of various polycations commonly employed in gene vector design 
[302].  The protocol was developed to address the limitations associated with sub-
optimized SEC conditions that are typically used to determine such parameters.  
Conditions including an inappropriate ionic strength of the eluent and the anionic 
charge of the column packing can interact unfavorably with polycationic samples 
leading to inaccurate molar mass and distribution characterization.  Such inaccuracies, 
in turn, can result in false structure-function relationships and erroneous conclusions.   
 A number of analytical techniques have also emerged as a result of efforts 
aimed at unraveling the mechanisms by which various structural features enhance the 
ability for a polymer vector to overcome specific barriers of the gene delivery pathway.  
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 One such structure-function relationship that has been extensively probed is the 
putative endo-lysosomal escape functionality of protonatable amino groups present on 
several commonly used polymer vectors (e.g., PEI, poly(β-amino ester), PAMAM) 
[133, 303-305].  The prevailing mechanistic hypothesis behind this relationship, 
referred to as the “proton sponge” effect, asserts that such protonatable groups 
sequester protons upon endosomal acidification resulting in an influx of chloride ions 
to maintain electroneutrality, subsequent osmotic swelling, and finally rupture of the 
endosomal vesicle.  Release of the polyplexes from the endosome prevents trafficking 
to the enzymatically degradative lysosomal compartment thereby increasing the 
chance for nuclear delivery and ultimately greater transfection efficiency [133].  
Although the hypothesis dates back to over a decade ago, evidence supporting it has 
been largely qualitative [37, 134, 306, 307].  Assays developed to validate the 
hypothesis in a more quantitative manner have employed the combined use of pH-
sensitive and pH-insensitive fluorescent probes to double-label either the polymer 
vector or the DNA itself [133, 303-305]. Using flow cytometry to sort and quantify the 
ratio of fluorescence intensities, the local pH environment of the fluorescently-labeled 
entity can be determined and thus intracellular location (e.g., endosome, lysosome, 
cytosol) may be deduced.  Similarly, chlorine ion-sensitive and –insensitive 
fluorescent probes can be used to quantify the concentration of endosomal chloride 
ions and probes conjugated at self-quenching and low concentrations have been shown 
to enable estimations of endosome volume at various time points [308].  Collectively, 
the results from these assays have provided not only quantitative evidence in support 
of the proton sponge hypothesis, but also a set of methods by which the endo-
lysosomal trafficking fate of polymeric vectors can be quantifiably assessed.    
 For the purpose of understanding the interactions that polyplexes potentially 
face as they confront the cellular membrane, Dubruel et al. developed a simple, 
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 quantitative assay using surface plasmon resonance spectroscopy to study the ionic 
interactions between positively charged polyplexes and anionic components of the 
plasma membrane [309].  The authors evaluated hyaluronic acid (HA), a major 
glycosaminoglycan component of membrane-bound proteoglycans (See Section 
2.4.2.1), against PEI- and PDMAEMA-based polyplexes as a model system.  The 
results from their investigation revealed a greater degree of interaction presumably 
between the positive charge carriers of PEI and the anionic carboxyl groups of HA 
compared to those of PDMAEMA and HA.  Moreover, the interaction was intensified 
as the N:P ratio was increased for both types of  polyplexes, providing quantitative 
evidence to support the hypothesis that ionic interactions may facilitate the non-
specific uptake of positively charged polyplexes in a polymer-dependent manner.   
 Considerable effort has also been devoted toward characterizing the global 
intracellular transport dynamics of polyplexes using microscopy techniques adapted 
for monitoring polyplexes within live cells in real time.  Hanes and co-workers 
demonstrated the use of multiple particle tracking to examine the transport rate, mode, 
trajectory, and directionality of individual polyplexes within the intracellular 
environment [177, 310].  Kulkarni et al. employed spatial-temporal image correlation 
spectroscopy, an ensemble-averaged technique used to determine aggregate transport 
behavior, to monitor intracellular polyplex trafficking [176].  Both groups observed a 
saltatory (i.e., stop and go) motion of the internalized polyplexes, which was 
interpreted to be indicative of motor protein-mediated active transport along 
microtubules.  Hanes and colleagues further distinguished transport into three major 
modes: 1) subdiffusive – to characterize polyplexes that are possibly encaged within 
quasi-stationary endosomes or trapped within the molecularly congested cytosolic 
space; 2) diffusive – to describe the cytosolic transport of polyplexes that have either 
escaped from endosomes or remained in endosomes that have detached from 
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 microtubules and begun to diffuse randomly; and 3) active – to describe motor 
protein-driven transport of either the polyplexes themselves or within intracellular 
vesicles (e.g. endosomes).  Additionally, Kulkarni et al. observed a demarcation of 
polyplex transport into two temporal regimes. At short time intervals lasting up to 10 
seconds, polyplexes appeared to be transported in a non-random, directed linear 
fashion with the assistance of motor proteins.  However, at longer time intervals (~60 
seconds), transport appeared to be stochastic and non-directional.   The mechanism 
rationalizing the two temporal regimes attributes non-random transport at short time 
intervals to be the activity of one group of motor proteins propelling the cargo in a 
directed motion.  At longer time intervals, the polyplexes themselves or within 
endosomes may be transferred to a different set of motor proteins or possibly 
redirected along other microtubule tracks resulting in a non-directional, stochastic 
motion.  Only after hours of motion did most of the polyplexes arrive in the 
perinuclear region, standing in stark contrast to the observation by Hanes and co-
workers where they detected ~40% of polyplexes accumulated in the perinuclear 
region within 30 minutes and remaining at ~40% at all time points afterwards. It is 
unclear whether the discrepancy in the kinetics of perinuclear accumulation is due to 
an artifact of the different monitoring techniques employed by each group, difference 
in cell types (COS-7 versus HeLa), N:P ratio (6 versus 5), or some other unknown 
factor.  Nevertheless, both groups have introduced powerful tools for studying the 
complex dynamics of intracellular trafficking and have brought gene delivery research 
one step closer toward quantitatively understanding how synthetic gene vectors are 
transported inside cells.   
 Adopting a different approach, Mitragotri and colleagues recently reported a 
computational framework for exploring the characteristics of intracellular polyplex 
transport phenomena [311].  Using experimentally-determined data, they developed a 
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 detailed mathematical model to simulate the gene delivery pathway.  The model, 
designed to calculate the probability that an internalized polyplex successfully delivers 
DNA to the nucleus, was used to determine and optimize the parameters that most 
greatly influenced delivery efficiency.  The results of their study revealed that the 
spatio-temporal distribution of internalized polyplexes, and hence the systems and 
polyplex parameters that determine their distribution, are critical determinants of 
delivery efficiency.  Further, the optimal values for these parameters are significantly 
influenced by the morphology of the cell, a factor often overlooked in gene delivery 
research.  Cell morphology, described as the circularity of the cell and its size 
(quantified to be the average distance between the plasma and the nuclear membrane), 
was predicted to have almost an order of magnitude effect on delivery efficiency based 
on its influence on the spatio-temporal positioning of internalized polyplexes.  For 
instance, small (i.e., cells with a relatively short average distance between the plasma 
and nuclear membrane), elongated cells have a larger fraction of the cell area nearer to 
the nucleus, providing internalized polyplexes greater access to the nucleus and hence 
higher delivery efficiency compared to larger, more circular cells.  The implications of 
this finding are relevant from both a therapeutic applications and experimental 
standpoint.  With regard to the former, since human cells exist in a broad range of 
morphologies, different vector design strategies may be required to deliver genes to 
flat and elongated cells (e.g., muscle cells) compared to round, stellate cells (e.g., 
dermal fibroblasts).  From an experimental standpoint, because most synthetic gene 
delivery systems are evaluated and optimized in in vitro assays, assumptions that 
performance in vitro will be the same under in vivo conditions may be inaccurate or 
perhaps even invalid.   
 The authors also demonstrated the ability of their model to estimate the extent 
to which the delivery efficiency of synthetic vectors can be improved using PEI/DNA 
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 (25 kDa) as a model polyplex system.  The simulation predicted that optimal 
parametric configurations could afford a 20 to 100-fold increase in delivery efficiency.  
However, even under such conditions, for both in vitro and in vivo simulations, 
maximum efficiency was less than 3%, compared to the typical 10-100% efficiency of 
viral vectors.  The authors posit that the limited efficiency of PEI-based polyplexes is 
primarily due to the inability of such vectors to protect the DNA, after endosomal 
escape, against enzymatic degradation through the cytosol until nuclear entry.  
Efficiency may therefore be enhanced if synthetic vectors could recruit motor proteins 
to direct transport toward the nucleus, similar to their viral counterparts.  Even so, the 
maximum delivery efficiency achieved was still inferior to viral efficiencies, a 
prediction worth considering when assessing the relative merits of viral and non-viral 
vectors. 
 
2.11.4. Resolving the biological landscape 
Research has recently shed light on previously unsuspected intracellular 
entities and pathways and their involvement in vector-mediated gene delivery.  One 
such intracellular organelle is the proteasome, a multicomponent protein complex that 
selectively degrades intracellular proteins that are marked for destruction [312].  Rice 
and co-workers conjectured that these cytosolic complexes may play a role in limiting 
the transfection efficiency of peptide-based gene delivery systems by metabolizing the 
peptide carriers and causing naked DNA to be released into the cytosol where it is 
susceptible to nuclease degradation [313].    Indeed, peptide-mediated gene expression 
was enhanced in the presence of proteasome inhibitors in a dose-dependent manner 
whereas delivery mediated by nonpeptide-based vectors (i.e., PEI, Lipofectamine) was 
not, further substantiating the peptide specificity of proteasome degradation. 
 Two additional intracellular pathways, namely potocytosis and cellular exit, 
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 have also been implicated in having a potentially significant impact on polycation-
based gene delivery [314].  Potocytosis is a cavealoe-mediated uptake mechanism that 
leads to the transport of internalized molecules to various intracellular locations (e.g., 
the cytoplasm, endoplasmic reticulum (ER), other organelles) [315].  Fajac and 
collaborators observed that polyplexes ≤ 100 nm in diameter were internalized 
primarily via potocytosis and subsequently trafficked to the ER after which their fate 
remains unclear.  Further, polyplexes of all sizes were seen exiting the cell, an 
interesting observation considering that the airway epithelial cells used in the 
transfection studies are non-secretory in nature.  Taken together, the potential role in 
gene delivery of the proteasome, potocytosis, and cellular exiting pathways represent 
not only additional hurdles that gene delivery systems must overcome, but perhaps 
more importantly, they represent potential opportunities that can be exploited to 
enhance the transfection capabilities of these systems. 
 
2.12. CONCLUDING REMARKS 
 It is encouraging to recognize the tremendous progress that has been made 
toward developing multifaceted polymeric systems for gene delivery.   From the 
perspective of functional polymers research, a wealth of sophisticated and innovative 
technology has been brought forth.  From the perspective of cell biology, considerable 
insight has been gained into the physical and biochemical intricacies of the cellular 
landscape.  From the perspective of gene therapy, however, polymer-based gene 
delivery systems have yet to achieve a significant presence in a clinical capacity based 
on the small percentage of non-viral vectors currently used in clinical trials [316].  As 
such, the challenge still stands before us to push beyond the boundaries of technology 
and probe deeper for a clearer understanding of the biological and cellular realm until 
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 we arrive at a point where gene therapy is a safe and viable modality for disease 
treatment. 
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 CHAPTER 3 
 
3 SYNTHESIS AND CHARACTERIZATION OF FUNCTIONALIZED 
POLYMERIC GENE VECTORS1  
 
3.1. ABSTRACT 
 Combinatorial polymer libraries have recently gained popularity for the 
development of novel materials for a variety of biomedical applications including non-
viral gene delivery systems and biodegradable polymers for tissue engineering.  To 
streamline the non-trivial task of library synthesis, activated ester homopolymers have 
been used to serve as a backbone to which primary amine-containing functional 
groups (NH2-FGs) can be covalently bound at varying ratios. 
Poly(methacryloxysuccinimide) (poly(MAOS)) is one such homopolymer that was 
previously reported to be an attractive precursor for polymeric drug and gene delivery 
systems.   The reported functionalization protocols entailed conjugating the precursor 
with two equivalents of the NH2-FG at a reaction concentration of 25 mg 
poly(MAOS)/150μL DMSO for either 5 hours at 50 °C or 16 hours at 25 °C.  More 
recently, both protocols were revealed to be associated with ring-opening and 
glutarimide-forming side reactions that compromise the utility of the homopolymer.  
Using 1-dimensional and 2-dimensional NMR spectroscopy techniques, we have 
characterized the side product distributions that result from conjugations performed at 
50 °C/5 hours and 25 °C/16 hours.  Moreover, by systematically altering the 
equivalents of the NH2-FGs, polymer concentration, reaction time, and reaction 
                                                 
1 Reproduced with permission from Wong, S., Putnam, D., Overcoming limiting side reactions 
associated with an NHS-activated precursor of polymethacrylamide-based polymers, Bioconjugate 
Chemistry, 18, 3, 970-982 (2007).  Copyright [2007] American Chemical Society. 
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 temperature, we have established a protocol that overcomes these side reactions.  
Using a final reaction protocol of five equivalents of the NH2-FG at a reaction 
concentration of 25mg poly(MAOS)/600μL DMSO for 24 hours at 75 °C, we have 
obtained functionalized polymers with minimal side products.  This protocol is 
applicable for polymers ranging from 5K to 50K g/mol, compatible with a variety of 
functional groups, and amenable to conjugating combinations of functional groups.   
 
3.2. INTRODUCTION 
 With the ever-increasing demand for more sophisticated, multifaceted 
polymeric materials in various applications, many researchers have begun looking to 
combinatorial approaches to facilitate the materials discovery process.  One of the first 
successful demonstrations of employing combinatorial strategies to develop 
degradable polymers for medical applications was reported almost a decade ago by 
Kohn and coworkers. [1, 2]   Their work exemplified how combinatorial strategies can 
1) offer a systematic approach to designing libraries of compounds that encompass a 
broad range of physicochemical properties and 2) assist in identifying structure-
function relationships that correlate a polymeric structural feature to a biological 
response.    
 Building on this work, Brocchini and coworkers, Haddleton and coworkers, 
and others have applied the combinatorial approach towards developing water-soluble 
polymers for drug and gene delivery systems. [3-9]  To expedite the library synthesis 
process, the former two groups employed the use of the activated homopolymeric 
precursor, poly(methacryloxysuccinimide) (poly(MAOS), 1) to which primary amine-
containing functional groups (NH2-FGs) can be covalently bound via amidation 
chemistry. [10] (Figure 3-1).  
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Figure  3-1.  Theoretical synthetic scheme for functionalizing the N-
hydroxysuccinimide (NHS)-activated precursor, poly(methacryloxysuccinimide) 
(poly(MAOS), 1), to form poly(methacrylamide)-based polymers. 
 
Recently, greater resolution of the potential side reactions that can occur with the 
poly(MAOS) precursor was reported. [11]  In our hands, we also observed similar 
problems upon functionalizing poly(MAOS) that resulted in at least two unexpected 
side reactions: 1) ring opening of the succinimide moiety and 2) glutarimide formation 
between presumably neighboring active esters.  These side products were confirmed 
by 1H NMR, diffusion ordered spectroscopy (DOSY), heteronuclear multi bond 
correlation spectroscopy (HMBC), and homonuclear correlated spectroscopy (COSY) 
analyses (Figure 3-2). 
However, these limitations do not ultimately preclude the use of this polymeric 
precursor as was previously suggested. [11]  In this report, we describe the protocol 
that we have established to overcome these side reactions allowing poly(MAOS) to 
serve as a viable precursor for poly(methacrylamide)-based materials.  Additionally, 
we show that this protocol is applicable for polymers ranging from 5K to 50K g/mol, 
compatible with a variety of functional groups, and amenable to conjugating 
combinations of functional groups. 
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Figure  3-2.  Side reactions can occur during conjugation of NH2-FGs to 1 resulting in 
a functionalized polymer with three pendant groups: 1) the desired amide-bound 
conjugate; 2) a hydrolytically-unstable ring-opened conjugate; and 3) a glutarimide-
bound conjugate. 
 
3.3. EXPERIMENTAL PROCEDURE 
 N-methacryloxysuccinimide monomer was synthesized as previously reported. 
[12]  Cu(I)Br (99.999%), Cu(II)Br2 (99.999%), 2,2’-dipyridyl (≥ 99%), ethyl 2-
bromoisobutyrate (98%), benzylamine (≥ 99.5%), n-butylamine (≥ 99.5%), 
hexylamine (≥ 99.5%), 1-amino-2-propanol (≥ 98%), N-Boc-N-
methylethylenediamine (≥98.0%), N-Boc-ethylenediamine (≥ 98%), N,N-
dimethylethylenediamine (≥ 98%), 2-(aminoethyl)-trimethylammonium chloride – 
HCl (99%), histamine (≥ 97%), anhydrous DMSO, DMSO-d6, DMF-d7 were all 
purchased from Aldrich. 
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 3.3.1. General procedure for synthesis of poly(methacryloxysuccinimide) 
(poly(MAOS) 
 The polymer precursor was synthesized with a slight modification to a 
previously reported method. [5]  A 5 ml pear shaped flask with flea magnetic stir bar 
was fitted with a rubber septum and flame dried while purging with N2(g) until cooled 
to ambient temperature.  N-methacryloxysuccinimide (0.5 g, 2.73 mmol), Cu(I)Br 
(0.0078 g, 0.055 mmol), Cu(II)Br2 (0.0122 g, 0.055 mmol), and 2,2’-dipyridyl (0.0171 
g, 0.11 mmol) were placed in the flask and placed under a nitrogen atmosphere for 10 
minutes.  Cu(II)Br2 was added to the reaction as an inhibitor of chain terminations to 
control polydispersities. [13]  Deoxygenated anhydrous DMSO (0.2 mL) was injected 
into the flask and the contents were stirred until dissolved.  Ethyl-2-bromoisobutyrate 
(81 μl, 0.55 mmol) was weighed directly into a separate dram vial and dissolved in 
deoxygenated anhydrous DMSO (0.5 mL).  Upon complete dissolution of the 
contents, a 1/10 aliquot (50 μL) of the ethyl 2-bromoisobutyrate solution was injected 
into the flask and immersed into a 100 °C thermostated oil bath.  To stop the 
polymerization, the flask was quenched in an ice bath and the product was diluted with 
anhydrous DMSO (1.5 mL).  The final polymer was isolated as a white powder by 
precipitating into stirring acetone. 1H NMR (DMSO-d6) δ: 1.44 (b,3H,CH3), 2.41 
(b,2H,CH2), 2.78 (b,4H,CH2CH2). 
 Molecular weight and polydispersity were determined by hydrolyzing 
poly(MAOS) to its Na-salt.  Upon dissolving poly(MAOS) (0.010 g, 0.055 mmol) in 
DMSO (0.080 mL),  22 μL of 5M NaOH was added dropwise to the reaction and 
allowed to stir for 7 hours at room temperature.  The cloudy solution was redissolved 
with 0.8 mL of filtered deionized water and allowed to stir overnight at room 
temperature.  The reaction was then dialyzed against deionized water using 
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 Spectra/Por regenerated cellulose tubing (MWCO 3500 Da) for 3 days.  The dialysate 
was subsequently lyophilized to give a white feathery powder. 
 
3.3.2. General procedure for functionalized poly(MAOS) 
 Prior to each reaction, a 5 ml pear shaped flask with flea magnetic stir bar was 
fitted with a rubber septum and flame dried while purging with N2(g) until cooled to 
ambient temperature.  Poly(MAOS) (0.025 g, 0.14 mmol) was added to the flask and 
dissolved with deoxygenated anhydrous DMSO (0.6 mL).  Upon dissolution of the 
contents, 5 equivalents of the NH2-FG was dropwise added via a Hamilton syringe and 
immersed in a 75 °C thermostated oil bath.  For the binary conjugations, the first 
amine was dropwise added via a Hamilton syringe followed immediately by dropwise 
addition of the second amine via a separate Hamilton syringe.  The flask was removed 
from the oil bath after 24 hours and the septum removed.  To remove excess solvent, 
the flask mouth was covered with Parafilm, punctured approximately seven times with 
a 21 gauge needle, and placed in vacuo for 4 hours.  The final product was isolated via 
dropwise addition into stirring acetone and filtered through a fine fritted Buchner 
funnel and washed twice with acetone, twice with diethyl ether, and dried overnight in 
vacuo.  N-Boc-protected functionalized polymers were isolated via dropwise addition 
into diethyl ether.  The gummy precipitate was redissolved in methylene chloride and 
reprecipitated into diethyl ether as a white flaky powder.  The powder was filtered 
through a fine fritted Buchner funnel and immediately deprotected with 20 equivalents 
of neat trifluoroacetic acid for 8 minutes.  The final product was isolated via dropwise 
addition into stirring diethyl ether and filtered through a fine fritted Buchner funnel.  
Polymers functionalized with water solubilizing FGs, including all binary 
conjugations, were redissolved in, and dialyzed against, 0.1N HCl in Spectra/Por 
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 regenerated cellulose tubing (MWCO 3500 Da) for 4 days.  The dialysate was 
subsequently lyophilized to give a flaky solid. 
 
3.3.2.1. Characterization 
 Benzylamine-functionalized poly(MAOS): 1H NMR (DMSO-d6) δ: 0.89 
(b,3H,CH3), 1.89 (b,2H,CH2), 7.86 (b,1H,NH), 4.11 (b,2H,CH2), 7.26 (b,5H,C6H5), 
4.68 (b,2H,glutarimide-CH2); butylamine-functionalized poly(MAOS): 1H NMR 
(DMSO-d6) δ: 0.89 (b,3H,CH3), 1.89 (b,2H,CH2), 7.29 (b,1H,NH), 2.93 (b,2H,CH2), 
1.25 (b,4H,CH2CH2), 0.86 (b,3H,CH3); hexylamine-functionalized poly(MAOS): 1H 
NMR (DMSO-d6) δ: 0.89 (b,3H,CH3), 1.89 (b,2H,CH2), 7.29 (b,1H,NH), 2.93 
(b,2H,CH2), 1.24 (b,8H,(CH2)4), 0.86 (b,3H,CH3); ethylenediamine-functionalized 
poly(MAOS): 1H NMR (D2O) δ: 1.14 (b,3H,CH3), 1.84 (b,2H,CH2), 3.43 (b,2H,CH2), 
3.13 (b,2H,CH2); N-methylethylenediamine-functionalized poly(MAOS): 1H NMR 
(D2O) δ: 1.14 (b,3H,CH3), 1.84 (b,2H,CH2), 3.44 (b,2H,CH2), 3.17 (b,2H,CH2), 2.76 
(b,3H,CH3); N,N-dimethylethylenediamine-functionalized poly(MAOS): 1H NMR 
(D2O) δ: 1.14 (b,3H,CH3), 1.84 (b,2H,CH2), 3.52 (b,2H,CH2), 3.28 (b,2H,CH2), 2.94 
(b,6H,CH3CH3), 4.05 (b,2H,glutarimide-CH2); 2-(aminoethyl)-trimethylammonium-
functionalized poly(MAOS): 1H NMR (D2O) δ: 1.14 (b,3H,CH3), 1.84 (b,2H,CH2), 
3.61 (b,2H,CH2), 3.44 (b,2H,CH2), 3.20 (b,6H,(CH3)3), 4.15 (b,2H,glutarimide-CH2); 
1-amino-2-propanol-functionalized poly(MAOS): 1H NMR (D2O) δ: 1.14 (b,3H,CH3), 
1.84 (b,2H,CH2), 3.14 (b,2H,CH2), 3.91 (b,1H,CH), 1.17 (b,3H,CH3); histamine-
functionalized poly(MAOS): 1H NMR (D2O) δ: 1.14 (b,3H,CH3), 1.84 (b,2H,CH2), 
3.43 (b,2H,CH2), 2.93 (b,2H,CH2), 7.29 (b,1H,CH), 8.61 (b,1H,CH), 3.97 
(b,2H,glutarimide-CH2). 
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 3.3.3. Determination of relative percent conjugation 
 For mono-functionalized conjugations, a sample calculation of the relative 
percent conjugation of each pendant group is demonstrated with benzylamine-
conjugated poly(MAOS) as determined from the 1H NMR spectra using the following 
equations: 
100
2
% 68.4 ×= IZ
100
4
% 4.2 ×= IY
ZYX %%100% −−=
 
where Z=glutarimide-bound conjugate, Y=ring-opened conjugate, X=desired amide-
bound conjugate, I4.68 = signal intensity of the two glutarimide methylene protons, and 
I2.4 = signal intensity of the four ring-opened methylene protons.  Iδ = signal intensity 
at δ ppm when I7.26 = 5.0.   
 For binary conjugations, the relative percent conjugation of each functional 
group is demonstrated with the N,N-dimethylethylenediamine(3N)/benzylamine 
conjugation as determined from the 1H NMR spectra using the following equations: 
100
5
1
5
26.7
26.7
×
+
= I
I
% Benzylamine
% 3N = 100 - % Benzylamine
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 where I7.26= peak intensity of the five benzyl protons at 7.26 ppm when I2.94= 6.0.  
I2.94= peak intensity of the six methyl protons of 3N. 
 
3.3.4. Molecular weight characterization 
 Gel permeation chromatography was carried out using Waters Ultrahydrogel 
250 and 500 columns in series coupled to UV (Waters 2487) and RI (Waters 2414) 
detectors.   The mobile phase was phosphate buffered saline (pH=7.4) at a flow rate of 
0.8 mL/min at 30 °C.  Calibration was performed using PMAA-Na standards 
(Polysciences, Inc. and Polymer Standards Service-USA, Inc.) in the range of 1.6 kg 
mol-1 to 110 kg-mol-1. 
 
3.3.5. NMR spectroscopy 
 All NMR analyses were performed with 7 mg of sample dissolved in 1 mL of 
deuterated solvent and all spectra were processed using standard Varian software.  
One-dimensional 1H NMR analyses were performed at room temperature on an Inova 
600 MHz spectrometer with a proton observation frequency of 599.8 MHz.  Chemical 
shifts were referenced relative to tetramethylsilane (0.0 ppm) when possible or the 
residual solvent signal - D2O (4.8 ppm), DMSO-d6 (2.5 ppm) or DMF-d7 (2.75 ppm).  
Spectra were acquired with a 5.6 μs pulse width corresponding to a 45° flip angle, 3 s 
acquisition time, 4.8 kHz spectral width, 16 transients, and a 1 s recycle delay.  An 
exponential multiplication of approximately 0.3 Hz was applied prior to Fourier 
transformation.  
 Proton homonuclear correlated spectroscopy (1H-1H COSY) was performed at 
120 °C on an Inova 500 MHz spectrometer with a proton observation frequency of 
499.9 MHz.  Spectra were obtained using the gCOSY pulse program in the VnmrJ 
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 software with 1,024 (t2) × 512 (t1) data points collected at 2 scans per t1 increment.   
Spectral widths of 6.4 kHz in F2 and F1 were used along with a 0.1608 s acquisition 
time and a 1 s recycle delay time.  Fourier transformation was done on a 2K x 2K data 
matrix with sine bell window function applied to F1 and F2.   
 The long-range 1H–13C correlation spectroscopy (HMBC) was performed at 
room temperature on an Inova 600 MHz spectrometer with a proton frequency of 
599.8 MHz.  Spectra were obtained using the gHMBC pulse program in the VnmrJ 
software with 1,024 (t2) × 400 (t1) data points collected at 28 scans per t1 increment.  
Spectral widths of 7 kHz in F2 and 36.2 kHz in F1 were used along with a 0.1608 s 
acquisition time and a 1 s recycle delay.  Fourier transformation was done on a 1K 
(F2) x 4K (F1) data matrix with Gaussian processing applied to F2 only. 
 
3.3.6. Diffusion – ordered NMR spectroscopy 
 1H detected DOSY experiments were performed at 22 °C on an Inova 600 
MHz spectrometer equipped with a triple resonance probe head capable of producing 
gradients in the z direction with strength of up to 70 G cm-1.  DOSY experiments were 
performed using a bipolar pulse pair double stimulated echo experiment.  The gradient 
strength was logarithmically incremented in 16 steps from 2.3 up to 60 G cm-1.  
Diffusion times and gradient pulse durations were optimized for each experiment in 
order to achieve a 90% decrease in the resonance intensity at the largest gradient 
amplitude.  Diffusion times varied between 600 and 900 ms, and bipolar rectangular 
gradient pulses of 2 ms were employed.  Data was analyzed using the VnmrJ software 
package. 
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 3.4. RESULTS AND DISCUSSION 
 Our initial attempts to conjugate benzylamine to poly(MAOS) following two 
independent protocols resulted in two unexpected side reactions that accompanied the 
desired conjugation: 1) ring opening of the succinimide moiety and 2) glutarimide 
formation between presumably neighboring active esters.  These side reactions were 
thoughtfully characterized and recently reported by Devenish et al. and shown again in 
Figure 3-3 and Figure 3-4 for ease of reference. [11] 
 
 
 
 
Figure  3-3.  Resultant functionalized polymer produced from previously reported 
protocols. Two unexpected side reaction products accompany the desired conjugation: 
1) a labile ring-opened conjugate and 2) a glutarimide-bound conjugate.  (Protocol 1-
Ref 7; Protocol 2-Ref 8). 
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Figure  3-4.  Representative 1H NMR spectra of resultant functionalized polymer 
produced from (a) Protocol 1- 2 equivalents benzylamine, 50 °C, 5 hrs, 25mg 
poly(MAOS)/150μL DMSO and (b) Protocol 2 - 2 equivalents benzylamine, 25 °C, 
16 hrs, 25mg poly(MAOS)/150μL DMSO.  Both spectra provide evidence of a ring-
opened side product (indicated by peaks F, d’, and c’) and glutarimide-bound side 
product (indicated by peak D”).  Peaks labeled in capital letters were used for 
quantification via signal integration of the respective pendant groups.  Note: These 
spectra were obtained during our analysis but are consistent with the results of 
Devenish et al. and are shown here to clarify the method of quantification. 
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  To further verify that the 1H NMR peak corresponding to the methylene 
protons of the ring-opened pendant group (peak F in Figure 3-4) was not just residual 
low molecular weight by-product, we performed DOSY experiments to provide 
evidence of covalent linkage to the backbone. [14]  This pulsed field gradient NMR 
experiment yields a 2D spectrum with NMR chemical shifts on the horizontal axis and 
relative diffusion coefficients on the vertical axis.  DOSY has been used for the 
analysis of polymer mixtures to determine the molecular weight (MW) of individual 
components. [15]  In this paper, DOSY was utilized to confirm that the ring-opened 
side reaction product was diffusing at a similar rate as the polymer and thus covalently 
bound to the polymer as evidenced in Figure 3-5.  Additionally, HMBC experiments 
were performed to identify long-range (2-3 bonds) correlations between protons and 
neighboring carbons.  Figure 3-6 reveals that the ring-opened methylene protons (peak 
f) are correlated to carbonyl carbons (carbons 4 and 5).  Taken together, these data 
provide strong evidence that the ring-opened pendant group is indeed covalently 
bound to the polymer.  
Using signal integration of the 1H NMR spectra (Figure 3-4) to quantify the 
relative degree of conjugation of each pendant group, we observed a marked disparity 
in pendant distribution between the two protocols which essentially differ only by time 
and temperature.  Protocol 1 produces approximately 75% of the desired conjugation 
(x), 20% ring-opened side product (y), and 5% glutarimide-bound conjugate (z).  
Protocol 2 generates conjugations estimated to be about 30%, 70%, and 0%, 
respectively.   
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Figure  3-5.  1H-detected DOSY spectrum of poly(MAOS) functionalized with 
benzylamine following protocol 2 - 2 equivalents benzylamine, 25 °C, 16 hrs, 25mg 
poly(MAOS)/150μL DMSO.  Peak f, corresponding to the methylene protons of the 
ring-opened side product, has a similar diffusion coefficient as the rest of the polymer 
providing evidence that the side reaction product is covalently bound to the polymer. 
Peaks corresponding to low molecular weight solvents are shown to diffuse faster as 
expected.   
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Figure  3-6.  1H-13C HMBC spectrum of poly(MAOS) functionalized with 
benzylamine following protocol 2 - 2 equivalents benzylamine, 25 °C, 16 hrs, 25mg 
poly(MAOS)/150μL DMSO. Peak f, corresponding to the ring-opened side product, is 
shown to correlate with carbonyl carbons thus providing further evidence of the 
presence and identity of the ring-opened side product (Correlations f/4 and f/5).  Peaks 
labeled with letters correspond to protons and numbers correspond to carbons.  (* = 
excess benzylamine) 
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 Incidentally, the benzylamine-conjugated polymer synthesized by Monge and 
Haddleton employed a low MW polymer precursor (~3K g/mol).  To examine whether 
MW might play a role in the resultant conjugation profile, we evaluated Protocol 1 at 
three different MWs- 5K, 30K, and 50K g/mol.  We also explored the effects of 
several other reaction parameters, namely poly(MAOS) concentration, reaction time, 
and reaction temperature, on the resultant conjugation profile.  The data shown in 
Figures 3-7 to 3-9 suggest that the pendant distribution is independent of MW, 
precursor concentration, and reaction time, yet greatly dependent upon reaction 
temperature where an increase in temperature leads to a greater proportion of the 
desired and glutarimide-bound conjugates and less of the ring-opened conjugate.  In 
contrast to the time dependency of the resultant conjugation profile reported by 
Devenish et al., our examination did not reveal any appreciable reduction in the ring-
opened side product at either temperature evaluated (25°C and 50°C).  However, the 
reaction time range of 5 to 16 hours evaluated in our study contrasts sharply with that 
of Devenish et al.’s 5 hours to 7 days.  As such, our time range may have been too 
narrow to produce any noticeable effects on conjugation profile and does not 
necessarily contradict the findings by Devenish et al.   
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Figure  3-7.  The effect of molecular weight on conjugation profile following protocol 
1- 2 equivalents benzylamine, 50 °C, 5 hrs, 25mg poly(MAOS)/150μL. Pendant 
distribution remained similar for all three molecular weights evaluated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3-8.  The effect of poly(MAOS) concentration on conjugation profile 
following two reported protocols.  Each protocol results in similar pendant 
distributions regardless of precursor concentration. Low conc. = 25mg 
poly(MAOS)/1mL DMSO; Mid Conc. = 25 mg poly(MAOS)/600μL DMSO; High 
Conc. = 25 mg poly(MAOS)/150μL DMSO.  30K g/mol poly(MAOS) was used for 
all reactions.  Reactions performed at low and mid concentrations included an 
additional 4 hours in vacuo concentration of the reaction mixture prior to precipitation. 
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Figure  3-9.  The effect of reaction time and temperature on conjugation profile.  
Increasing temperature leads to a greater proportion of the desired and glutarimide-
bound conjugates and less of the ring-opened conjugate. 2 equivalents benzylamine, 
25mg poly(MAOS)/150μL DMSO, 30K g/mol poly(MAOS) was used for all 
reactions. 
 
Guided by the apparent time and temperature dependency of poly(MAOS) 
conjugation, we modified the previously reported protocols by increasing time, 
temperature, and equivalents of NH2-FG while decreasing the precursor concentration.  
This revised protocol minimizes both labile ring-opened side products (as indicated by 
the disappearance of the 2.4, 4.3, and 8.4 ppm peaks) with a minimal amount of the 
glutarimide-bound conjugate (~7%) remaining (Figures 3-10 and 3-11).  Because the 
glutarimide linkage is stable, its minimal presence is acceptable for polymer library 
synthesis.  The revised protocol was further verified to be independent of MWs 
ranging from 5K – 50K g/mol and reaction concentrations ranging from 25mg 
poly(MAOS)/600μL DMSO to 25mg poly(MAOS)/mL DMSO (data not shown). 
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Figure  3-10.  Preparation of functionalized poly(MAOS) free of ring-opened side 
product. 
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Figure  3-11.  Representative 1H NMR spectra of resultant functionalized polymer 
produced from the revised protocol - 5 equivalents benzylamine, 75 °C, 24 hrs, 4 hrs 
evacuation,  25mg poly(MAOS)/600μL DMSO -  showing the absence of the ring-
opened side product.  Peaks labeled in capital letters were used for quantification via 
signal integration of respective pendant groups. 
 
To address our initial goal of utilizing poly(MAOS) to synthesize molecularly 
diverse libraries, we extended the conjugation protocol to both single and binary 
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 conjugations of other alkyl (e.g., butylamine, hexylamine) and water-solubilizing 
functional groups (e.g., histamine, 1-amino-2-propanol) (Table 3-1). 
 
Table  3-1.  Diverse functional groups conjugated to poly(MAOS). 
 
Alkyl Functional Groups 
Name  Structure 
butylamine   
hexylamine   
Water Solubilizing Functional Groups 
Name Abbreviation Structure 
1-amino-2-propanol 1A2P 
 
ethylenediamine a 1N  
N-methylethylenediamine a 2N  
N,N-dimethylethylenediamine 3N 
 
2-(aminoethyl)-trimethylammonium 
chloride - HCl 
4N 
 
histamine  
 
a derived from its N-Boc-protected precursor 
 
 No apparent side reaction conjugations resulted from butylamine and 
hexylamine functionalization presumably due to less steric hindrance relative to 
benzylamine functionalization.   In the case of the water-solubilizing moieties, solvent 
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 solubility appears to be the predominant factor affecting conjugation dynamics.  3N 
and histamine, both soluble in DMSO in their free base state, render poly(MAOS) 
notably less soluble in DMSO upon functionalization, which we believe results in an 
increased presence of glutarimide-bound conjugation relative to the alkyl functional 
group conjugations.  We hypothesize that as conjugation proceeds, the decreasing 
solubility causes the semi-functionalized polymer precursor to assume a more tightly 
coiled and closed conformation.  Consequently, accessibility of the primary amine to 
the activated esters becomes limited leaving any remaining esters to form N-
substituted glutarimides with neighboring amides (Figure 3-12). [11]  
 
 
 
 
 
Figure  3-12.  Proposed route for N-substituted glutarimide formation presumably 
between amide-bound conjugates and neighboring active esters. 
 
To further support this hypothesis, we look to the 1A2P, 1N, and 2N 
conjugations.   1A2P, also miscible in DMSO in its primary amine reactant state, 
renders poly(MAOS) readily soluble in both water and DMSO upon conjugation.  The 
proposed effect of the polymer coiling up upon conjugation would be expected not to 
occur to any appreciable degree which is supported by the absence of the glutarimide-
indicating 1H NMR peak.  In the case of the 1N and 2N pendant groups, it is important 
to clarify that their pendant distributions shown in Figure 3-13 were quantified from 
polymers that were synthesized by functionalizing poly(MAOS) with their respective 
Boc-protected precursor and subsequently deprotected.  Because 1N and 2N would 
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 render poly(MAOS) relatively insoluble in DMSO, one might expect their conjugation 
profiles to liken that of 3N conjugation.  However, their conjugation dynamics were 
dictated by their Boc-protected precursor which results in a readily DMSO-soluble 
functionalized polymer.  Thus it is not surprising that their conjugation profiles are 
similar to those of other DMSO-soluble polymers, namely the alkyl functionalized 
polymers.  Furthermore, direct conjugation of 2N (i.e., no Boc-protected precursor 
was used) resulted in a polymer whose NMR spectra yielded the expected desired and 
glutarimide-bound conjugates, presumably influenced by the hypothesized coiling up 
effect, in addition to other side reaction products, presumably between the 2° amine 
and activated esters.   
 
Figure  3-13.  Conjugation profile of various NH2-FGs to poly(MAOS). The revised 
protocol -5 equivalents NH2-FG, 75 °C, 24 hrs, 4 hrs evacuation, 25mg 
poly(MAOS)/600μL DMSO-  results in the absence of any labile ring-opened 
conjugates for a diverse set of functional groups with only a minimal amount (~4%) 
remaining for the 4N conjugation. 50K g/mol poly(MAOS) was used for all reactions. 
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  In addition to the solubility effects of the functionalized polymer, the solubility 
of the nucleophilic reactant also appears to influence conjugation behavior.  4N, 
insoluble in DMSO in both its salt reactant state and upon conjugating to poly(MAOS) 
resulted in a small, but persistent amount of the ring-opened pendant group remaining 
on the functionalized polymer.  Efforts to eliminate all ring-opened conjugates by 
varying temperature and time conditions were ineffective and resulted in a similar 
pendant distribution at all conditions (Figure 3-14).  Nevertheless, the conjugation 
behavior of 4N provides evidence that the solubility of both the nucleophilic reactant 
and the functionalized polymer plays a role in conjugation behavior.   
 
 
Figure  3-14.  Conjugation profile of 2-(aminoethyl)-trimethylammonium chloride – 
HCl (4N) to poly(MAOS) under various time and temperature reaction conditions.  A 
similar pendant distribution persists upon conjugating 4N to poly(MAOS).  (5 
equivalents 4N, 4 hrs evacuation, 25mg poly(MAOS)/600μL DMSO) 50K g/mol 
poly(MAOS) was used for all reactions. 
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 Due to proton exchange between hydroxyl protons and deuterium in D2O, 1H 
NMR analysis was also performed for all water-soluble samples in DMSO-d6. [16]  
This additional analysis was performed to ensure that premature hydrolysis of the 
activated ester to its carboxylic acid did not occur either during the conjugation 
reaction or isolation process (Figure 3-15).  The 1H NMR spectra of the functionalized 
polymers in DMSO-d6 were evaluated for the presence of a hydroxyl peak.   
 
Figure  3-15.  Potential hydrolysis of NHS-activated ester to methacrylic acid from 
residual water may occur during the conjugation or isolation process.  Due to proton 
exchange between the hydroxyl proton of the carboxylic acid and deuterium in D2O, 
NMR analysis was performed in DMSO-d6 to ensure the absence of a hydroxyl peak.  
 
Polymers functionalized with 4N and 1N (i.e., NBoc-1N deprotected to the 1N 
form) were insoluble in DMSO and prevented this additional evaluation.  To illustrate 
the analysis, Figure 3-16a shows the 1H NMR spectrum of a polymer functionalized 
with 1A2P that was used as-received from the manufacturer.  Residual water in the 
1A2P may have contributed to premature hydrolysis of the activated esters during 
conjugation resulting in the presence of a hydroxyl peak in the 1H NMR spectrum 
(peak h in Figure 3-16a).  Drying the 1A2P over 3Å molecular sieves resulted in a 
functionalized polymer with no apparent hydrolysis as shown in Figure 3-16b.  This 
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 analysis demonstrates the importance of using dried reagents with poly(MAOS) to 
ensure the desired products.   
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Figure  3-16.  1H NMR spectra of poly(MAOS) functionalized with a) 1A2P as 
received and b) 1A2P dried over 3Å molecular sieves.  Note the absence of the 
hydroxyl peak in (b) thus indicating that premature hydrolysis of the activated ester to 
its carboxylic acid did not occur.  Both conjugations followed the revised protocol - 5 
equivalents 1-amino-2-propanol, 75 °C, 24 hrs, 4 hrs evacuation, 25mg 
poly(MAOS)/600μL DMSO.  50K g/mol poly(MAOS) was used for all reactions. 
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 Figure  3-16 (continued) 
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For functional groups with other nucleophilic atoms (e.g., 3° NH2 on N,N-
dimethylethylenediamine, imidazole on histamine), 1H-1H COSY was used to 
determine the presence of any additional side reactions.  Figure 3-17 exemplifies how 
we used this technique to determine the side reaction products for the 3N-conjugated 
polymer.  The peak at 4.0 ppm (peak d’ in Figure 3-17) is shown to correlate with the 
3.8 ppm peak (peak e in Figure 3-17) thus indicating the formation of side reaction z 
as opposed to side reaction z’.   
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Figure  3-17.  1H-1H COSY of poly(MAOS) functionalized with N,N-
dimethylethylenediamine (3N) following the revised protocol - 5 equivalents amine, 
75 °C, 24 hrs, 4 hrs evacuation, 25mg poly(MAOS)/600μL DMSO.  The correlation 
between the d’ and e protons provide evidence that side product z is formed as 
opposed to z’.    
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 Finally, we extended our protocol to binary conjugations using 1) benzylamine 
and 3N and 2) 1A2P and 3N as two independent model functional groups.  Figure 3-
18 shows the representative 1H NMR spectra for both binary conjugations that were 
used to quantify the relative percent conjugations.  
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Figure  3-18.  Representative 1H NMR spectrum of poly(MAOS) functionalized with a 
binary mixture of  a) 2.5 equivalents of N,N-dimethylethylenediamine (3N) and 2.5 
equivalents of benzylamine and b) 2.5 equivalents of N,N-dimethylethylenediamine 
(3N) and 2.5 equivalents of 1-amino-2-propanol (1A2P).  Both conjugations followed 
the revised protocol - 5 total equivalents of amine, 75 °C, 24 hrs, 4 hrs evacuation, 
25mg poly(MAOS)/600μL DMSO.  50K g/mol poly(MAOS) was used for all 
reactions.  Peaks labeled in capital letters were used for quantification via signal 
integration of respective pendant groups.   
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 Figure 3-18 (continued) 
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Figure 3-19 summarizes the conjugation profiles at various 3N equivalents for 
both binary conjugation experiments.  The conjugation profile for the 3N/benzylamine 
system appears to follow a logarithmic trend compared to the linearly trending 
3N/1A2P system.    The difference in profiles is likely due to a dissimilarity in the 
degree of nucleophilicity between the conjugating pairs (i.e., 3N compared to 
benzylamine; 3N compared to 1A2P). [17]  Further parametric studies, such as the 
effects of introducing each functional group at various times during the conjugation 
reaction, may be conducted to optimize the ligand distribution.  
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Figure  3-19.  Conjugation profiles of a) N,N-dimethylethylenediamine (3N) 
(▲)/benzylamine (●) binary mixtures (logarithmic fit; R2 = 0.9893) and b) 3N (▲) /1-
amino-2-propanol (1A2P) (■) binary mixtures (linear fit; R2=0.9844) at various feed 
equivalents of 3N. The conjugation profile of the 3N/1A2P mixtures resembles the 
theoretical conjugation and is likely due to a similar degree of nucleophilicity in 
contrast to the 3N/benzylamine conjugation profile.   
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 In conclusion, we have established a protocol that overcomes the side reactions 
that are associated with the NHS-activated polymer precursor, poly(MAOS).  The 
revised protocol entails conjugating poly(MAOS) in the presence of a five-mole 
excess of the primary amine-containing nucleophile for 24 hours at 75 °C at a reaction 
concentration of 25 mg poly(MAOS)/600μL DMSO.  Using 1H NMR and 1H-1H 
COSY analyses, we have quantified and characterized the resultant mono-
functionalized polymer for a diverse range of functional groups.   Moreover, we have 
also characterized the conjugation of two model binary systems: 1) N,N-
dimethylethylenediamine (3N) and benzylamine and 2) N,N-dimethylethylenediamine 
(3N) and 1-amino-2-propanol (1A2P).  Both systems were evaluated at various binary 
mixture compositions to demonstrate the compatibility of our protocol to conjugations 
comprising combinations of various functional groups.  
 An important and active area of research for which this work is applicable is 
the use of chemically and structurally diverse combinatorial libraries to develop 
polymeric biomaterials for drug and gene delivery systems.  This area of research 
faces multiple challenges including: 1) a limited understanding of the biochemical and 
physical environment under which the materials must withstand thereby making 
rational design an extremely difficult task; and 2) resource constraints associated with 
synthesizing and evaluating a large number of diverse compounds efficiently.  
 Combinatorial strategies offer a systematic approach to designing libraries of 
polymer candidates that encompass a broad range of properties.  Subsequent screening 
of each polymer enables the identification of both “hits” - specific polymers that 
possess desirable properties - and trends that demonstrate how an incrementally varied 
feature affects the measured output. [1]  Hits are desired because they identify specific 
polymers that possess the desired biophysical and chemical properties (e.g., high 
drug/gene transfer efficiency, low cytotoxicity) as determined by screening assays.   
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 Equally important are the trends that are observed between polymers that share an 
incrementally varied feature.  These trends may provide information about the 
functional effects of a particular structural feature and potentially shed light on the 
underlying biochemical and physical environment and mechanisms that govern the 
system.  Ultimately, the information gained from these libraries can point to ways to 
improve the design of drug and gene delivery systems. 
 The protocol that we have established offers a facile method to use 
poly(MAOS) precursor as the molecular backbone for each compound in a 
combinatorial library where chemical and structural properties can be easily imparted 
and modified by conjugating different functional groups at various ratios to the 
precursor. Coupled with high throughput methods, these libraries can be feasibly 
synthesized and evaluated efficiently and reliably, posing the potential for these 
promising research tools to significantly change the way new materials are discovered. 
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 CHAPTER 4 
 
4 STRUCTURE-FUNCTION RELATIONSHIPS OF MOLECULAR 
WEIGHT, CATIONS, PH-SENSITIVE MOIETIES, AND 
HYDROPHOBIC RESIDUES DEDUCED FROM A COMBINATORIAL 
LIBRARY OF POLYMERIC GENE VECTORS 
 
4.1. ABSTRACT 
Three combinatorial libraries of polymeric vectors were evaluated in the 
present study to investigate the functional roles of molecular weight, cationic pendant 
groups, pH-sensitive moieties, and hydrophobic derivitization in polymer-mediated 
gene delivery.  Four cationic and pH-sensitive moieties (primary amino, secondary 
amino, tertiary amino, and imidazole) and three hydrophobic residues (C4 butyl, C6 
hexyl, and C8 octyl) were conjugated in single and serially-incremented binary 
combinations to a common polymer precursor of a single molecular weight and 
polydispersity index.  Three molecular weights were evaluated herein – 10 kDa, 30 
kDa, and 50kDa.   Transfection levels comparable to branched-PEI (25 kDa) were 
achieved by several 30 kDa and 50 kDa formulations, most of which contained 
imidazole and primary amino groups.  All but two of the ten highest transfecting 
polymers possessed IC50 values greater than the maximum concentration of free 
polymers exposed to cells (200 μg/mL).  These high-transfecting polymers appeared 
to harness the superior charge neutralizing and size condensing capacity of primary 
amino groups while benefiting from the polyplex stabilizing role of imidazole groups.  
Contrary to the widely held belief that imidazole groups facilitate endo-lysosomal 
escape via their enhanced buffering capacity, imidazole groups appeared to enhance 
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 transfection primarily through their ability to bind to DNA via non-electrostatically 
mediated interactions, which stabilized resultant polyplexes and ultimately resulted in 
more efficient delivery to cells.  The results from this study have not only identified 
highly efficient polymeric formulations with superb toxicity profiles, but have also 
shed light on the functional roles that the investigated polymeric pendant groups play 
in the transfection process.  Future studies will be critical to fully understand and 
clearly define the structure-function relationships that govern gene delivery. The 
reported polymeric system offers a simple and robust platform upon which such 
structure-function studies may be based in a move towards safer and more efficient 
polymeric vectors. 
 
4.2. INTRODUCTION 
 Significant advances in molecular biology and genomic research have 
uncovered the genetic basis for a variety of diseases, and have given rise to the use of 
gene therapy as a possible mode of treatment. [1-4]   Unfortunately, one of the primary 
obstacles preventing human gene therapy from becoming widely available is the lack 
of safe and efficient gene delivery systems.  
 A variety of vectors have been designed to overcome the known biological 
barriers that hinder safe and efficient delivery of exogenous genes.  Most delivery 
systems developed to date fall under the general categories of viral, lipid-based, 
inorganic, and polymeric delivery systems. [5-8]  However, safety concerns and 
inefficient delivery profiles have restricted the advancement of any one of these 
systems towards a broader clinical application.  In particular, polymeric systems have 
fallen short in their delivery efficiency, despite the diverse strategies for improving 
polymer-mediated gene delivery that have been reported in the past two decades. [8]  
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 Many of the polymeric systems currently in development are based on design concepts 
that have been reinforced by a number of reports.  Such design concepts include the 
use of cationic moieties to complex with DNA; pH-sensitive functional groups to 
promote intracellular trafficking; derivitization with carbohydrates to enhance 
biocompatibility and facilitate both cellular and nuclear targeting; and hydrophobic 
functionalization to promote cellular uptake. [9-14]  The wealth of information 
produced from these studies has reinforced the strategy of altering the chemical and 
structural characteristics of polymeric vectors to enhance and fine-tune their 
biophysical properties and transfection capacities.  However, because many of these 
studies have been conducted under heterogeneous experimental conditions (e.g., the 
use of different polymeric backbones of different molecular weights and 
polydispersities, diverse synthetic techniques, various cell lines transfected, different 
transfection protocols, etc.), it is difficult to directly correlate how the chemical and 
structural attributes of polymeric vectors influence transfection efficiency based solely 
on analysis of the existing literature.  In the absence of clearly defined structure-
function relationships, the rational modification of polymer vector designs remains a 
challenge.   
 This study aims to determine the structure-function relationships that govern 
one class of polymer-mediated gene delivery by systematically altering molecular 
weight and side chain composition in a combinatorial fashion.  To explore 1) the 
effects of different charge groups and 2) the hypothesized role of pH-sensitive 
moieties as buffering agents that facilitate intracellular trafficking and enhance 
transfection efficiency, we evaluated primary, secondary, tertiary amino, and 
imidazole groups. [9, 14-16]  To understand whether the hydrophobic properties of 
linear hydrocarbon alkyl chains affect the transfection capacity of polymeric vectors, 
C4 butyl, C6 hexyl, and C8 octyl group were also investigated.  The effect of each 
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 functional group was systematically evaluated by forming single and binary 
combinations of all moieties at 75/25, 50/50, and 25/75 molar ratios to constitute a 
combinatorial library of polymeric vector candidates.  Three such combinatorial 
libraries were synthesized, each representing a different molecular weight (10, 30, and 
50 kDa) and comprising the same polymer formulations.  Characterization of the 
polymeric vectors included in vitro transfection capacity, polyplex size, zeta potential, 
relative binding affinity, polyplex stability, buffering capacity, and cytotoxicity. 
 The results from this study have 1) revealed the structure-function 
relationships of different charge groups, pH-sensitive moieties, and hydrophobic 
residues; 2) identified several polymeric vectors with transfection capacities as high as 
branched PEI (25 kDa) with more favorable cytotoxicity profiles; and 3) established a 
robust system of polymers for future structure-function studies in a move towards 
safer and more efficient polymeric vector designs.   
 
4.3. MATERIALS AND METHODS 
4.3.1. Reagents 
Cu(I)Br, Cu(II)Br2, 2,2’-dipyridyl, N,N,N′,N′′,N′′-pentamethyldiethylenetriamine, 
ethyl 2-bromoisobutyrate, benzylamine, butylamine, hexylamine, octylamine, N-Boc-
ethylenediamine, N-Boc-N-methylethylenediamine, N,N-dimethylethylenediamine, 
histamine, anhydrous DMSO, anhydrous DMF, anisole, heparin sodium salt (# 
H9399) were all purchased from Sigma-Aldrich (St. Louis, MO) and used without 
further purification.  Dowex® Marathon® MSC hydrogen ion exchange resin was 
purchased from Sigma-Aldrich and dried in vacuo overnight before use.  Cell culture 
reagents were purchased from Gibco® (Carlsbad, CA), pCMV-luc reporter gene 
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 plasmid was purchased from Elim Biopharmaceuticals (Hayward, CA), and reporter 
gene assays were purchased from Promega (Madison, WI).   
 
4.3.2. General procedure for the synthesis of polymer precursor, 
poly(methacryloxysuccimimide) (poly(MAOS)) 
 The monomer, N-methacryloxysuccinimide was synthesized as previously 
reported. [17]  The polymer precursor, poly(methacryloxysuccinimide), was 
synthesized with a slight modification to two previously reported methods. [18, 19]  
To obtain a precursor molecular weight of 10 kDa, the protocol reported by 
Shunmugam and Tew was adopted, whereas a modified version of the protocol by 
Godwin et al. was employed for synthesis of the precursor at 30 kDa and 50 kDa.  
Both protocols followed the same experimental set-up with the only difference being 
the reaction temperature, transition metal ligand, and solvent used.  Reaction 
conditions are summarized in Table 4-1.  Briefly, a 5 ml pear shaped flask with a flea 
magnetic stir bar was fitted with a rubber septum and flame dried while purging with 
N2(g), then cooled to ambient temperature.  Cu(I)Br, Cu(II)Br2, and the ligand were 
added to the flask and resealed with the septum.  Solvent that was purged with N2(g) 
for ten minutes prior to use was injected into the flask and the contents were stirred 
under a nitrogen atmosphere for approximately ten minutes until dissolved.  N-
methacryloxysuccinimide was added to the flask and allowed to dissolve for another 
ten minutes.  The initiator, ethyl-2-bromoisobutyrate, was directly injected through the 
septum into the flask with a Hamilton syringe and immersed into a thermostated oil 
bath.  To stop the polymerization, the flask was quenched in an ice bath and the 
product was dissolved with anhydrous DMF at a 1:3.75 (w/w) ratio of monomer:DMF.  
Approximately 20 mg of Dowex® Marathon® MSC hydrogen ion exchange resin was 
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 added to the redissolved solution and allowed to stir for approximately ten minutes.  
The ion exchange resin was added to remove any active copper catalysts remaining in 
the solution. [20]  The final polymer was isolated as a white powder by precipitation 
into stirring acetone.  The precipitated polymer was filtered through a fine-fritted 
Buchner funnel, washed three times with fresh acetone, and dried overnight in vacuo.  
1H NMR (DMSO-d6) δ:1.44 (b,3H,CH3), 2.41 (b,2H,CH2), 2.78 (b,4H,CH2CH2).   
 Molecular weight and polydispersity index were determined by hydrolyzing 
poly(MAOS) to its sodium salt form.  Upon dissolving poly(MAOS) in DMSO at a 
1:8.8 (w/w) ratio of poly(MAOS):DMSO,  a two-fold excess of 5M NaOH was added  
dropwise to the reaction and allowed to stir for 7 hours at room temperature.  The 
cloudy solution was redissolved in filtered deionized water at a 1:80 (w/w) ratio of 
poly(MAOS):water and allowed to stir overnight at room temperature.  The solution 
was then dialyzed against deionized water using Spectra/Por regenerated cellulose 
tubing (MWCO 3500 Da) for three days.  The dialysate was subsequently lyophilized 
to give a white powder.   
 
4.3.3. General procedure for amine conjugation  
 The seven pendant groups of interest, shown in Figure 4-1a, were conjugated 
to the poly(MAOS) precursor in single and binary combinations.  Binary combinations 
of the pendant groups were evaluated at 25/75, 50/50, and 75/25 input molar ratios.  
The details of the mono- and bi-functionalized polymer syntheses have been 
previously reported by our group. [21]  
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 4.3.4. Polymer characterization 
4.3.4.1. Molecular weight and chemical composition of polymer precursor 
 The molecular weight and polydispersity index of each poly(MAOS) precursor 
were evaluated via gel permeation chromatography of the hydrolyzed sodium salt.  
The chemical composition of the polymer precursor was confirmed via 1H NMR 
spectroscopy.  The details of the characterization protocol for both methods are 
provided in our previous report. [21]  Table 4-1 summarizes the molecular weight and 
polydispersity index values determined for each of the three precursors used in the 
present study.   
 
4.3.4.2. Chemical composition of bi-functionalized polymer 
 To characterize the conjugation ratio of polymers that were bi-functionalized 
with two of the pendant groups in Figure 4-1a, a secondary set of polymer conjugates 
were first synthesized, according to our previously reported protocol, comprising each 
pendant group in Figure 4-1a co-functionalized with benzylamine at 25/75, 50/50, and 
75/25 molar input ratios. [21]  Owing to benzylamine’s characteristic UV/Vis 
absorbance wavelength of 260 nm and 1H NMR chemical shift of ~7.2 ppm, the 
benzylamine content of the secondary set of polymer conjugates could be quantified 
using both analytical methods.  Indirectly, the conjugation efficiency of the co-
functionalized pendant group could then be determined.   
 To quantify the benzylamine content via UV/Vis spectrophotometry, 5 mg of 
the polymer, co-functionalized with benzylamine and the amine of interest (1N, 2N, 
3N, histamine (i.e., imidazole group), hexylamine), was dissolved in 6 mL of either 
methanol or tetrahydrofuran and vortexed until visibly dissolved.  All polymers 
containing 1N, 2N, 3N, and histamine were soluble in methanol.  Polymers co-
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 functionalized with hexylamine were soluble in tetrahydrofuran.  Benzylamine content 
was quantified by aliquoting 1 mL of dissolved solution into a quartz cuvette and 
obtaining absorbance values at 260 nm on a Molecular Devices SpectraMax Plus384 
UV/Vis spectrophotometer.  Absorbance values were corrected for background 
absorbance by subtracting the absorbance of the solvent measured on the same day as 
the samples. Poly(methacrylic acid) (MW~100 kDa purchased from Polysciences, 
Inc.) and poly(methyl methacrylate) (MW~120 kDa from Sigma Aldrich) were used 
as the negative controls for samples soluble in methanol and tetrahydrofuran, 
respectively.   
 To determine the conjugation ratio of benzylamine from the measured 
absorbance values of the benzylamine co-functionalized polymers, the benzylamine 
concentration that corresponded to different theoretical conjugation ratios of 
benzylamine was calculated according to the following equations: 
 
x
MWyxMWyMWx
MW backboneybenzxbipoly
))(()()(
,
+++=  (4.1) 
where MWbipoly,x is the molecular weight of a repeat unit containing x conjugation ratio 
of benzylamine in units of g/mol of benzylamine; x is the theoretical benzylamine 
conjugation ratio; MWbenz is the calculated molecular weight of conjugated 
benzylamine (106 g/mol); y = 1-x is the theoretical conjugation ratio of the co-
functionalized pendant group; MWy is the calculated molecular weight of the 
conjugated co-functionalized pendant group; and MWbackbone is the calculated 
molecular weight of a repeat unit of the polymeric backbone (69 g/mol).   
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 where Cbenz is the benzylamine concentration in units of mol/L that corresponds to the 
theoretical benzylamine conjugation ratio, x, of a UV/Vis polymer sample of weight, 
m (0.005 g), dissolved in volume, v (0.006 L), of solvent.  
 Absorbance values at 260 nm, A260, corresponding to Cbenz values were 
determined from a calibration curve generated from free base benzylamine dissolved 
in the same solvent as the bi-functionalized polymeric samples.  A linear trendline 
fitted to the plot of x vs. A260 for each bi-functionalized pair was then used to convert 
the measured UV/Vis absorbance of bi-functionalized polymers to the conjugation 
ratio of benzylamine, Xbenz.  
 The conjugation ratio of the pendant group, m, that was co-functionalized with 
benzylamine, Xexp,r,m, was then calculated by: 
benzmr XX −=1,exp,   (4.3) 
where Xbenz is the conjugation ratio of benzylamine determined by either UV/Vis 
spectrophotometry, as described above, or 1H NMR spectroscopy, as described in our 
previously reported protocol. [21]  A conjugation efficiency value relative to 
benzylamine, CEB,r,m, was then calculated according to the following equation: 
m
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X
CE ,exp,,, =   (4.4) 
where r is the input molar ratio (0.25, 0.50, 0.75) of pendant group m.   
 To calculate the coefficient efficiency of each pendant group relative to each 
other, the following equation was used: 
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The final conjugation ratio of polymers that were bi-functionalized with two pendant 
groups in Figure 4-1a at the molar input ratios of 25/75, 50/50, and 75/25 was 
calculated according to the following equation: 
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where Xcalc,m1 is the calculated conjugation ratio of pendant group m1 when co-
functionalized with pendant group m2.  An example of the conjugation calculations 
determined by the UV/Vis spectrophotometry method is provided in the appendix at 
the end of the chapter.  
4.3.5. Cell culture 
 The murine embryonic fibroblast NIH/3T3 cell line was purchased from the 
American Type Culture Collection (Manassas, VA).  Cells were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% v/v fetal calf 
serum, 100 units/mL penicillin, and 100 μg/mL streptomycin.  Cells were grown at 
37°C and 5% CO2 to an approximately 70% confluent monolayer and passaged every 
3-4 days.   
 
4.3.6. Preparation of polymer-DNA complex (polyplex) transfection solutions 
and free polymer cytotoxicity solutions 
 For each unique polymer, five polymer:DNA (w:w) ratios were evaluated – 
0.5:1, 1:1, 2.5:1, 5:1, and 10:1.  First, 140 μL of polymer solution for each ratio was 
prepared by combining the appropriate volume of 1.5 mg/mL polymer stock solution 
with 10 mM HEPES buffer (pH 7.2) such that each 150 μL of polyplex transfection 
solution contained the intended amount of polymer required to condense 3 μg of 
plasmid.  Polymer solutions were briefly vortexed before adding 140 μL of pCMV-luc 
stock solution (150 μg/mL pCMV-luc in 10mM HEPES buffer, pH 7.2) to each of the 
140 μL of polymer solution.  The polymer/DNA mixture was then vortexed for five 
seconds and incubated at room temperature for 15 minutes to allow for complex 
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 formation.  Serum-free OPTI-MEM I® medium (770 μL) was added to each polyplex 
solution and briefly vortexed to form the final polyplex transfection solution.    
 For the free polymer cytotoxicity solutions, 140 μL polymer solutions for each 
polymer:DNA ratio were prepared as previously described.  Then, 140 μL of 10 mM 
HEPES buffer (pH 7.2) and 770 μL of OPTI-MEM I® medium were added to each 
solution and briefly vortexed to form the final free polymer cytotoxicity solution.   
 
4.3.7. Plasmid DNA (pCMV-luc) transfection 
 NIH/3T3 cells were grown in clear and opaque, flat-bottomed tissue culture 
polystyrene 96-well plates (Costar, Corning, NY) at an initial density of 5,000 
cells/well in 200 μL of phenol red-free, supplemented DMEM.  Following 24 hours of 
incubation at 37°C and 5% CO2, the growth medium was removed and replaced with 
150 μL of polyplex transfection solution, which was prepared as described previously.  
Each 150 μL aliquot of transfection solution contained 3 μg of plasmid DNA.  Cells 
were incubated with the polyplexes for 4 hours, after which the complex-containing 
medium was aspirated and replaced with 100 μL of phenol red-free, supplemented 
DMEM.  Following 44 hours of additional incubation at 37°C and 5% CO2, opaque 
plates were assayed for luciferase expression using the Bright-GloTM Luciferase Assay 
(Promega, Madison, WI) and clear plates were assayed for total protein content using 
the BCATM Protein Quantitation Assay (Pierce Biotechnology, Rockford, IL).  All 
polymers were evaluated in triplicate.  Transfection results are expressed as the ratio 
of relative light units to absorbance at 562 nm.   
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 4.3.8. Bright-GloTM  luciferase assay 
 After a total incubation time of 48 hours from the time of polyplex solution 
addition, growth medium was aspirated and each well was rinsed with 200 μL of 
phosphate buffered saline (pH 7.4).  In a Veritas™ Microplate Luminometer (Turner 
Biosystems, Sunnyvale, CA) 100 μL of Bright-GloTM working solution, prepared 
according to the manufacturer’s direction, was added to each well of the opaque 96-
well plate.  After two minutes of incubation at room temperature, luciferase expression 
was quantified as the relative light units measured in the luminometer. 
 
4.3.9. BCATM protein quantitation assay 
 After a total incubation time of 48 hours from the time of polyplex solution 
addition, growth medium was aspirated and each well was rinsed with 200 μL of 
phosphate buffered saline (pH 7.4).  RIPA buffer (20 μL) (Pierce Biotechnology, 
Rockford, IL) was added to each well of the clear 96-well plate and incubated at room 
temperature for 10 minutes with gentle shaking.  BCATM working reagent (200 μL) 
(Pierce Biotechnology, Rockford, IL), prepared according to the manufacturer’s 
directions, was then added to each well and gently shaken for 30 seconds at room 
temperature.  Plates were incubated at 37°C and 5% CO2 for one hour before being 
read at 562 nm on a Molecular Devices SpectraMax Plus384 UV/Vis 
spectrophotometer. 
 
4.3.10. Relative binding affinity and polyplex stability assay 
 The relative degree of electrostatic binding between DNA and polymer in the 
absence and presence of a competing polyanion was measured using ethidium bromide 
(EtBr) (Fisher Scientific, Pittsburgh, PA) fluorescence quenching and recovery. [22-
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 24] Heparin sodium salt (4.38 mM) dissolved in 10mM HEPES buffer (pH 7.2) was 
used as the competing polyanion. [23]  A free polymer solution (180 μL) for each 
polymer:DNA ratio was prepared by combining the appropriate volume of 1.5 mg/mL 
polymer stock solution with 10mM HEPES buffer (pH 7.2) such that each 50 μL 
aliquot resulted in the intended w:w ratio of polymer and pCMV-luc.  A stock solution 
of EtBr/DNA was made by combining equal volumes of pCMV-luc (150 μg/mL 
pCMV-luc in 10mM HEPES buffer, pH 7.2) and EtBr (0.1095mM EtBr in 10mM 
HEPES buffer, pH 7.2) stock solutions, resulting in a 4:1 ratio of phosphate groups to 
EtBr monomer units.  All fluorescence readings were obtained in a Molecular Devices 
SpectraMax GeminiXS at λex = 535 nm and λem = 595nm (automatic calibration, 10 
seconds of mixing prior to reading, and automatic sensitivity of PMT detector).  All 
polymers were evaluated in triplicate. 
 First, 100 μL of EtBr/DNA solution was added to each well of a black 
polystyrene 96-well plate (Costar, Corning, NY) and the fluorescence was measured.  
An aliquot of 50 μL of free polymer solution was then added to each EtBr/DNA-
containing well, gently shaken at room temperature on a microplate shaker for 15 
minutes, and the fluorescence measured again.  A 50 μL aliquot of 4.38 mM heparin 
was added to each well, gently shaken at room temperature on a microplate shaker for 
4 hours, and the fluorescence measured for a final time.  The relative binding affinity 
(BA) and relative binding strength (BS) were calculated from the following equations: 
 
DE
polymerDE
F
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BA
/
/ −=   (4.7) 
 
polymerDE
hepDE
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BS −
−=
/
/   (4.8) 
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 where FE/D is the corrected fluorescence of  EtBr/DNA in the absence of polymeric 
vector; Fpolymer is the corrected fluorescence of  EtBr/DNA in the presence of 
polymeric vector; Fhep is the corrected fluorescence of EtBr/DNA in the presence of 
polymeric vector and heparin.    
 All fluorescence measurements were corrected by subtracting background 
fluorescence due to free EtBr and due to volume effects.  Background values from free 
EtBr were obtained from triplicate wells, on each 96 well plate, containing EtBr and 
10mM HEPES buffer for the first two fluorescence readings and EtBr, HEPES buffer, 
and heparin for the final fluorescence measurement.  Background values due to 
volume effects were determined from triplicate wells, on each 96 well plate, 
containing EtBr/DNA and HEPES buffer in volumes equal to those added to the 
polymer samples.   
 
4.3.11. Polyplex size and zeta potential measurement 
 A 140 μL solution of free polymer was prepared for each polymer:DNA ratio 
by combining the appropriate volume of 1.5 mg/mL polymer stock solution with 10 
mM HEPES buffer (pH 7.2) such that the final 1.05 mL polyplex solution contained 
the intended w:w ratio of polymer and pCMV-luc.  Polymer solutions were briefly 
vortexed before adding 140 μL of pCMV-luc stock solution (150 μg/mL pCMV-luc in 
10mM HEPES buffer, pH 7.2) to each of the 140 μL of free polymer solution.  The 
polymer:DNA mixture was vortexed for five seconds and incubated at room 
temperature for 15 minutes to allow for complex formation.  Then, 770 μL of 10mM 
HEPES buffer (pH 7.2) was added to each polymer:DNA solution and briefly vortexed 
to form the final polyplex solution used in both sizing and zeta potential 
measurements.   
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  Size and zeta potential characterizations were performed using the Nanosizer 
Nano ZS (Malvern Instruments).  The refractive index and viscosity values of water 
were used as parameter inputs.  Malvern Dispersion Technology Software was used 
for data acquisition and analysis, applying the general purpose algorithm for 
calculating size distributions and the Smoluchowski approximation for determining 
zeta potential. 
 
4.3.12. Buffering capacity assay 
 Titration curves were generated for each polymer to assess their respective 
buffering capacities.  First, 4 mg of polymer was dissolved in 10mL of 18.2MΩ 
distilled water.  Using a TitraLab 856 automatic titrator (Radiometer Analytical, Lyon, 
France), the pH of the polymer-containing solution was adjusted to 11.5 with 1 M 
NaOH (25 seconds pH stabilization time before and after the addition of NaOH at a 
rate of 0.06 mL/min) and subsequently titrated with 1M HCl until the solution was 
stabilized at pH 2 (25 seconds pH stabilization time before and after the addition of 
HCl at a rate of 0.06 mL/min).  Hydrogen ion concentrations were monitored with 
TitraMaster 85 software v.1.2.1.  Using the OriginPro 8 software, titration curves were 
fitted to a Boltzmann sigmoidal curve, from which the slope at the inflection point was 
determined.   The buffering capacity of each polymer is expressed as the absolute 
value of the reciprocal slope.   
 
4.3.13. MTS cell viability assay   
 NIH/3T3 cells were grown and incubated with the free polymer solution, 
which was prepared as described previously, according to the protocol described for 
pCMV-luc transfection.  The final free polymer concentrations evaluated were 10, 20, 
 146
 50, 100, and 200 μg/mL, which corresponded to the polymer:DNA weight ratios of 
0.5:1, 1:1, 2.5:1, 5:1, and 10:1, respectively.  For cell viability measurements of 
branched PEI, the additional free polymer concentrations of 1-9 μg/mL in increments 
of 1 μg/mL were evaluated.  After 48 hours of total incubation and rinsing with 200 
μL of phosphate buffered saline (pH 7.4), 20 μL of CellTitre 96® AQueous One 
Solution Cell Proliferation Assay (MTS) reagent (Promega, Madison, WI) was added 
to each well.  Plates were incubated for an additional two hours at 37°C, after which 
the absorbance at 490 nm of each well was read in a Molecular Devices SpectraMax 
Plus384 UV/Vis spectrophotometer.  All polymers were evaluated in triplicate.  Using 
the OriginPro 8 software, data points were fitted to a Boltzmann sigmoidal curve.  
Cytotoxicity results are expressed as IC50 values and calculated as the concentration of 
free polymer, in micrograms per milliliter, at which the measured absorbance was one-
half the absorbance measured at a polymer concentration of 0 μg/mL.  
 
4.3.14. Statistical testing 
 Statistical testing between samples was performed via a two-sample t-test 
assuming unknown variances with an alpha level of 0.05.   
 
4.4. RESULTS 
4.4.1. Polymer synthesis and characterization 
 To isolate the effects of the various pendant groups on transfection and 
polyplex properties, pendant groups were conjugated to a polymer precursor, 
poly(MAOS), of a single molecular weight (MW) and polydispersity index (PDI), to 
form the functionalized polymeric vector.  Three polymer libraries were synthesized, 
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 each representing a different MW but comprising the same polymeric vector 
formulations.  The MW and PDI of the three libraries are summarized in Table 4-1.   
 
Table  4-1.  Conditions and results for the synthesis of homopolymer precursor, 
poly(methacryloxysuccinimide)  
Library
monomer : initiator : CuBr : 
ligand : Cu(II)Br2
(molar ratio)
Reaction solvent 
(wt solvent:wt monomer)
Temperature 
(°C)
Reaction 
time (min) Mp (kDa)
Polydispersity 
index
Low MW 50 : 1 : 1 : 2a : 0 anisole (200%) 90 20 10 1.22
Mid MW 50 : 1 : 1 : 2b : 1 anhydrous DMSO (150%) 100 10 29 1.26
High MW 200 : 1 : 1 : 2b : 1 anhydrous DMSO (125%) 100 15 49 1.25
a ligand = N,N,N′,N′′,N′′ -pentamethyldiethylenetriamine
b ligand = 2,2’-dipyridyl
 
 The pendant groups investigated in this study are shown in Figure 4-1a and the 
general reaction scheme for the synthesis of the mono- and bi-functionalized polymers 
is shown in Figure 4-1b.  Pendant groups were conjugated in single and binary 
combinations to poly(MAOS) to form the functionalized polymeric vector.  Within the 
binary combinations, the following input molar ratios were evaluated – 25/75, 50/50, 
and 75/25.    Seventy unique formulations may be generated from the single and 
serially-incremented binary combinations.  However, solubility issues associated with 
polymers co-functionalized with the hydrophobic alkyl groups limited the total 
number of water-soluble polymers to 38 unique formulations within the combinatorial 
library.  Detailed characterization of the mono-functionalized polymer conjugates are 
reported elsewhere. [21]  The conjugation profiles of bi-functionalized polymers are 
shown in Figure 4-2 and illustrate the nearly quantitative conjugation efficiencies at 
the three molar input ratios for all bi-conjugated pairs.   
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 (a) 
 
(b) 
 
Figure  4-1.  a)  Cationic, pH-sensitive, and hydrophobic pendant groups b) General 
synthetic scheme for functionalizing pendant groups to the 
poly(methacryloxysuccimide) (poly(MAOS)) precursor to form mono- and bi-
functionalized polymeric vectors   
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Figure  4-2.  Conjugation profiles of polymers bi-functionalized with a) 1N b) 2N c) 
3N d) imidazole and e) C6 hexyl and the pendant group indicated.  The co-
functionalization profiles for C4 and C8 were estimated by the C6 conjugation profile 
shown in (e).  The results presented are based on the 1H NMR characterization method 
and correspond to the profiles quantified via UV/Vis spectrophotometry (data not 
shown). 
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 4.4.2. Trends in transfection and biophysical properties 
 For organizational purposes, all transfection and biophysical characterization 
results are divided into two sub-populations of polymers and referred to hereafter as 
the cationic polymers and the alkylated polymers.  The cationic polymers comprise all 
mono- and bi-functionalized polymer formulations containing only cationic pendant 
groups.  The alkylated polymers comprise formulations that contain an alkyl group.  
To conveniently identify the effects of alkylation, data from the four mono-
functionalized cationic polymers are also included with the results for the alkylated 
polymers. 
 
4.4.2.1. Trends in transfection as a function of polymer pendant group 
 An exhaustive screen of the 30 kDa MW library of polymers revealed several 
interesting trends in transfection as a function of the pendant groups conjugated to the 
polymeric vector.  Amongst the cationic polymers, those co-functionalized with up to 
50% imidazole or at least 50% 1N mediated the greatest levels of transfection at a 
polymer:DNA weight ratio of at least 5:1 (labeled with †), while polymers containing 
2N and 3N mediated only moderate levels of transfection at their best (Figure 4-3a).    
 Figure 4-3b shows the transfection profiles of the alkylated polymers arranged 
as a function of hydrocarbon chain length and as a function of the degree of alkyl 
conjugation.  In general, conjugating alkyl groups to cationic polymers did not result 
in any outstanding benefits towards transfection.   Transfection profiles of the 
alkylated polymers did not appear to trend in any specific manner with respect to 
either hydrocarbon chain length or degree of conjugation, with one exception.  As 
alkyl chain length increased for alkylated polymers co-functionalized with 3N, 
transfection efficiency also appeared to increase.  Of the alkylated polymers the 
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 25%Octyl/75%3N formulation mediated the greatest level of transfection at a 
polymer:DNA weight ratio of 10:1, although still one order of magnitude less than the 
highest transfecting cationic formulation.  In addition, polymers co-functionalized 
with C6 and 1N or 2N mediated a relatively high degree of transfection compared to 
their C4 and C8 counterparts (labeled with *).   
 
 
(a) 
 
Figure  4-3.  Transfection profile of NIH/3T3 cells with a) cationic polymers and b) 
alkylated polymers.  The molecular weight of all polymers is 30 kDa.  Transfection 
efficiency is expressed as the relative light units (RLU) measured from luciferase 
reporter protein expression normalized to the absorbance measured at 562 nm.  Each 
polymer was evaluated at five polymer:DNA weight ratios – 0.5:1, 1:1, 2.5:1, 5:1, and 
10:1.  Samples labeled with a dagger (†) represent polymer formulations with the 
highest transfection capacities.  Samples labeled with an asterisk (*) represent C6-
containing formulations that mediated relatively high levels of transfection compared 
to their C4 and C8 counterparts.  
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 Figure  4-3 (continued) 
4.4.2.
e diameter of polyplexes; and buffering capacity and cytotoxicity 
f free polymers.   
 
 
 
(b) 
2. Trends in biophysical properties as a function of polymer pendant group 
 To understand how physicochemical changes to the polymeric vectors may 
give rise to the observed transfection trends, we evaluated various biophysical 
properties of resultant polyplexes as a function of the pendant groups conjugated to the 
polymer.  For reasons provided below, the following polyplex and free polymer 
properties were investigated- relative binding affinity, polyplex stability, net surface 
charge, and effectiv
o
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 4.4.2.2.1 Relative binding affinity and polyplex stability  
 One of the principal design criteria for polymeric delivery systems is the 
ability to bind with DNA and protect it from enzymatic degradation. [25-27]  
Furthermore, this binding interaction must be sufficiently stable to withstand 
competitive interactions from anionic species, such as extracellular and intracellular 
proteins, cytosolic RNA, or nuclear DNA, that can displace the bound DNA and result 
in its premature release. [28, 29]  To assess the binding affinity of polymer to DNA 
and the stability of resultant polyplexes, we employed the EtBr fluorescence 
quenching and recovery assay. [9, 22, 23]  The EtBr assay makes use of the increase in 
fluorescence intensity of the EtBr dye when it intercalates into DNA.  Upon addition 
of a polycation and its subsequent complexation with DNA, EtBr is expelled from 
DNA, resulting in the reduction of fluorescence intensity.  The relative binding 
affinity between polymer vector and DNA may be quantified by the magnitude to 
which fluorescence is quenched.  To further quantify the strength of the binding 
affinity, recovery of the quenched fluorescence may be measured by subsequent 
addition of a polyanion, which serves to represent the competitive anionic 
environment encountered by polyplexes during transfection.  Addition of the 
polyanion competes for binding with the polymeric vector and displaces DNA.  
EtBr/DNA interaction may then resume, resulting in the recovery of the fluorescence 
intensity.  A ten-fold molar excess of the competing polyanion heparin, relative to 
DNA was employed in the polyplex stability studies to ensure that heparin competed 
with DNA and bound not only with uncomplexed free polymer that may be present in 
solution. [22] 
 Overall inspection of the relative binding affinities of the cationic polymers 
(Figure 4-4a) shows that 1N-containing polymers generally possessed the greatest 
binding affinities.  Quantitative analysis of polymers at the 5:1 and 10:1 polymer:DNA 
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 ratios revealed that 1N-containing polymers had approximately 10% greater binding 
affinities over 2N- and imidazole-containing polymers and 25% greater affinities over 
3N-containing polymers.  Imidazole-containing polymers possessed comparable 
binding affinities to 2N-containing polymers and roughly 15% greater binding 
affinities over 3N-containing polymers. 
 To summarize the effects of alkylation on the relative binding affinity, Figure 
4-4b plots the percent change in binding levels of alkylated polymers relative to their 
respective mono-functionalized cationic polymer.  The effects of alkyl co-
functionalization appeared to be specific to the cationic co-functionalized partner as 
well as to the polymer:DNA weight ratio.  In particular, when compared to mono-
functionalized polymers of 1N or 2N, alkyl groups reduced the levels of binding by 
approximately 30% at weight ratios of 10:1, regardless of the hydrocarbon chain 
length of the alkyl group.  In contrast, alkylation of imidazole-containing polymers 
generally reduced binding to a degree that was proportional to chain length; however, 
at a 10:1 polymer:DNA ratio, the trend was reversed with binding reduced more so 
with shorter chained alkyl groups.  Of particular interest was the increase in relative 
binding affinities due to alkylation of 3N-containing polymers.  However, as the butyl 
content increased from 25% to 75% conjugation, the effects were reversed and binding 
affinity was reduced relative to the 100% 3N polymer.   
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 (a) 
(b) 
Figure  4-4.  Relative binding affinities of a) cationic polymers and b) alkylated 
polymers.  Alkylation effects on binding affinity are summarized as the percentage 
change in binding affinity relative to the mono-functionalized cationic polymer.  
Results for the alkylated polymers are shown in reverse order of the polymer:DNA 
weight ratios for clarity.  Binding affinities were measured with the ethidium bromide 
fluorescence quenching assay.  Each polymer was evaluated at five polymer:DNA 
weight ratios – 0.5:1, 1:1, 2.5:1, 5:1, and 10:1.    
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  The relative strengths of polyplex binding for the cationic polymers, which 
estimate the stability of resultant polyplexes, are shown in Figure 4-5a.  In general, 
imidazole-containing polymers formed more stable polyplexes that were more 
resistant to dissociation compared to polymers that contained only 1N, 2N, and 3N at 
nearly all polymer:DNA weight ratios.  In particular, at polymer:DNA ratios of 5:1 
and 10:1, imidazole-based polyplexes were on average 140% more resistant to 
dissociation than 1N-based polyplexes.  Compared to 2N- and 3N-based polyplexes, 
enhanced resistance was approximately 75% and 50%, respectively. 
   The effects of alkylation on polyplex stability are summarized similarly to the 
binding affinities of alkylated polymers where the percent change in dissociation 
relative to the mono-functionalized polymer is plotted (Figure 4-5b).  In general, 
alkylation reduced the degree to which DNA dissociated from 1N-, 2N-, and 3N-
containing polymers, thus indicating an enhancement in binding strength.  This 
enhancement did not appear to follow any consistent trends as a function of 
hydrocarbon chain length or degree of conjugation.  In the case of the 75%1N/25%C8 
formulation, the binding strength was increased by nearly 75% at a polymer:DNA 
ratio of 5:1.   In contrast, alkylation decreased the strength of the binding interactions 
between DNA and polymers co-functionalized with imidazole groups. 
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Figure  4-5.  Polyplex stability is shown as a) the relative binding strength for the 
cationic polymers and b) summarized for the alkylated polymers as the percentage 
change in polyplex dissociation relative to the mono-functionalized cationic polymer.  
Positive values represent an increase in dissociation, or decrease in binding strength, 
due to alkylation and vice versa for negative values.  Results for the alkylated 
polymers are shown in reverse order of the polymer:DNA weight ratios for clarity.  
Polyplex stability was evaluated with the ethidium bromide fluorescence recovery 
assay performed immediately subsequent to the relative binding affinity quenching 
assay.  Each polymer was evaluated at five polymer:DNA weight ratios – 0.5:1, 1:1, 
2.5:1, 5:1, and 10:1.   
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 (a) 
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 4.4.2.2.2 Zeta potential and size 
 In addition to protecting DNA from enzymatic degradation, polymer/DNA 
complexation also acts to neutralize the negatively charged phosphate backbone of 
DNA and condense its bulky structure to appropriate length scales for cellular 
internalization. [30]  It is generally accepted that a neutral to slightly electropositive 
surface charge favors transfection, presumably through non-specific interactions with 
membrane-associated, anionic proteoglycans. [27, 31]  Additionally, an effective 
polyplex diameter of 200 nm or less is typically desired to promote uptake via 
endocytic pathways. [30]  Based on the zeta potential profiles of both cationic and 
alkylated libraries shown in Figures 4-6a and 6b, the charge neutralizing capacities of 
the cations decrease in the order of 1N > 2N ~ 3N > imidazole.  This relative order of 
charge neutralizing capacity is illustrated in the alkylated library where alkylated 
polymers co-functionalized with 1N produced polyplexes with a more positive zeta 
potential than 3N, which produced polyplexes with a slightly higher zeta potential than 
2N.  In contrast to the greater charge neutralizing power of 3N over 2N seen amongst 
the alkylated polymers, polymers within the cationic library suggested otherwise.  
Comparison of the mono-functionalized 2N and 3N polymers revealed that 100% 2N 
polymers had approximately +4 mV higher zeta potentials than 100% 3N polymers at 
comparable polymer: DNA ratios; while comparison of 1N/2N formulations and 
1N/3N formulations showed comparable zeta potentials.  Imidazole, on the other hand, 
possessed clearly less charge neutralizing ability compared to 1N, 2N, and 3N.  All 
alkylated imidazole-containing polymers were unable to charge neutralize DNA.  The 
weak charge neutralizing capacity of imidazole was further supported by the zeta 
potential profiles of the cationic polymers seen in Figure 4-6a where the 
polymer:DNA ratio required to produce a positive zeta potential was at least 5:1 
compared to the 2.5:1 ratio required by non-imidazole containing polymers.  
 160
 Moreover, polymers containing 100% imidazole formed polyplexes that were barely 
neutralized (+1.3mV) at the highest polymer:DNA ratio (10:1).   
 Alkyl co-functionalization resulted in a markedly lower charge neutralizing 
power observed amongst alkylated polymers compared to their respective mono-
functionalized polymers.  In general, the charge neutralizing power of alkylated 
polymers appeared to decrease with decreasing chain length.  That is, polymers 
alkylated with 25% C8 resulted in polyplexes with a zeta potential more positive than 
those produced from 25% C6 polymers, which were more positive than those from 
25% C4 polymers.  However, as alkyl content increased beyond 25% 
functionalization, charge neutralization was not achieved with any of the cationic co-
functionalization partners (Figure 4-6b).   
   
(a) 
 
Figure  4-6.  Surface charge measurements of polyplexes formed by a) cationic 
polymers and b) alkylated polymers.  Each polymer was evaluated at five 
polymer:DNA weight ratios – 0.5:1, 1:1, 2.5:1, 5:1, and 10:1.  
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 Figure  4-6 (continued) 
 
(b) 
 
 Similar to the trends in charge neutralizing power as a function of the cationic 
group, the relative size condensing capacity decreased in the order of 1N > 3N > 2N> 
imidazole (data not shown).  Specifically, polyplexes formed by cationic and alkylated 
polymers containing 1N, 3N, and 2N were generally less than 200, 250, 300 nm in 
size, respectively.  Polyplexes larger than these respective size limits were typically 
polymers that were co-functionalized with either alkyl or imidazole groups.    
 
4.4.2.2.3 Buffering capacity 
 If cellular entry is gained by endocytosis, polyplexes are sequestered within 
membrane-bound vesicles and shuttled along intracellular routes including the endo-
lysosomal pathway.  Release from these vesicles is paramount for avoiding enzymatic 
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 degradation within the lysosomal compartment. [32]  One strategy for avoiding 
lysosomal degradation is by incorporating pH-sensitive moieties into polymeric vector 
designs to act as buffering agents within endosomes.  It has been hypothesized that the 
buffering effect induces vesicle swelling, rupture, and finally release of the polyplexes 
into the cytosol. [33, 34]  In this study, we have evaluated the buffering capacity of 
each polymer in its free uncomplexed state via acid-base titration.   
  The buffering capacities for the cationic and alkylated polymers are shown in 
Figures 4-7a and 7b. In general, the polymers with the greatest buffering capacity were 
those functionalized with 100% imidazole and 100% 3N.  However, upon co-
functionalizing with another cationic group, the buffering capacities of resultant 
polymers were diminished.  In some cases, buffering capacities were reduced to levels 
below that of the two mono-functionalized polymers containing 100% of each cation 
of the conjugation pair.  For comparison, the buffering capacities of b-PEI and water 
are shown in the buffering capacity plots.  The buffering capacity of b-PEI was clearly 
greater than any of the polymers in the library.   
 Amongst the alkylated polymers, alkylation reduced the buffering capacity 
compared to the respective mono-functionalized polymers, with the exception of 2N-
containing polymers, which remained relatively unaffected by alkylation.  With the 
imidazole containing polymers, buffering capacity generally decreased with increasing 
alkyl chain length; whereas the reduction in buffering capacity of 1N- and 3N- 
containing polymers appeared to be independent of chain length and remained 
constant at all degrees of alkyl conjugation. 
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(b) 
Figure  4-7.  Buffering capacity of free, uncomplexed a) cationic polymers and b) 
alkylated polymers.  The buffering capacity was evaluated via acid-base titration.  
Titration curves were fitted to a Boltzmann sigmoidal curve, from which the slope at 
the inflection point was determined.  Buffering capacities are expressed as the absolute 
value of the reciprocal slope.  Error bars represent the standard error propagated from 
data fitted to the sigmoidal curve. 
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 4.4.2.2.4 Cytotoxicity 
 One of the biggest challenges facing synthetic delivery systems, second to 
subtherapeutic transfection efficiencies, is cytotoxicity.  For gene delivery to be 
successful, the cells receiving the therapeutic genes must remain viable to sustain the 
expression of the prescribed proteins.  Therefore, an important design consideration is 
the cytotoxic effect of both the polyplex and the free polymer, derived from any 
uncomplexed vector remaining after polyplex formation or upon intracellular release 
of the DNA. [35, 36]   
 The in vitro cytotoxicity of each polymer was assessed by the MTS cell 
viability assay following the same protocol as the transfection assay but measuring 
metabolic activity at the conclusion of the assay rather than reporter gene expression.  
Cytotoxicity was quantified as the concentration of free polymer at which the 
metabolic activity of cells, as determined by the measured UV/Vis absorbance 
associated with the MTS cell viability assay, was one-half the metabolic activity of 
cells that were treated with free polymer solutions containing 0 μg/mL of polymer.  
All polymers were evaluated in their free, uncomplexed form at the polymer 
concentrations that corresponded with the five polymer:DNA weight ratios evaluated 
in the transfection assay.  Since the cytotoxic effects of polymeric vectors are typically 
greater in their free form compared to their complexed state, the cell viability 
measurements reported herein represent a conservative cytotoxicity estimate of each 
polymeric vector. [9, 37]    
 All cationic and alkylated polymers in the library possessed IC50 values greater 
than 200 μg/mL, with only a single exception (data not shown).  The 100% 1N 
polymer formulation possessed an IC50 value of approximately 50 μg/mL.  For 
comparison, the IC50 value of b-PEI was approximately 5 μg/mL.   
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 4.4.2.3. Characteristics of high transfecting polymers 
 Shown in Figure 4-8 are the aggregated transfection levels as a function of the 
biophysical properties of the polyplex or the free polymer. In general, the greatest 
levels of transfection were achieved by polyplexes with at least a +10 mV zeta 
potential and less than 220 nm in size.  Also characteristic of high transfecting 
formulations was the ability to quench at least 40% of the EtBr/DNA fluorescence and 
maintain at least 10% and at most 30% of the quenched fluorescence in the presence 
of competing polyanions.  Based on the trends shown in Figures 4-8e and 4-8f, there 
appears to be little correlation between transfection levels and either the buffering 
capacity or the cytotoxicity of polymers.   
 
(a) 
 
Figure  4-8.  Aggregated trends in transfection as a function of a) polyplex surface 
charge, b) effective diameter of polyplexes, c) relative binding affinity, d) relative 
binding strength, e) buffering capacity, and f) cytotoxicity.  In general, high levels of 
transfection correlated with polyplexes that carried at least a +10 mV surface charge 
and were less than 220 nm in size.  Also correlative of high transfecting polymers 
were those with ≥ 10% binding affinity and binding strengths ranging between 10-
30%.  No salient correlations were observed with buffering capacity and cytotoxicity.  
The samples with IC50 = 5 ug/mL represent b-PEI and those with IC50 = 50 ug/mL 
represent 100% 1N. 
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 Figure  4-8 (continued) 
 
 
 
 
 
 
 
(b) 
(c) 
(d) 
 167
 Figure  4-8 (continued) 
 
(e) 
 
(f) 
 
4.4.3. Effects of MW on transfection trends 
 Numerous reports have shown MW to be a critical structural attribute that can 
greatly influence the transfection capacity and biophysical properties of polymeric 
delivery systems.  In general, high MW (≥ 25 kDa) polymers are typically associated 
with enhanced transfection efficiency and higher levels of cytotoxicity; while low MW 
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 polymers (≤ 2 kDa) typically result in lower levels of transfection and are less 
cytotoxic. [38-41]   
   To investigate the effects of MW on this system of polymers, two additional 
libraries were synthesized and screened - one at 10 kDa and the other at 50 kDa, each 
comprising the same polymer formulations as the previously described 30 kDa library.  
The transfection profiles of cationic polymers at all three MWs are shown in Figure 4-
9a.   
 In general, the trends in transfection within the 10 kDa and 50 kDa libraries 
remained fairly consistent with those observed in the 30 kDa library.  That is, 
polymers containing up to 50% imidazole or at least 50% 1N afforded the greatest 
levels of transfection and polymers co-functionalized with either 2N or 3N mediated 
only moderate levels of transfection.  Although the trends remained the same, the 
levels of transfection appeared to increase with increasing MW.  Overall inspection of 
Figure 4-9a shows that the 50 kDa polymer library is populated with a greater number 
of high performing polymers that mediated high levels of transfection at a lower 
polymer:DNA ratio compared to the 30 kDa polymer library.  Within the 10 kDa 
polymer library, the highest transfecting polymers mediated an order of magnitude 
less transfection compared to the highest performing polymers identified in the 30 kDa 
and 50 kDa libraries.   
 MW did not have as marked of an effect on the alkylated polymers as it did 
with the cationic polymers. (Figure 4-9b) Although the trends generally remained the 
same - polymers co-functionalized with C6 and either 1N, 2N, or 3N resulted in 
moderate degrees of transfection; and the 25%OCtyl/75%3N formulation mediated the 
greatest level of transfection of the alkylated polymers, though still less than the 
highest transfecting cationic polymers – they were not enhanced or diminished as a 
result of MW effects. 
 169
  
 
 
 
(a) 
 
Figure  4-9.  Effects of molecular weight on the transfection profile of NIH/3T3 cells 
with a) cationic polymers and b) alkylated polymers.  Molecular weights of 10, 30, 
and 50 kDa were evaluated.  The three molecular weight libraries had comparable 
polydispersity indices of 1.2-1.3.  Transfection efficiency is expressed as the relative 
light units (RLU) measured from luciferase reporter protein expression normalized to 
the absorbance measured at 562 nm.  Each polymer was evaluated at five 
polymer:DNA weight ratios – 0.5:1, 1:1, 2.5:1, 5:1, and 10:1.  For clarity, not all 
formulations are labeled on the x-axis. 
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Figure  4-9 (continued) 
 
 
(b) 
 
 Figure 4-10 shows the highest transfecting 30 kDa and 50 kDa polymers 
plotted alongside their 50 kDa and 30 kDa counterparts, respectively.  The highest 
transfecting polymers (labeled with †) mediated statistically comparable levels of 
transfection to b-PEI (25 kDa) at its optimal weight ratio with DNA (0.5:1).  Labeled 
with an asterisk (*) are the formulations for which an increase in MW from 30 kDa to 
50 kDa resulted in statistically higher levels of transfection. 
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Figure  4-10.  Transfection profiles of 30 kDa and 50 kDa polymers that mediated 
statistically comparable levels of transfection to b-PEI (25 kDa) at its optimal weight 
ratio with DNA (0.5:1) (labeled with a dagger (†)).  Labeled with an asterisk (*) are 
the 50 kDa formulations that mediated statistically higher levels of transfection 
compared to their 30 kDa counterparts.  The biophysical properties corresponding to 
each formulation are detailed in Table 4-2. 
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 Table  4-2.   Biophysical properties of high transfecting 30 kDa and 50 kDa polymers compared with branched PEI (25 kDa). 
Polymer formulation a Molecular Weight
polymer : DNA
(w:w)
Size
(nm) Zeta potential (mV)
Relative binding 
affinity 
Relative binding 
strength
Buffering 
capacity 
(x105 a.u.)
IC50
(μg/mL)
30 kDa 118 ± 1.0 21 ± 0.15 0.45 ± 0.005 0.28 ± 0.001 171 ± 4.7 > 200
50 kDa 114 ± 0.6 21 ± 0.65 0.48 ± 0.012 0.12 ± 0.002 149 ± 7.5 > 200
30 kDa 219 ± 2.3 14 ± 0.31 0.4 ± 0.004 0.14 ± 0.001 171 ± 4.7 > 200
50 kDa 256 ± 11.5 13.2 ± 0.40 0.4 ± 0.008 0.17 ± 0.002 149 ± 7.5 > 200
30 kDa 119 ± 2.9 28 ± 0.81 0.57 ± 0.022 0.15 ± 0.003 164 ± 6.2 > 200
50 kDa 107 ± 0.1 33 ± 0.85 0.42 ± 0.016 0.48 ± 0.005 184 ± 7.9 > 200
30 kDa 98 ± 1.1 24 ± 0.55 0.48 ± 0.016 0.18 ± 0.003 164 ± 6.2 > 200
50 kDa 140 ± 7.5 30 ± 1.15 0.44 ± 0.016 0.41 ± 0.004 184 ± 7.9 > 200
30 kDa 10 : 1 99 ± 2.5 38 ± 0.35 0.59 ± 0.009 0.11 ± 0.001 172 ± 8.2 76.6 ± 1.0
50 kDa 5 : 1 87 ± 0.5 26 ± 0.32 0.56 ± 0.015 0.25 ± 0.001 202 ± 8.0 48.9 ± 0.3
30 kDa 802 ± 18.8 8.1 ± 0.27 0.40 ± 0.006 0.41 ± 0.002 166 ± 7.7 > 200
50 kDa 397 ± 31.2 10 ± 0.59 0.37 ± 0.014 0.49 ± 0.009 124 ± 6.6 > 200
30 kDa 179 ± 1.0 16 ± 0.26 0.45 ± 0.005 0.13 ± 0.001 197 ± 4.5 > 200
50 kDa 99 ± 1.9 16 ± 1.08 0.40 ± 0.011 0.43 ± 0.005 171 ± 7.7 > 200
b-PEI  25 kDa 0.5 : 1 152 ± 6.7 33 ± 0.56 0.95 ± 0.169 0.33 ± 0.014 893 ± 34.7
b-PEI  25 kDa 1 : 1 84 ± 1.8 36 ± 0.87 0.99 ± 1.10 0.18 ± 0.745 893 ± 34.7
4.83 ± 0.17
75% 1N / 25% Imidazole 10 : 1 
75% 1N / 25% Imidazole 5 : 1
100% 1N
25% 1N / 75% Imidazole
50% 2N / 50% Imidazole
10 : 1 
10 : 1 
50% 1N / 50% Imidazole 10 : 1 
50% 1N / 50% Imidazole 5 : 1
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a Formulations in bold achieved statistically higher levels of transfection than their 30 kDa counterparts 
 
 
 4.4.4. Effects of MW on biophysical trends 
 Biophysical characterization of the high-transfecting polymers, identified in 
Figure 4-10, uncovered some interesting trends, particularly amongst the formulations 
for which transfection efficiencies were enhanced due to an increase in MW. (Table 4-
2).  In general, higher transfection efficiencies afforded by a higher MW corresponded 
with polyplexes with slightly greater zeta potentials and reduced effective diameters, 
although polyplexes as large as 400 nm were still able to mediate high levels of 
transfection.  Interestingly, MW appeared to have little effect on the relative binding 
affinity, yet significantly affected the stability of polyplexes, with over a three-fold 
increase in the relative binding strengths afforded by some 50 kDa polymers compared 
to equivalent 30 kDa formulations.   Higher transfection efficiencies did not appear to 
correlate with buffering capacities nor coincide with any salient compromises in cell 
viability.   
 To further examine whether the trends in biophysical properties observed 
amongst the high performing 50 kDa polymers were representative of the rest of the 
50 kDa library, the relative binding affinities, relative binding strengths, and 
cytotoxicity profiles were characterized for the entire 50 kDa library.  Molecular 
weight appeared to have little appreciable effect on the relative binding affinity of 
cationic and alkylated polymers, unaffecting both the trends and magnitude of binding 
affinities (data not shown). 
 In contrast, MW appeared to have a more pronounced effect on the stability of 
polyplexes and their ability to resist dissociation by competing anionic species.  These 
MW effects, however, seemed to affect the cationic polymers only.  To summarize the 
general effects of MW on polyplex stability, Figure 4-11 shows the aggregated 
binding strengths of all 1N-, 2N-, 3N-, and imidzole-containing formulations, at the 
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 5:1 and 10:1 weight ratios, amongst the cationic polymers.  Based on the upward trend 
of binding strengths as the MW of cationic polymers increased, high MW polymers 
appeared to form polyplexes that were more stable and resistant to dissociation.  In 
contrast, no salient trends as a function of MW were observed amongst the alkylated 
polymers (data not shown).   
 
 
Figure  4-11.  Effects of molecular weight on the binding strengths of cationic 
polymers.  The binding strengths of 1N-, 2N-, 3N-, and imidazole-containing 
polymers were averaged together to summarize the general trend in binding strength 
as a function of molecular weight.  Averages for each group of polymers were based 
on polyplexes formed at the polymer:DNA weight ratios of 5:1 and 10:1. 
  
 The cytotoxic effects of the free polymers increased slightly with increasing 
MW.  Figure 4-12 shows a decrease in IC50 values of three formulations as MW 
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 increases from 10 kDa to 50 kDa.  All other formulations maintained IC50 values 
greater than 200 μg/mL (data not shown).   
 
igure  4-12.  Effects of molecular weight on the cytotoxicity of polymeric vectors.  
4.5. DISCUSSION 
his study have revealed several important correlations with 
 
F
The in vitro cytotoxicity of each polymer was assessed by the MTS cell viability assay 
at the free polymer concentrations - 10, 20, 50, 100, and 200 μg/mL, which 
corresponded to the following polymer:DNA weight ratios evaluated in the 
transfection assay - 0.5:1, 1:1, 2.5:1, 5:1, and 10:1, respectively. Cytotoxicity results 
are expressed as IC50 values and calculated as the concentration of free polymer at 
which the measured absorbance (MTS cell viability assay) was one-half the 
absorbance measured at a polymer concentration of 0 μg/mL. 
 
 The results in t
regard to the chemical attributes of polymeric vectors that favor transfection.  In 
particular, polymers containing ≥ 50% 1N or ≤ 50% imidazole groups mediated the 
greatest levels of transfection.  Based on the biophysical trends observed as a function 
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 of the chemical changes made to the polymeric vector, the functional role of 1N 
appeared to be based on its superior ability to efficiently complex with DNA.  Figure 
4-4a shows the relatively high binding affinities of 1N-containing polymers, which 
resulted in polyplexes that were less than 220 nm in size and carried a net positive zeta 
potential (Figure 4-6a).   
 The transfection enhancing activity of imidazole also appeared to stem from its 
of binding mediated by imidazole groups.   
function as a DNA-complexing agent.  However, in contrast to 1N, its mode of 
interaction with DNA seemed to include non-electrostatic interactions, which may 
have explained its enhanced ability to prevent polyplexes from dissociating in the 
presence of competing polyanions and prematurely releasing DNA.  Imidazole’s non-
electrostatically mediated condensing property has been reported previously by others 
and is supported here by several lines of evidence. [9, 24, 42]  First, Figure 4-6a shows 
that imidazole-containing polymers have a weaker ability to charge neutralize DNA 
relative to polymers containing 1N, 2N, or 3N.  In principle, the zeta potential of 
polyplexes should be closely related to the binding affinity of cationic polymers since 
the electrostatic interaction between cation and anionic DNA is the condensation mode 
for which cations are employed in polymeric vector designs.  Cationic polymers that 
induce polyplexes with a more positive zeta potential presumably bind to DNA more 
tightly. [43]  Thus, one might expect the binding affinity of the cationic pendant 
groups to trend in the same order as that determined for charge neutralizing power 
(i.e., 1N>2N~3N>imidazole).  Figure 4-4a, however, suggests that imidazole-
containing polymers possessed comparable levels of binding to 2N-containing 
polymers and in fact, 15% greater binding levels than 3N-containing polymers.  The 
enhanced binding, yet inferior charge neutralizing and size condensing capacity of 
imidazole, compared to both 2N and 3N, suggest an additional, non-electrostatic mode 
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  A second line of evidence for the non-ionic binding interactions of imidazole 
with DNA is provided by the results from the polyplex stability studies shown in 
purportedly enables them to mediate endo-lysosomal 
ssed a mechanism by which DNA may be released, an event that is 
Figure 4-5a.  In this study, the stability of polyplex binding, or the binding strength, 
was evaluated by the degree to which polyplexes were dissociated upon exposure to an 
excess of a competing polyanion.  The use of an ionic species to effect polyplex 
dissociation assumes that any interaction that is of an electrostatic nature or weaker, 
between the polymer and DNA, will be disrupted by the competing electrostatics.  The 
results from the stability studies revealed that imidazole-containing polymers 
dissociated less compared to 1N-, 2N-, and 3N-containing polymers, suggesting that 
1) the strength of the binding interactions between DNA and imidazole-containing 
polymers was greater than that between DNA and 1N-, 2N-,and 3N-containing 
polymers; and/or 2) binding interactions between imidazole and DNA may be 
mediated by non-electrostatic forces, which stabilized polyplexes and resulted in more 
efficient delivery to cells.   
 Imidazole has also been employed in numerous vector designs for their 
buffering capacity, which 
escape.[9, 15, 16]  Indeed, Figure 4-7a shows that amongst the mono-functionalized 
cationic polymers, imidazole had the greatest buffering capacity.  Upon co-
functionalization with 1N, however, the buffering contributions by imidazole groups 
appeared to be masked as suggested by the diminished buffering levels of 
imidazole/1N co-functionalized polymers.  Therefore, it is unclear whether the high 
transfection levels achieved by 1N/imidazole co-functionalized polymers are 
attributable to any endo-lysosomal escape functionality that the imidazole groups may 
have contributed. 
 Collectively, the results from the polyplex stability studies showed that all of 
the polymers posse
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 b d to be necessary in order for efficient gene expression to occur. [29, 44]  
However, the ability to release DNA must also be balanced with the capacity to 
prevent premature dissociation into non-productive or enzymatically degradative 
environments. [45]  Indeed, Figure 4-8d shows that high levels of transfection are 
associated with an optimal range of polymer binding strengths, outside of which 
transfection efficiency is diminished.  Based on the binding affinity, dissociation, and 
transfection results, polymers co-functionalized with imidazole groups were able to 
afford appropriate levels of binding and subsequent release.  Additionally, the fact that 
high levels of transfection were mediated mostly by imidazole-containing polymers, 
despite their similar buffering capacities to low-transfecting polymers, suggests that 
imidazole’s primary transfection- enhancing effect in this system of polymers may not 
be its purported buffering capacity.  Rather, it may lie in its ability to effectively 
interact with DNA to form stable polyplexes that were able to withstand competing 
anionic forces without dissociating.  Further evaluation of the intracellular trafficking 
mechanisms, cellular localization, and transport dynamics will be needed to correlate 
with the stability results observed here in order to fully resolve the spatial and 
temporal details of DNA dissociation from imidazole-based polymers.  The 
information obtained from these studies could have important implications on the 
strategic use of imidazole groups in polymer vector design.   
The highest transfecting polymers identified in the 50 kDa library also 
included imidazole and 1N co-functionalized together.  
elieve  
Figure 4-10 shows the 
transfection levels of the highest-transfecting polymers identified in both the 30 kDa 
and 50 kDa libraries, with their respective biophysical properties summarized in Table 
4-2.  Although a MW increase did not necessarily enhance the transfection levels of all 
the high-performing polymers identified in the 30 kDa library (e.g., 50%1N/50% 
imidazole at 10:1 polymer:DNA ratio), a couple of trends emerged that were common 
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 amongst polymers that did mediate statistically higher levels of transfection as a result 
of a higher MW.  For the most part, polyplexes formed by the high-transfecting 50 
kDa polymers carried a greater zeta potential, were smaller in size, and dissociated 
less readily in the presence of competing polyanions, compared to their 30 kDa 
counterparts.   
 Interestingly, the chemical and structural features shared by high performing 
polymers in this study stand in direct contrast to previous reports from our group that 
nt groups.  In general, polymers containing these pendant groups did 
ot me
ering capacity results in 
showed improved transfection profiles with lower MW and increasing imidazole 
conjugation, upwards of 85%, to a polylysine backbone. [9, 16]  A likely explanation 
for the disparate trends may be attributed to the different polymer backbone employed 
in each study.  Whereas the previous two studies employed a polylysine backbone to 
which imidazole groups were attached, the present study utilized a methyl 
methacrylate backbone to which pendant groups were conjugated.  Although the 
pendant groups evaluated in each of the three reports are similar, they are not 
identical, highlighting the dramatic effects that seemingly subtle structural and 
chemical modifications may have on the transfection capacity of polymeric 
vectors.[46-48]   
 Also observed in this study were the trends associated with the 2N, 3N, C4, 
C6, and C8 penda
n diate high levels of transfection; however, the correlations between their 
biophysical characterizations and transfection profiles have provided important 
insights into their respective functional roles in transfection.   
 Like imidazole groups, 3N has been proposed to offer enhanced buffering 
capabilities to facilitate endo-lysosomal escape. [49]  The buff
Figure 4-7a show that at certain conjugation ratios, 3N increased the buffering 
capacity of polymers when co-functionalized with 1N and 2N, compared to 100% 1N 
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 and 100% 2N polymers, respectively.  However, the added capacity did not translate 
to enhancements in transfection efficiency.  In light of other reports that have also 
questioned the endo-lysosomal disrupting ability of 3N-containing polymers, further 
studies will be needed to clarify the buffering role of the 3N moiety in gene delivery. 
[50]   
 Similar to 1N, 2N and 3N functioned primarily as cationic centers that 
electrostatically interacted with DNA to bind, condense, and neutralize its charge, 
 membrane components that result in cellular 
though to a lesser degree than 1N.  (Figure 4-4a, Figure 4-6a)  When co-functionalized 
with 1N, 2N and 3N appeared to function as charge moderators, forming polyplexes 
with less positive zeta potentials compared to 100% 1N polymers.  In contrast, when 
co-functionalized with less cationic groups, (e.g., imidazole and alkyl groups), 2N and 
3N facilitated DNA complexation through their relatively greater charge capacity.  
However, based on the collective results of all biophysical properties evaluated in the 
present work, there appeared to be little other transfection-enhancing ability offered by 
2N and 3N and their use merely as cationic centers did not appear to be advantageous, 
at least in this system of polymers.  
 Hydrophobic residues have been shown to enhance transfection presumably 
through favorable interactions with
uptake. [43, 51]  To investigate the effects of hydrophobic derivitization on 
transfection and the biophysical properties of resultant polyplexes, we evaluated both 
the effect of hydrocarbon chain length and degree of alkyl conjugation using the C4 
butyl, C6 hexyl, and C8 octyl hydrophobic alkyl groups.  Based on the binding affinity 
and polyplex stability trends observed amongst the alkylated polymers (Figure 4-4b, 
Figure 4-5b), hydrophobic moieties appeared to function primarily in altering the 
dynamics of polyplex formation.  Particularly noteworthy was the reduced ability for 
DNA to dissociate from alkylated polymers that were co-functionalized with either 
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 1N, 2N, or 3N, compared to their respective mono-functionalized cationic polymers.  
This result was surprising since the trends in Figure 4-6b show that alkylation tended 
to reduce the charge neutralizing capacity of cationic polymers.  The reduction in 
charge neutralization might imply a weaker interaction between alkylated polymers 
and DNA and thus an increased tendency for dissociating in the presence of competing 
polyanions.  However, the observed decrease in dissociation suggests that alkylation 
may induce a hydrophobically-driven conformational rearrangement of the polymer 
perhaps during polyplex formation.  That is, to achieve a more thermodynamically-
favorable conformation, hydrophobic residues may drive the polyplex to assume a 
conformation that collapses down on the DNA thereby preventing it from dissociating 
readily, even in the presence of a ten-fold excess of a competing polyanion.  In 
contrast to the benefits that a reduced ability for polyplex dissociation appeared to 
have for imidazole-based polyplexes, this characteristic seemed to be detrimental for 
alkylated polymers.  Since the dissociation properties for alkylated polymers did not 
appear to change with MW (data not shown), it was difficult to verify whether the 
inability for the polyplex to unravel explains the poor transfection profiles of the 
alkylated polymers.  In light of other reports that have conjectured similar clustering 
effects of hydophobically-derivitized polymeric vectors and their subsequent effect on 
transfection, it is clear that hydrophobic derivitization of polymers may be a strategy 
for enhancing transfection. [10, 43]  However, further investigation will be needed to 
fully understand the underlying mechanisms by which hydrophobic moieties can 
augment the transfection process before they can be strategically incorporated into 
polymeric gene delivery systems.   
 Despite the relatively unfavorable biophysical properties of polyplexes formed 
by alkylated polymers, there were a few formulations that resulted in moderate levels 
of transfection.  Specifically, polymers co-functionalized with 25% C6 and either 1N 
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 or 2N mediated moderate levels of transfection.  This result was rather unexpected 
considering formulations of 25% C4 and 25% C8 resulted in negligible transfection. In 
the case of 25% alkylation with 75% 3N, moderate levels of transfection were realized 
with C6 and further enhanced as the alkyl chain length increased to C8.  Taken 
together, these results suggest that an optimal degree of hydrophobicity may be 
beneficial towards transfection, and deviations from that optimum may be deleterious.  
Similar observations have been reported by others and serve to reinforce the critical, 
yet poorly understood, hydrophobic/hydrophilic balance that must be considered in 
polymeric vector design. [10, 43]  Analysis of the biophysical properties of the 
moderately transfecting alkylated polyplexes did not reveal any obvious incongruities 
that might explain the disparate transfection profiles.   
 An important general attribute worth noting is the favorable cytotoxicity 
profiles of the polymers examined in this study, even those with a MW of 50 kDa.  Of 
the 114 total polymers evaluated, only four formulations possessed IC50 values less 
than the maximum concentration of free polymers exposed to cells (200 μg/mL). 
(Figure 4-12)  Amongst the ten highest-transfecting formulations identified in the 
present study, only two possessed IC50 values less than 200 μg/mL. (Table 4-2)  For 
comparison, the IC50 value of b-PEI was approximately 5 μg/mL.  Considering that 
the majority of polymers within the three MW libraries exhibited relatively good cell 
viability, it is likely that cytotoxicity was not a predominant factor in explaining the 
transfection differential observed between the three libraries of polymers.  More 
importantly, in light of the cytotoxic effects of b-PEI and many PEI-based vector 
designs, these favorable cytotoxicity profiles further reinforce the utility of the 
polymeric system reported herein as a viable, alternative platform for future studies of 
various polymeric chemical and structural features and their functional roles in gene 
delivery.  
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  In conclusion, we have demonstrated the utility of combinatorial strategies for 
systematically evaluating the functional role of cationic, pH-sensitive, and 
hydrophobic pendant groups in the transfection process.  In addition to reporting the 
olymep ric chemical and structural features that most favor transfection and their 
purported mechanisms, this work introduces a simple and robust polymeric platform 
upon which future structure-function studies may be based.  By standardizing the 
polymeric structures and synthetic protocols, the structure-function relationships that 
govern polymer-mediated gene delivery may be more clearly defined, potentially 
leading to safer and more efficient polymeric delivery systems.  
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 APPENDIX 
Conversion of measured UV/Vis absorbance (at 260 nm) of polymers co-
functionalized with benzylamine to conjugation ratio 
 
Example: 
Bi-functionalized polymer with 25% benzylamine and 75% 3N   (A260=0.346) 
 
Bi-functionalized polymer with 75% benzylamine and 25% imidazole   
(A260=0.842) 
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  To determine the benzylamine concentration that corresponds to different 
theoretical conjugation ratios of benzylamine, the following equations were used: 
 
x
MWyxMWyMWx
MW backboneybenzxbipoly
))(()()(
,
+++=   (4.1) 
where MWbipoly,x is the molecular weight of a repeat unit containing x conjugation ratio 
of benzylamine in units of g/mol of benzylamine; x is the theoretical benzylamine 
conjugation ratio; MWbenz is the calculated molecular weight of conjugated 
benzylamine (106 g/mol); y  = 1 - x is the theoretical conjugation ratio of the co-
functionalized pendant group; MWy is the calculated molecular weight of the 
conjugated co-functionalized pendant group; and MWbackbone is the calculated 
molecular weight of a repeat unit of the polymeric backbone (69 g/mol).   
 
xbipoly
benz MWv
mC
,∗
=     (4.2) 
where Cbenz is the benzylamine concentration in units of mol/L that corresponds to the 
theoretical benzylamine conjugation ratio, x, of a UV/Vis polymer sample of weight, 
m (0.005 g), dissolved in volume, v (0.006 L), of solvent.  Absorbance values at 260 
nm, A260, corresponding to Cbenz values were determined from a calibration curve 
generated from free base benzylamine dissolved in the same solvent as the bi-
functionalized polymeric samples.   
x y
MWbipoly,x
(g/mol benzylamine)
Cbenz
(mol/L) A260a
MWbipoly,x
(g/mol benzylamine)
Cbenz
(mol/L) A260a
1.0 0.0 175 0.0048 0.849 175 0.0048 0.849
0.9 0.1 192 0.0043 0.774 195 0.0043 0.764
0.8 0.2 214 0.0039 0.697 220 0.0038 0.679
0.7 0.3 242 0.0034 0.618 252 0.0033 0.594
0.6 0.4 279 0.0030 0.537 294 0.0028 0.510
0.5 0.5 331 0.0025 0.455 354 0.0024 0.426
0.4 0.6 409 0.0020 0.370 444 0.0019 0.343
0.3 0.7 539 0.0015 0.284 593 0.0014 0.259
0.2 0.8 799 0.0010 0.196 891 0.0009 0.177
0.1 0.9 1579 0.0005 0.105 1786 0.0005 0.094
benzylamine/3N co-functionalization benzylamine/imidazole co-functionalization
a  The absorbance values were determined from a calibration curve generated from free base benzylamine dissolved in 0.1N HCl at 
concentrations ranging from 0.1mM - 5 mM.  The linear fit trendline used in this example is A260 = 175.69*Cbenz + 0.0124.
 186
  A linear trendline fitted to the plot of x vs. A260 for each bi-functionalized pair 
was then used to convert the measured absorbance of bi-functionalized polymers to 
the conjugation ratio of benzylamine, Xbenz. 
 
A260 for benzylamine/3N polymer = 0.346 corresponds to Xbenz = 32% 
benzylamine conjugation 
A260 for benzylamine/imidazole polymer = 0.842 corresponds to Xbenz  = 71% 
benzylamine conjugation 
 
The conjugation ratios of 3N and imidazole were calculated by: 
benzmr XX −=1,exp,   (4.3) 
 
Xexp, 0.75,3N = 68% conjugation of 3N 
Xexp, 0.25,imid = 29% conjugation of imidazole 
 
A conjugation efficiency value relative to benzylamine, CEB,r,m, was then calculated 
according to the following equation: 
m
mr
mrB r
X
CE ,exp,,, =   (4.4) 
where r is the input molar ratio (0.25, 0.50, 0.75) of pendant group m.   
 
CEB, 0.75,3N = 0.68/0.75 =0.91 
CEB, 0.25,imid = 0.29/0.25 =1.16 
 
To calculate the coefficient efficiency of each pendant group relative to each other, the 
following equation was used: 
2,,
1,,
,
2
1
21
mrB
mrB
m
m
mm CE
CE
r
r
CE ∗=   (4.5) 
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For 25% input molar percentage (r=0.25) of imidazole: 
CEimid,3N = (0.25/0.75) * (1.16/0.91) = 0.42 
 
For 75% input molar percentage (r=0.75) of 3N: 
CE3N,imid = (0.75/0.25) * (0.91/1.16) = 2.35 
 
To calculate the conjugation ratio of a polymer bi-functionalized with 75%3N and 
25% imidazole, the following equation was used: 
 
)(
1221
21
1
,,
,
,
mmmm
mm
mcalc CECE
CE
X +=   (4.6) 
where Xcalc,m1 is the calculated conjugation ratio of pendant group, m1, when co-
functionalized with pendant group, m2.   
 
Xcalc,3N = 0.42 / (0.42+ 2.35) = 15% 
Xcalc,imid = 2.35 / (0.42+ 2.35) = 85% 
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 CHAPTER 5 
 
5 EFFECTS OF THE POLYDISPERSITY INDEX OF POLYMERIC 
VECTORS ON GENE DELIVERY 
5.1. ABSTRACT 
 The molecular weight distribution, or polydispersity index (PDI), of polymeric 
vectors has been implicated as an important parameter for gene delivery.  Yet, direct 
investigation of the functional role that PDI may have on the transfection capacity of 
polymeric gene delivery systems has been scarce in the literature.  In this report, we 
examined the effects of the PDI on the in vitro transfection efficiency and biophysical 
properties of one class of polymeric vectors.  Two polymer libraries, both with 
identically-formulated polymeric vector candidates, were evaluated - 1) a low PDI 
library comprising polymers with PDI=1.3 and 2) a high PDI library comprising 
polymers with PDI =2.0.  The results from this study showed that polymers with a 
high PDI, in general, mediated higher levels of transfection compared to equivalent 
polymers with a low PDI.  The effects of PDI on transfection were found to be 
molecular weight (MW)-specific.  Polymers with a MW = 30 kDa and PDI = 2.0 by 
and large possessed greater transfection efficiencies than equivalent polymers with 
PDI=1.3.  In contrast, PDI effects on 50 kDa polymers were more formulation-specific 
with high PDI polymers affording greater levels of transfection in some cases while 
offering a negligible difference in others.  Particularly interesting were three high PDI 
polymers that mediated transfection levels three-fold greater than branched PEI (25 
kDa), while maintaining superior cell viability profiles.  Biophysical characterization 
revealed that high PDI polymers may provide greater polyplex stability than their low 
PDI counterparts, which may prevent premature polyplex dissociation and enhance 
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 cellular delivery.  Collectively, these results show that the molecular weight 
distribution of polymeric vectors can significantly influence their biophysical 
properties and enhance transfection efficiency and is an important structural attribute 
that should be considered in the design of polymeric gene delivery systems.   
 
5.2. INTRODUCTION 
 The development of polymer-based gene delivery systems has been an active 
and important area of research for over two decades. [1, 2]  Numerous studies 
investigating the functional roles that various chemical and structural polymeric 
features play in the gene transfer process have emerged.  Such structure-function 
studies have revealed the significance and strategic opportunities that these polymeric 
attributes may provide toward enhancing the transfection capacity of polymeric gene 
vectors.  Surprisingly, there has been little research to investigate the effects of an 
important characteristic of synthetic polymers – the molecular weight distribution, or 
polydispersity index (PDI). [3]   
 Conventional wisdom suggests that monodisperse polymers offer more 
uniform and well defined biophysical properties, which presumably translate to better 
transfection capacities. [4]  Indeed, several studies have suggested the importance of 
PDI on gene delivery by investigating polymers with comparable PDIs while varying 
other polymeric attributes such as molecular weight, polymer backbone formulation, 
and side chain composition. [5-7]  However, studies that investigate comparable 
polymeric vectors with different PDIs have been scarcely reported in the existing 
literature. [8]  
 As a step toward a more critical analysis of the effects of PDI on polymer-
mediated transfection, we have evaluated two libraries of polymeric vectors, each 
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 comprising identically-formulated polymers, but with different PDIs.  Polymers with a 
PDI of 1.3 were synthesized to represent the low PDI library and polymers with a PDI 
of 2.0 represented the high PDI library.  Characterization of the polymeric vectors 
included in vitro transfection capacity, polyplex size, zeta potential, relative binding 
affinity, polyplex stability, buffering capacity, and cytotoxicity. 
 The results from this study showed that polymers with a high PDI, in general, 
mediated higher levels of transfection compared to equivalent polymers with a low 
PDI.  Three high PDI formulations were identified to possess transfection capacities 
superior to branched PEI (25 kDa), while maintaining more favorable cell viability 
profiles.  Biophysical characterization revealed that high PDI polymers may provide 
greater polyplex stability than their low PDI counterparts, which may prevent 
premature polyplex dissociation and enhance cellular delivery.  The results from this 
study show that the molecular weight distribution of polymeric vectors can 
significantly influence their biophysical properties and enhance transfection efficiency 
and is an important structural attribute that should be considered in the design of 
polymeric gene delivery systems.   
 
5.3. MATERIALS AND METHODS 
5.3.1. Reagents  
 All chemicals were purchased from Sigma-Aldrich without further purification 
unless otherwise specified.  Cell culture reagents were purchased from Gibco® 
(Carlsbad, CA), pCMV-luc reporter gene plasmid was purchased from Elim 
Biopharmaceuticals (Hayward, CA), and reporter gene assays were purchased from 
Promega (Madison, WI).   
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 5.3.2. General procedure for the synthesis and characterization of homopolymer 
precursor, poly(methacryloxysuccimimide) (poly(MAOS)) 
 The monomer, N-methacryloxysuccinimide was synthesized as previously 
reported. [9]  Details of the synthetic protocol for the polymer precursor, 
poly(MAOS), with a polydispersity index of 1.3 have been previously reported by our 
group. [10]  In brief, a 5 ml pear shaped flask with a flea magnetic stir bar was fitted 
with a rubber septum and flame dried while purging with N2(g), then cooled to 
ambient temperature.  Cu(I)Br, Cu(II)Br2, and the ligand were added to the flask and 
resealed with the septum.  Solvent that was purged with N2(g) for ten minutes prior to 
use was injected into the flask and the contents were stirred under a nitrogen 
atmosphere for approximately ten minutes until dissolved.  N-
methacryloxysuccinimide was added to the flask and allowed to dissolve for another 
ten minutes.  The initiator, ethyl-2-bromoisobutyrate, was directly injected through the 
septum into the flask with a Hamilton syringe and immersed into a thermostated oil 
bath.  To stop the polymerization, the flask was quenched in an ice bath and the 
product was dissolved with anhydrous DMF at a 1:3.75 (w/w) ratio of monomer:DMF.  
Approximately 20 mg of Dowex® Marathon® MSC hydrogen ion exchange resin was 
added to the redissolved solution and allowed to stir for approximately ten minutes.  
The ion exchange resin was added to remove any active copper catalysts remaining in 
the solution. [11]  The final polymer was isolated as a white powder by precipitation 
into stirring acetone.  The precipitated polymer was filtered through a fine-fritted 
Buchner funnel, washed three times with fresh acetone, and dried overnight in vacuo.  
Reaction conditions for the synthesis of the low PDI polymer precursors are 
summarized in Table 5-1.   
 Polymer precursors with a polydispersity index of 2.0 were synthesized with a 
slight modification to a previously reported method. [12]  The initiator used to 
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 synthesize the high PDI precursors, azobisisobutyronitrile (AIBN), was recrystallized 
in methanol prior to use.  For polymer precursor synthesis, a 10 mL round bottom 
flask with a flea magnetic stir bar was fitted with a rubber septum and flame dried 
while purging with N2(g), then cooled to ambient temperature.  N-
methacryloxysuccinimide and AIBN were added to the flask and resealed with the 
rubber septum.  The reaction solvent, acetone, was purged with N2(g) for ten minutes 
before injecting with a Hamilton syringe through the septum into the reaction flask.  
The contents were stirred under a nitrogen atmosphere for approximately ten minutes 
until dissolved.  The reaction flask was then immersed into a thermostated oil bath for 
24 hours during which polymer precipitated out of solution.  To stop the 
polymerization, the flask was quenched in an ice bath.  The precipitated polymer was 
filtered through a fine-fritted Buchner funnel, washed three times with fresh acetone, 
and dried overnight in vacuo.  Reaction conditions for the synthesis of the high PDI 
polymer precursors are summarized in Table 5-1.   
  Molecular weight and polydispersity index were determined by hydrolyzing 
poly(MAOS) to its sodium salt form.  Upon dissolving poly(MAOS) in DMSO at a 
1:8.8 (w/w) ratio of poly(MAOS):DMSO,  a two-fold excess of 5M NaOH was added  
dropwise to the reaction and allowed to stir for 7 hours at room temperature.  The 
cloudy solution was redissolved in filtered deionized water at a 1:80 (w/w) ratio of 
poly(MAOS):water and allowed to stir overnight at room temperature.  The solution 
was then dialyzed against deionized water using Spectra/Por regenerated cellulose 
tubing (MWCO 3500 Da) for three days.  The dialysate was subsequently lyophilized 
to give a white powder.   
 The molecular weight and polydispersity index of each poly(MAOS) precursor 
were evaluated via gel permeation chromatography of the hydrolyzed sodium salt.  
The chemical composition of the polymer precursor was confirmed via 1H NMR 
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 spectroscopy.  The details of the characterization protocol for both methods are 
provided in our previous report.  [13]  Table 5-1 summarizes the molecular weight and 
polydispersity index values determined for each of the polymer precursors used in the 
present study.   
 
Table  5-1.  Conditions and results for the synthesis of homopolymer precursor, 
poly(methacryloxysuccinimide)  
I)  Low polydispersity library - synthesis via atom transfer radical polymerization (Ref. 10)
monomer : ethyl 2-
bromoisobutyrate : CuBr : 
2,2'-dipyridyl : Cu(II)Br2
(molar ratio)
Reaction solvent 
(wt solvent:wt monomer)
Temperature 
(°C)
Reaction 
time Mp (kDa)
Polydispersity 
index
1 50 : 1 : 1 : 2 : 1 anhydrous DMSO (150%) 100 10 mins 29 1.26
2 200 : 1 : 1 : 2 : 1 anhydrous DMSO (125%) 100 15 mins 49 1.25
II)  High polydispersity library - synthesis via free radical polymerization 
monomer : 
azobisisobutyronitrile
(wt : wt)
Reaction solvent 
(wt solvent:wt monomer)
Temperature 
(°C)
Reaction 
time Mp (kDa)
Polydispersity 
index
1 4.5 : 1 acetone (700%) 50 24 hrs 34 1.95
2 18 : 1 acetone (700%) 50 24 hrs 49 1.97
 
5.3.3. General procedure for the synthesis and characterization of functionalized 
polymers  
 The details of the mono- and bi-functionalized polymer syntheses have been 
previously reported by our group. [13]  Briefly, a 5 ml pear shaped flask with flea 
magnetic stir bar was fitted with a rubber septum and flame dried while purging with 
N2(g) until cooled to ambient temperature.  Poly(MAOS) was added to the flask and 
dissolved with deoxygenated anhydrous DMSO at a 1:26.4 (w/w) ratio of 
poly(MAOS):DMSO.  Upon dissolution of the contents, 5 equivalents of the NH2-
containing functional group was dropwise added via a Hamilton syringe and immersed 
in a 75 °C thermostated oil bath.  For the binary conjugations, the first NH2-containing 
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 functional group was dropwise added via a Hamilton syringe followed immediately by 
dropwise addition of the second NH2-containing functional group via a separate 
Hamilton syringe.  After 24 hours, the septum was replaced with a punctured piece of  
Parafilm and placed in vacuo for 4 hours to remove excess solvent.  The final product 
was isolated via dropwise addition into stirring acetone and filtered through a fine 
fritted Buchner funnel and washed twice with acetone, twice with diethyl ether, and 
dried overnight in vacuo.  N-Boc-protected functionalized polymers were isolated via 
dropwise addition into diethyl ether.  The gummy precipitate was redissolved in 
methylene chloride and reprecipitated into diethyl ether to give a white flaky powder.  
The powder was filtered through a fine fritted Buchner funnel and immediately 
deprotected with 20 equivalents of neat trifluoroacetic acid for 8 minutes.  The final 
product was isolated via dropwise addition into stirring diethyl ether and filtered 
through a fine fritted Buchner funnel.  All functionalized polymers were redissolved in 
and dialyzed against 0.1N HCl in Spectra/Por regenerated cellulose tubing (MWCO 
3500 Da) for 4 days.  The dialysate was subsequently lyophilized to give a flaky solid.    
 Conjugation profiles of the functionalized polymers were characterized by 
UV/Vis spectrophotometry and 1H NMR spectroscopy.  The details and results of the 
characterization protocol for both methods are provided in our previous report.  [10] 
 
5.3.4. Cell culture 
 The murine embryonic fibroblast NIH/3T3 cell line was purchased from the 
American Type Culture Collection (Manassas, VA).  Cells were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% v/v fetal calf 
serum, 100 units/mL penicillin, and 100 μg/mL streptomycin.  Cells were grown at 
 201
 37°C and 5% CO2 to an approximately 70% confluent monolayer and passaged every 
3-4 days.   
 
5.3.5. Preparation of polymer-DNA complex (polyplex) transfection solutions 
and free polymer cytotoxicity solutions 
 For each unique polymer, five polymer:DNA (w:w) ratios were evaluated – 
0.5:1, 1:1, 2.5:1, 5:1, and 10:1.  First, 140 μL of polymer solution for each ratio was 
prepared by combining the appropriate volume of 1.5 mg/mL polymer stock solution 
with 10 mM HEPES buffer (pH 7.2) such that each 150 μL of polyplex transfection 
solution contained the intended amount of polymer required to condense 3 μg of 
plasmid.  Polymer solutions were briefly vortexed before adding 140 μL of pCMV-luc 
stock solution (150 μg/mL pCMV-luc in 10mM HEPES buffer, pH 7.2) to each of the 
140 μL of polymer solution.  The polymer/DNA mixture was then vortexed for five 
seconds and incubated at room temperature for 15 minutes to allow for complex 
formation.  Serum-free OPTI-MEM I® medium (770 μL) was added to each polyplex 
solution and briefly vortexed to form the final polyplex transfection solution.    
 For the free polymer cytotoxicity solutions, 140 μL polymer solutions for each 
polymer:DNA ratio were prepared as previously described.  Then, 140 μL of 10 mM 
HEPES buffer (pH 7.2) and 770 μL of OPTI-MEM I® medium were added to each 
solution and briefly vortexed to form the final free polymer cytotoxicity solution.   
 
5.3.6. Plasmid DNA (pCMV-luc) transfection 
 NIH/3T3 cells were grown in clear and opaque, flat-bottomed tissue culture 
polystyrene 96-well plates (Costar, Corning, NY) at an initial density of 5,000 
cells/well in 200 μL of phenol red-free, supplemented DMEM.  Following 24 hours of 
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 incubation at 37°C and 5% CO2, the growth medium was removed and replaced with 
150 μL of polyplex transfection solution, which was prepared as described previously.  
Each 150 μL aliquot of transfection solution contained 3 μg of plasmid DNA.  Cells 
were incubated with the polyplexes for 4 hours, after which the complex-containing 
medium was aspirated and replaced with 100 μL of phenol red-free, supplemented 
DMEM.  Following 44 hours of additional incubation at 37°C and 5% CO2, opaque 
plates were assayed for luciferase expression using the Bright-GloTM Luciferase Assay 
(Promega, Madison, WI) and clear plates were assayed for total protein content using 
the BCATM Protein Quantitation Assay (Pierce Biotechnology, Rockford, IL).  All 
polymers were evaluated in triplicate.  Transfection results are expressed as the ratio 
of relative light units to absorbance at 562 nm.   
 
5.3.7. Bright-GloTM  luciferase assay 
 After a total incubation time of 48 hours from the time of polyplex solution 
addition, growth medium was aspirated and each well was rinsed with 200 μL of 
phosphate buffered saline (pH 7.4).  In a Veritas™ Microplate Luminometer (Turner 
Biosystems, Sunnyvale, CA) 100 μL of Bright-GloTM working solution, prepared 
according to the manufacturer’s direction, was added to each well of the opaque 96-
well plate.  After two minutes of incubation at room temperature, luciferase expression 
was quantified as the relative light units measured in the luminometer. 
 
5.3.8. BCATM protein quantitation assay 
 After a total incubation time of 48 hours from the time of polyplex solution 
addition, growth medium was aspirated and each well was rinsed with 200 μL of 
phosphate buffered saline (pH 7.4).  RIPA buffer (20 μL) (Pierce Biotechnology, 
 203
 Rockford, IL) was added to each well of the clear 96-well plate and incubated at room 
temperature for 10 minutes with gentle shaking.  BCATM working reagent (200 μL) 
(Pierce Biotechnology, Rockford, IL), prepared according to the manufacturer’s 
directions, was then added to each well and gently shaken for 30 seconds at room 
temperature.  Plates were incubated at 37°C and 5% CO2 for one hour before being 
read at 562 nm on a Molecular Devices SpectraMax Plus384 UV/Vis 
spectrophotometer. 
 
5.3.9. Relative binding affinity and polyplex stability assay 
 The relative degree of electrostatic binding between DNA and polymer in the 
absence and presence of a competing polyanion was measured using ethidium bromide 
(EtBr) (Fisher Scientific, Pittsburgh, PA) fluorescence quenching and recovery. [14-
16]  Heparin sodium salt (4.38 mM) dissolved in 10mM HEPES buffer (pH 7.2) was 
used as the competing polyanion. [15]  A free polymer solution (180 μL) for each 
polymer:DNA ratio was prepared by combining the appropriate volume of 1.5 mg/mL 
polymer stock solution with 10mM HEPES buffer (pH 7.2) such that each 50 μL 
aliquot resulted in the intended w:w ratio of polymer and pCMV-luc.  A stock solution 
of EtBr/DNA was made by combining equal volumes of pCMV-luc (150 μg/mL 
pCMV-luc in 10mM HEPES buffer, pH 7.2) and EtBr (0.1095mM EtBr in 10mM 
HEPES buffer, pH 7.2) stock solutions, resulting in a 4:1 ratio of phosphate groups to 
EtBr monomer units.  All fluorescence readings were obtained in a Molecular Devices 
SpectraMax GeminiXS at λex = 535 nm and λem = 595nm (automatic calibration, 10 
seconds of mixing prior to reading, and automatic sensitivity of PMT detector).  All 
polymers were evaluated in triplicate. 
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  First, 100 μL of EtBr/DNA solution was added to each well of a black 
polystyrene 96-well plate (Costar, Corning, NY) and the fluorescence was measured.  
An aliquot of 50 μL of free polymer solution was then added to each EtBr/DNA-
containing well, gently shaken at room temperature on a microplate shaker for 15 
minutes, and the fluorescence measured again.  A 50 μL aliquot of 4.38 mM heparin 
was added to each well, gently shaken at room temperature on a microplate shaker for 
4 hours, and the fluorescence measured for a final time.  The relative binding affinity 
(BA) and relative binding strength (BS) were calculated from the following equations: 
 
DE
polymerDE
F
FF
BA
/
/ −=   (5.1) 
 
polymerDE
hepDE
FF
FF
BS −
−=
/
/   (5.2) 
 
where FE/D is the corrected fluorescence of  EtBr/DNA in the absence of polymeric 
vector; Fpolymer is the corrected fluorescence of  EtBr/DNA in the presence of 
polymeric vector; Fhep is the corrected fluorescence of EtBr/DNA in the presence of 
polymeric vector and heparin.    
 All fluorescence measurements were corrected by subtracting background 
fluorescence due to free EtBr and due to volume effects.  Background values from free 
EtBr were obtained from triplicate wells, on each 96 well plate, containing EtBr and 
10mM HEPES buffer for the first two fluorescence readings and EtBr, HEPES buffer, 
and heparin for the final fluorescence measurement.  Background values due to 
volume effects were determined from triplicate wells, on each 96 well plate, 
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 containing EtBr/DNA and HEPES buffer in volumes equal to those added to the 
polymer samples.   
 
5.3.10. Polyplex size and zeta potential measurement 
 A 140 μL solution of free polymer was prepared for each polymer:DNA ratio 
by combining the appropriate volume of 1.5 mg/mL polymer stock solution with 10 
mM HEPES buffer (pH 7.2) such that the final 1.05 mL polyplex solution contained 
the intended w:w ratio of polymer and pCMV-luc.  Polymer solutions were briefly 
vortexed before adding 140 μL of pCMV-luc stock solution (150 μg/mL pCMV-luc in 
10mM HEPES buffer, pH 7.2) to each of the 140 μL of free polymer solution.  The 
polymer:DNA mixture was vortexed for five seconds and incubated at room 
temperature for 15 minutes to allow for complex formation.  Then, 770 μL of 10mM 
HEPES buffer (pH 7.2) was added to each polymer:DNA solution and briefly vortexed 
to form the final polyplex solution used in both sizing and zeta potential 
measurements.   
 Size and zeta potential characterizations were performed using the Nanosizer 
Nano ZS (Malvern Instruments).  The refractive index and viscosity values of water 
were used as parameter inputs.  Malvern Dispersion Technology Software was used 
for data acquisition and analysis, applying the general purpose algorithm for 
calculating size distributions and the Smoluchowski approximation for determining 
zeta potential. 
 
5.3.11. Buffering capacity assay 
 Titration curves were generated for each polymer to assess their respective 
buffering capacities.  First, 4 mg of polymer was dissolved in 10mL of 18.2MΩ 
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 distilled water.  Using a TitraLab 856 automatic titrator (Radiometer Analytical, Lyon, 
France), the pH of the polymer-containing solution was adjusted to 11.5 with 1 M 
NaOH (25 seconds pH stabilization time before and after the addition of NaOH at a 
rate of 0.06 mL/min) and subsequently titrated with 1M HCl until the solution was 
stabilized at pH 2 (25 seconds pH stabilization time before and after the addition of 
HCl at a rate of 0.06 mL/min).  Hydrogen ion concentrations were monitored with 
TitraMaster 85 software v.1.2.1.  Using the OriginPro 8 software, titration curves were 
fitted to a Boltzmann sigmoidal curve, from which the slope at the inflection point was 
determined.   The buffering capacity of each polymer is expressed as the absolute 
value of the reciprocal slope. 
   
5.3.12. MTS cell viability assay  
 NIH/3T3 cells were grown and incubated with the free polymer solution, 
which was prepared as described previously, according to the protocol described for 
pCMV-luc transfection.  The final free polymer concentrations evaluated were 10, 20, 
50, 100, and 200 μg/mL, which corresponded to the polymer:DNA weight ratios of 
0.5:1, 1:1, 2.5:1, 5:1, and 10:1, respectively.  For cell viability measurements of 
branched PEI, the additional free polymer concentrations of 1-9 μg/mL in increments 
of 1 μg/mL were evaluated.  After 48 hours of total incubation and rinsing with 200 
μL of phosphate buffered saline (pH 7.4), 20 μL of CellTitre 96® AQueous One 
Solution Cell Proliferation Assay (MTS) reagent (Promega, Madison, WI) was added 
to each well.  Plates were incubated for an additional two hours at 37°C, after which 
the absorbance at 490 nm of each well was read in a Molecular Devices SpectraMax 
Plus384 UV/Vis spectrophotometer.  All polymers were evaluated in triplicate.  Using 
the OriginPro 8 software, data points were fitted to a Boltzmann sigmoidal curve.  
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 Cytotoxicity results are expressed as IC50 values and calculated as the concentration of 
free polymer, in micrograms per milliliter, at which the measured absorbance was one-
half the absorbance measured at a polymer concentration of 0 μg/mL.  
5.4. RESULTS AND DISCUSSION  
 Two libraries of polymeric vectors were evaluated to investigate the effects of 
the polydispersity index (PDI) on the transfection capacity of polymer-based gene 
delivery systems.  Each library represented polymers that shared a common PDI – 1.3 
or 2.0 - and comprised the same set of vector formulations.  The polymeric vectors 
that constituted each PDI library were synthesized according to the synthetic scheme 
shown in Figure 5-1a, where one or two of the functional groups shown in Figure 5-1b 
were conjugated to the homopolymer precursor, poly(methacryloxysuccinimide). [13]  
The formulations of the functionalized polymeric vectors were chosen based on a 
previous study that identified such formulations to possess moderate to high 
transfection capacities. [10]  For the present study, high levels of transfection were 
defined as having within the same order of magnitude or greater levels of transfection 
as 25 kDa branched PEI (b-PEI). 
(a) 
Figure  5-1.  a) General synthetic scheme for polymer vectors.  One or two NH2-
containing functional groups were conjugated to the homopolymer precursor, 
poly(methacryloxysuccimide), to form the mono- and bi-functionalized polymeric 
vectors.  b) Functional groups conjugated to the polymer precursor 
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 Figure 5-1 (continued) 
 
 
 
(b) 
 
  
 All polymers were assessed for their utility as gene delivery vectors by an in 
vitro luciferase reporter gene transfection assay on NIH/3T3 cells. [10]  Figure 5-2 
shows the transfection profiles of the low PDI and high PDI libraries.  In general, 
polymers with a high PDI mediated moderately higher levels of transfection than 
polymers with a low PDI.  An interesting observation was the MW-specific effects of 
PDI on transfection capacity.  That is, amongst the 30 kDa polymers, those with a high 
PDI mediated greater levels of transfection compared to their low PDI counterparts.  
Whereas amongst the 50 kDa polymers, PDI effects were less consistent - some high 
PDI formulations possessed enhanced transfection capacities over their low PDI 
counterparts, while other formulations possessed diminished capacities or offered a 
negligible difference.   
 Closer examination of the highest performing polymers (i.e., polymers that 
mediated transfection efficiencies within an order of magnitude or greater than b-PEI) 
revealed several high PDI formulations that resulted in significant enhancements in 
transfection compared to both b-PEI and their low PDI counterparts.  Figure 5-3 
identifies the five high PDI formulations that resulted in statistically greater 
transfection efficiencies compared to their low PDI equivalents (labeled with *) and 
the three formulations that mediated transfection levels superior to b-PEI, with up to a 
three-fold improvement (labeled with †).  
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Figure  5-2.  Transfection efficiencies of all polymers within the low polydispersity 
and high polydispersity (PDI) libraries.  Transfection efficiencies are expressed as the 
measured relative light unit (RLU) of luciferase expression normalized to the UV/Vis 
absorbance at 562nm (BCATM protein quantitation assay).  Polymers were evaluated at 
the following polymer:DNA weight ratios – 0.5:1, 1:1, 2.5:1, 5:1, and 10:1.  Polymers 
with PDI=1.3 represented the low PDI library and those with PDI=2.0 represented the 
high PDI library.  All samples were performed in triplicate.  Standard errors for 
samples with RLU/A562 ≥100,000 were typically within 30% of the average value 
(data not shown). 
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Figure  5-3.  Transfection efficiencies of high-performing polymers at their optimal 
polymer:DNA weight ratios identified within the low and high polydispersity libraries.  
Transfection efficiencies are expressed as the measured relative light unit (RLU) of 
luciferase expression normalized to the UV/Vis absorbance at 562nm (BCATM protein 
quantitation assay).  Asterisks (*) denote statistical significance between the low and 
high PDI polymers of the same molecular weight and formulation.  Daggers (†) 
represent statistical significance compared to branched-PEI at a polymer:DNA weight 
ratio of 0.5:1.   Statistical testing between samples was performed via a two-sample t-
test assuming unknown variances with an alpha level of 0.05.  Samples were 
performed in triplicate and error bars represent +/- one standard deviation.     
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  To understand the transfection-enhancing effects of PDI, the biophysical 
properties of each polyplex were characterized to ascertain differences that might 
explain the divergent transfection profiles.  The biophysical properties investigated in 
this study have been shown in previous reports to be important for the transfection 
efficiency of polymeric vectors. [2, 17-22]  These properties include- the relative 
binding affinity, polyplex stability, net surface charge, and effective diameters of 
polyplexes; and the buffering capacity and cytotoxicity of free polymers.   
 Polymers with a high PDI, in general, had comparable buffering capacities and 
formed polyplexes that carried comparable zeta potentials as polymers with a low PDI 
(data not shown).  Although the relative binding affinity between polymeric vector and 
DNA was observed to be different between equivalent polymers of different PDIs, the 
difference did not appear to trend with transfection in any correlative manner and was 
therefore considered unlikely to be a predominant factor in explaining the PDI effects 
on transfection (data not shown).  The cytotoxicity levels and the size of resultant 
polyplexes formed by the high PDI polymers were generally greater than those of the 
low PDI polymers (data not shown).  However, upon examining the cytotoxicity 
profiles of the highest transfecting polymers, most maintained superb cell viability as 
evidenced in Figure 5-4a, which shows that most of the high performing formulations 
were associated with an IC50 value greater than the maximum free polymer 
concentration exposed to cells (200 μg/mL).  For comparison, the IC50 value of b-PEI 
was calculated to be approximately 4.8 μg/mL.  Furthermore, in contrast to the general 
trend that high PDI polymers produced polyplexes with greater effective diameters, 
most of the high performing polyplexes were less than 200 nm in size (Figure 5-4b).     
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(a) 
 
Figure  5-4 a) Cytotoxicity profiles of high-transfecting polymers.  The in vitro 
cytotoxicity of each polymer was assessed by the MTS cell viability assay at the free 
polymer concentrations - 10, 20, 50, 100, and 200 μg/mL, which corresponded to the 
following polymer:DNA weight ratios evaluated in the transfection assay - 0.5:1, 1:1, 
2.5:1, 5:1, and 10:1, respectively. Cytotoxicity results are expressed as IC50 values and 
calculated as the concentration of free polymer at which the measured absorbance 
(MTS cell viability assay) was one-half the absorbance measured at a polymer 
concentration of 0 μg/mL.  b) Size of high-transfecting polyplexes.  The polyplex size 
was measured using dynamic light scattering.  Arrows indicate formulations that 
achieved transfection efficiencies superior to branched PEI. Cytotoxicity and sizing 
samples were performed in triplicate and error bars represent +/- one standard 
deviation.  Polymers with an IC50 >200 μg/mL did not induce a decrease in 
absorbance by one-half at all free polymer concentrations evaluated.  Thus, exact IC50 
values for such samples and corresponding error bars are not shown.     
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 Figure 5-4 (continued) 
 
(b) 
 
 Of the biophysical properties evaluated in this study, the PDI of polymers had 
the most pronounced effect on the stability of resultant polyplexes.  Similar to the 
MW-specific effects of PDI observed in transfection efficiency, the effect on polyplex 
stability also differed between the 30 kDa and 50 kDa polymers.  Figure 5-5 shows the 
change in relative binding strengths between high PDI polymers and their low PDI 
counterparts, for all vector formulations, at the representative polymer:DNA weight 
ratio of 10:1.   
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Figure  5-5.  Change in relative binding strength between high polydispersity polymers 
and their low polydispersity (PDI) counterparts for all vector formulations. Shown are 
the results for each polymer at a polymer:DNA weight ratio of 10:1 as they are 
representative of the results obtained at the 5:1 and 2.5:1 weight ratios.  Positive 
values represent higher binding strengths of high PDI polymers compared to their low 
PDI equivalents.  Error bars represent the standard error associated with the calculated 
difference in average relative binding strengths between equivalent formulations at the 
low and high PDI values. 
 
With few exceptions, high PDI polymers with a molecular weight of 30 kDa 
generally afforded more stable polyplexes than their low PDI/30 kDa equivalents.  
However, this general trend was reversed for the 50 kDa set of polymers - those with a 
high PDI produced polyplexes that were less stable and dissociated more readily in the 
presence of competing polyanions.   
Interestingly, closer examination of the high PDI formulations that 
outperformed their low PDI counterparts (i.e., formulations labeled with an asterisk in 
Figure 5-3) revealed an anomaly to this trend (Figure 5-6).  The single 50kDa/high 
PDI formulation that mediated a statistically greater level of transfection than its low 
PDI counterpart had over 330% greater binding strength.  This result suggests that a 
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 higher PDI may enhance the transfection capacity of polymeric vectors by producing 
more stable polyplexes that are more resistant to dissociating in the presence of 
competing polyanions, compared to equivalent polymeric vectors with a lower PDI.   
 
igure  5-6.  Relative binding strengths of formulations that achieved statistically 
derlying molecular mechanisms that govern the different binding 
 
F
greater levels of transfection than their low PDI counterparts.  With only one 
exception, formulations with a high PDI had greater binding strengths than their 
respective low PDI formulation.   
  
 The un
stabilities observed between the low and high PDI polymers are not clearly 
understood.  Possible insight may be afforded, however, by the interpolyelectrolyte 
exchange and substitution theory postulated and extensively investigated by Kabanov 
and coworkers. [23-26]  Based on synthetic model polyions, they showed that in a 
polyelectrolyte system comprising a polycation and two polyanionic species, the 
polycation exists in dynamic electrostatic equilibrium with the polyanions, each of 
which exchange and substitute with the other, competing for interaction with the 
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 polycation. [24]  That is, polycation A electrostatically binds with polyanion B to form 
complex A/B.  Polyanion B, meanwhile, undergoes electrostatic exchange with 
polyanion C to form complex A/C.  The equilibrium that arises is the exchange 
between polyanions B and C to form complexes A/B and A/C, respectively.  
 Extending this investigation to polymeric gene delivery systems and 
employing DNA as one of the polyanions, they showed a similar exchange and 
substitution reaction between a polycationic vector and a synthetic polyanion, which 
represented competing biological polyanions that the polycation/DNA complex may 
encounter during the DNA delivery process. [24, 25]  Moreover, they provided 
evidence that the molecular weight of the polycation may affect the dynamics of the 
equilibrium and consequently the degree to which the polycationic vector could 
protect the DNA cargo from enzymatic degradation within extra- and intracellular 
spaces and prevent its premature release before arriving at the cell nucleus.   
 Applying this theory to the present study, the polyplex transfection solution 
may be considered as a system of independent polycation chains ranging in MWs.  In 
accordance with the MW dependence of the exchange and substitution reactions, the 
collective binding behavior of the polyplex solution will therefore be dictated by the 
range of the polycation MWs and the dynamic interplay between each polycation 
chain and DNA in the presence of a competing polyanion.  Further, if we compare two 
polyplex solutions, each composed of polymers with different PDIs, but otherwise 
identical in composition and experimental conditions, then it follows that polymers 
with a higher PDI will offer a broader range of polyplex binding behavior compared to 
their lower PDI counterparts.   
 Based on the relative binding strengths of the high-transfecting polymers 
identified amongst the present system of polymers (Figure 5-6), it appeared that a 
broader range of binding behavior provided by certain high PDI formulations 
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 enhanced the overall polyplex binding strength, which ultimately led to higher levels 
of transfection.  These results agree well with those observed by Koping-Hoggard et 
al. in that both studies show a PDI-dependent effect on the transfection capacity and 
polyplex stability of polymeric vectors. [8]  
 The effect that a higher PDI appeared to have toward increasing polyplex 
stability also resembles the observations from a previous report that showed a similar 
effect of higher molecular weights on polyplex stability. [10]  In both studies, 
enhanced transfection efficiencies were achieved by changes in a structural attribute of 
the polymeric vector that resulted in increased polyplex stability.  Together, these 
results underscore the importance of polyplex stability and the requirement for 
polymeric vectors to prevent premature dissociation for enhanced cellular delivery. 
[27]  
 In conclusion, the results reported herein demonstrate that the molecular 
weight distribution of polymeric vectors can greatly influence their biophysical 
properties and transfection capacities.  Contrary to the widely held assumption that 
polymers with near unity PDI values may result in greater transfection efficiencies, the 
polymers investigated in the present study with a PDI of 2.0 generally mediated higher 
levels of transfection than equivalent polymers with a PDI of 1.3.  Moreover, three 
formulations, all with a PDI of 2.0, were identified in this study to achieve transfection 
levels that exceeded the popular polymeric vector, b-PEI.  Biophysical 
characterization revealed that high PDI polymers may provide greater polyplex 
stability than equivalent polymers with a lower PDI, which may prevent premature 
polyplex dissociation and enhance cellular delivery.  Thus, the molecular weight 
distribution of polymers is an important consideration in both the design of polymer-
based gene delivery systems as well as the interpretation of transfection results that 
originate from polymers with disparate polydispersity indices. 
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 CHAPTER 6 
 
6 A SIMPLE AND ECONOMICAL HIGH – THROUGHPUT 
EQUILIBRIUM DIALYSIS SYSTEM 
 
6.1. ABSTRACT 
 As high-throughput strategies become increasingly employed by a broader and 
more diverse research community, simple yet reliable technology will be critical to 
fully realize the benefits that high-throughput strategies can offer.  In this report, we 
describe a robust 96-well equilibrium dialysis system designed to purify high 
molecular weight product from a mixture of low molecular byproducts in solution.  
The proposed high-throughput dialysis system offers important enhancements over 
both recently reported and commercially available systems in its easy integration with 
in-line automated high-throughput technology (e.g., robotic liquid and solid handling 
systems, 96-well plate readers), resistance to acidic environments, minimal creation of 
waste, and simple assembly.  Moreover, the dialysis apparatus can be economically 
constructed from commercially available materials and easily fabricated in a standard 
machine shop.  The validation protocol and detailed drawings presented herein can be 
readily modified and applied to other high-throughput platforms such as 6-, 24-, and 
384-well microtiter plates. 
 
6.2. INTRODUCTION 
 High-throughput technology (HTT) has transformed a broad and diverse range of 
research areas from DNA sequencing to compound synthesis to reaction protocol 
optimization.  The small molecule pharmaceutical industry is perhaps one of the most 
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 salient examples of this transformation.  With the introduction of automated 
dispensing systems, thousands of compounds can be synthesized simultaneously in 
multiwell microtiter plates, replacing the arduous task of synthesizing individual 
compounds in separate reaction flasks.  Coupling this technology with high throughput 
analytical equipment, the pace at which viable drug candidates can be identified and 
optimized has greatly accelerated [1]. 
 Given the potential benefits of HTT for small molecule drug development, the 
extension of these strategies to a polymeric biomaterials application may seem natural 
considering both areas of research share similar organic synthesis processes.  As such, 
we and others have adopted high-throughput strategies to facilitate the creation of 
polymer libraries for use in various biomedical research [2-4].  In particular, we have 
adopted HTT to facilitate the synthesis, purification, characterization, and screening of 
a combinatorial library of polymeric biomaterials.  Each step is amenable to high-
throughput processing within 96-well microtiter plates, with the exception of polymer 
purification from within the individual reaction wells.  In smaller scale experiments 
where the number of polymers to purify is modest and each polymer solution is on the 
milliliter scale or greater, traditional equilibrium dialysis is a reliable and commonly 
used method for purifying a high molecular weight (MW) product.  However, in high-
throughput experiments on the microliter scale, transferring individual reaction 
batches into separate dialysis tubes can quickly become unmanageable and inefficient.  
 Several high-throughput equilibrium dialysis systems were recently reported in 
the literature or are currently available commercially [5, 6].  Some were specifically 
designed to purify a desired high MW product from reaction batches, while others 
were designed for use in protein binding assays, but could likely be adapted for a 
purification application.  All of the systems, however, are either cumbersome to 
assemble, require access to specialized equipment (e.g., centrifuge), involve costly 
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 investment in start-up equipment, or require dialysis from a custom-made multiwell 
plate to and from which samples would need to be transferred.    
 In this report we describe a robust high-throughput equilibrium dialysis apparatus 
aimed at addressing the aforementioned limitations associated with the reported and 
commercially available systems.  The dialysis system reported herein was designed to 
purify a high molecular weight polymer from a reaction mixture comprising a two-
fold excess of a low MW molecule that represents reaction byproducts, reagents, and 
other contaminants.  Moreover, the dialysis apparatus can be economically constructed 
from commercially available materials and easily fabricated in an average machine 
shop.  Attributes of the reported system include 1) compatibility with automated liquid 
handling systems, 2) resistance to acidic environments, 3) minimal creation of waste, 
4) ease of assembly, 5) the obviation of specialized equipment, and 6) ready 
integration with in line high-throughput data acquisition technology (e.g., 96-well 
plate reader). 
 
6.3. MATERIALS AND METHODS 
 Figures 6-1a and 6-1b show an assembled and exploded illustration of the dialysis 
apparatus with the source of all materials summarized in Table 6-1.  Detailed drawings 
are provided in the appendix at the end of the chapter. 
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(a) 
 
(b) 
 
 
Figure  6-1.  High throughput equilibrium dialysis system a) Assembled view of 
dialysis apparatus b) Exploded view of dialysis apparatus including 96-well microtiter 
sample plate c) Well assignment of tartrazine and dextran-rhodamine for dialysis 
experiments (yellow).  All other wells contained an equivalent volume of 0.1N HCl 
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 Figure  6-1 (continued) 
 
 
(c) 
 
 
 
Table  6-1.  Materials for equilibrium dialysis system 
Material Manufacturer Catalog No. 
Regenerated Cellulose Dialysis Membrane 
(flat sheet) MWCO=3.5K Da 132723
Regenerated Cellulose Dialysis Membrane 
(flat sheet) MWCO=6-8K Da 132677
Clear gasket (silicone rubber) 86915K16
Orange gasket (silicone rubber) 8608K51
Polycarbonate sheet (12"x12"x 3/8") 8574K31
Polycarbonate sheet (12"x12"x 1/4") 8574K28
Polycarbonate bar (48"x1"x1/2") 1749K14
96 Well Assay Microplate (Flat Bottom; 
Polystyrene; Clear)
Matrix Technologies 
(Hudson, NY) 4915
Titanium Hex Nut (10-32) HNTT-1032
Titanium Threaded Rod (10-32) TRTT-1032
Spectra/Por 
(Rancho Dominguez, CA)
Small Parts, Inc. 
(Miramar, FL)
McMaster-Carr 
(Elmhurst, IL)
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 6.3.1. Samples 
 Dextran-rhodamine (D/R) was purchased from Molecular Probes, Inc. (#D-1824, 
Eugene, OR) and tartrazine from Sigma-Aldrich (#86310, St. Louis, MO).  D/R (10K 
g/mol, 1:1 mol ratio of rhodamine:dextran) and tartrazine (534 g/mol) were used as 
model compounds in this study to represent the high MW retentate and low MW 
dialysate, respectively, dissolved and dialyzed against 0.1N HCl.   All tartrazine and 
D/R calibration standards were made via serial dilutions from a 0.1mM and 0.12mM 
stock solution, respectively.  Solutions with final concentrations of either 50μM 
tartrazine only or 25μM D/R and 50μM tartrazine were made in scintillation vials, 
from which 200μL aliquots were taken and added to their assigned wells of the 96-
well assay plate as shown in Figure 6-1c.  Sample well positions were assigned as 
shown to monitor for cross contamination between wells during dialysis.   
 
6.3.2. Dialysis system assembly 
 The 96-well assay plate was set on the bottom plate of the dialysis apparatus as 
guided by the spacer.  Orange gasket #1 was placed over the assay plate, carefully 
aligning the gasket holes over each well.  A pre-soaked, trimmed dialysis membrane 
(soaked in 0.1N HCl for at least 30 minutes) was placed over gasket #1 and gently 
smoothened out with a gloved finger to remove any air pockets.  According to the 
manufacturer’s instruction, pre-soaking the membrane in an acidic medium is critical 
for neutralizing the cellulose membrane.  Failure in doing so may result in a negatively 
charged membrane that can electrostatically interact with ionic retentate and/or 
dialysate molecules and prevent dialysis.  Clear gasket #2 was placed over the dialysis 
membrane, carefully aligning the gasket holes over each well of the assay plate.  
Trimmed pieces of orange and clear gaskets were laid on the spacer bars before sliding 
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 the top plate through the screws.  (See Figure 6-1b)  Hex nuts were tightened over the 
top plate with a wrench beginning with the lengths of the plate before fastening the 
widths of the plate to ensure a leveled, secured top plate.   
 
6.3.3. Dialysis  
 The assembled dialysis system was flipped over and forcefully shaken in one 
downward motion such that the solution in each well was resting on the dialysis 
membrane.  Carefully rotating the apparatus by ninety degrees so that the dialyzing 
front was perpendicular to the liquid surface, the system was slowly lowered into the 
dialysis bath.  A plastic container with a 9” x 6” base and 5” height filled with 
approximately 4 liters of 0.1N HCl served as the dialysis bath.  The water in front of 
the top plate was manually agitated to relieve any air bubbles that may have become 
trapped in the holes of the top plate.  Upon removing all visible air bubbles, the 
apparatus was flipped over so that the dialyzing front faced the bottom of the water 
bath.  The apparatus was propped up in the water bath with 20mL scintillation vials, 
while remaining completely submerged, to allow for unobstructed stirring of a 
magnetic stir bar set underneath the apparatus.  The stirring speed was set to 
approximately 200rpm.  For experiments with D/R, the water bath was covered with 
aluminum foil.  The apparatus was removed from the bath and the assembly taken 
apart for UV/Vis spectrophotometry analysis at the designated time points, then 
reassembled using a fresh, pre-soaked dialysis membrane.  
 
6.3.4. UV/Vis spectrophotometry and data analysis 
 Absorbance values for tartrazine were read at 430nm and D/R at 550nm on a 
Molecular Devices SpectraMax Plus384 (pathlength check on; water blank cuvette).  
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 Absorbance values at 700nm were taken as a negative control.  Wells with abnormally 
high absorbance values at all three wavelengths due to dust were not included in the 
tartrazine and D/R average calculations.  Tartrazine and D/R values were corrected for 
background absorbance by subtracting the absorbance of 200μL of 0.1N HCl 
(background absorbance = .038 at 430nm, .036 at 550nm, and .035 at 700nm).  
Tartrazine absorbance values were additionally corrected for absorbance contributions 
at 430nm due to D/R.  All tartrazine and D/R concentrations at 430nm and 550 nm 
were quantified against their respective calibration curves.  Average tartrazine and 
D/R concentrations reported are averages of all sample wells (n=13) for one dialysis 
run taken at the designated time point. 
 
6.4. RESULTS AND DISCUSSION 
6.4.1. Time study of equilibrium dialysis of low MW compound through a 3.5K 
MWCO and 6-8K MWCO membrane 
 To characterize the time course of dialysis from the reported apparatus, dialysis of 
50μM of tartrazine through a 3.5K MWCO and a 6-8K MWCO membrane was 
quantified daily.  Experiments consisted of tartrazine dialysis from wells containing no 
high MW polymer.  Based on the dialysis profiles, shown in Figure 6-2, of three 
independent experiments at each MWCO, there is little disparity between tartrazine 
dialysis through a 3.5K and 6-8K MWCO membrane.  However, in one of the three 6-
8K experiments, a relatively large standard deviation was observed at t=38 hours 
(arrow in Figure 6-2).  Upon removing the apparatus to obtain the time point reading, 
it was discovered that an air bubble was present in a well of the top plate that 
corresponded to a tartrazine well in the 96-well assay plate.  The bubble prevented 
dialysis from the well resulting in the relatively large standard deviation.  Removing 
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 the air bubble for the remainder of the experiment resumed dialysis.  The results 
highlight the importance of expelling all air bubbles before commencing dialysis.  
Nevertheless, in both experimental setups, tartrazine was dialyzed to less than 10% of 
the initial concentration after 60 hours and less than 1% after 130 hours.    
 
 
 
Figure  6-2.  Dialysis profiles of tartrazine from wells initially containing 50μM 
tartrazine in 0.1N HCl.  Tartrazine dialyzed to less than 10% after approximately 60 
hours and less than 1% after approximately 130 hours.  Arrow marks the time point at 
which dialysis was delayed due to an air bubble trapped in one well of the top plate.  
Upon removing the air bubble, dialysis resumed.  Red lines represent dialysis through 
a 3.5K MWCO dialysis membrane; shapes represent dialysis through a 6-8K MWCO 
membrane.  Tartrazine concentrations reported are averages of all sample wells (n=13) 
for one dialysis run taken at the designated time point.  Error bars represent ± one 
standard deviation 
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 6.4.2. Effects of high MW polymer on equilibrium dialysis of low MW 
compound 
 In the presence of a high MW species, dialysis of a low MW molecule may be 
retarded due to accumulation of the high MW species at the membrane surface, which 
may prevent the low MW molecule from freely permeating through.  Alternatively, if 
both the high and low MW species possess aromatic functional groups, pi-pi orbital 
stacking interactions may also affect dialysis.  To determine the potential effects on 
dialysis of such situations, the time course for the dialysis of 50μM of tartrazine 
through a 3.5K and 6-8K MWCO membrane from wells containing 25μM D/R 
(MW=10,000 g/mol) was quantified.  Similar to the initial experiments of dialyzing 
tartrazine in the absence of a high MW polymer, there is little disparity between 
dialyzing through a 3.5K and a 6-8K MWCO membrane (data not shown).  However, 
tartrazine dialysis appeared to be slightly retarded in the presence of D/R with dialysis 
to less than 10% of the initial concentration occurring after 75 hours and to less than 
1% after 160 hours (Figure 6-3).  The precise cause for this is not fully understood 
although it is likely to be attributed to one or both of the previously mentioned factors. 
 The presence of D/R was also monitored throughout dialysis to confirm that it 
was not leaking out either during dialysis or while obtaining the time point readings.  
The D/R profiles shown in Figure 6-3 confirm that D/R was indeed present throughout 
dialysis at its initial concentration.   
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Figure  6-3.  Dialysis profiles of tartrazine from wells initially containing 25μM 
dextran-rhodamine (10K g/mol, 1:1 mol ratio of rhodamine:dextran) and 50μM 
tartrazine in 0.1N HCl.  Dialysis of tartrazine was slightly retarded in the presence of 
dextran-rhodamine (D/R) with dialysis to less than 10% occurring after approximately 
75 hours and less than 1% after approximately 160 hours.  D/R profiles were also 
monitored to confirm that leakage did not occur throughout dialysis.  Shapes represent 
tartrazine profiles in tartrazine only dialyses; red lines represent tartrazine profiles in 
tartrazine + D/R dialyses; blue lines represent D/R profiles in tartrazine + D/R dialyses.  
Tartrazine and D/R concentrations reported are averages of all sample wells (n=13) for 
one dialysis run taken at the designated time point.  Error bars represent ± one 
standard deviation 
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 6.4.3. Effects of membrane replacement and evaluation of leak resistance 
throughout dialysis 
 To confirm that replacing a fresh dialysis membrane between each UV/Vis 
absorbance time point reading in the daily experiments did not alter the time course 
for tartrazine dialysis, the presence of tartrazine was also quantified after 160 and 220 
hours of uninterrupted dialysis, for the tartrazine only and tartrazine plus D/R 
experiments, respectively.  The commercially available Harvard Apparatus 
DispoDialyzer with a 2K and a 5K MWCO membrane were also evaluated for 
comparison.  The results shown in Table 6-2 confirm that after the prescribed time 
course, tartrazine had indeed dialyzed out of their respective wells to less than 1% as 
expected.  Further, the presence of D/R at 100% of its initial concentration after the 
dialysis time course indicates no apparent leakage of the high MW molecule from 
their respective wells.  In contrast, D/R appears to have leaked out of the wells of the 
Harvard Apparatus system with a 5K MWCO membrane, a limitation also 
experienced by others even in a neutral pH dialyzing medium [7]. 
 
 
Table  6-2.  Comparison of percent tartrazine remaining after 160 hours and 220 hours 
of uninterrupted dialysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tartrazine Only dialysis
(160 hrs)
% Tartrazine % Tartrazine % Dextran-Rhodamine
3.5K MWCO 0.53% 0.58% 112.18%
Std Err 0.003% 0.028% 0.095%
6-8K MWCO 1.62% 0.63% 105.53%
Std Err 0.008% 0.015% 0.097%
% Tartrazine % Tartrazine % Dextran-Rhodamine
2K MWCO <.01% <.01% 100.70%
Std Err 0.002% 0.006% 0.226%
5K MWCO 0.69% <.01% 64.00%
Std Err 0.132% 0.012% 0.330%
Tartrazine + Dextran-Rhodamine dialysis
(220 hrs)
Reported dialysis system
Harvard Apparatus 
dialysis system
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 In all of the dialysis experiments, the presence of cross contamination of tartrazine 
and/or D/R into neighboring wells was monitored by observing increases in 
absorbance at 430nm and 550nm, respectively, within wells that originally contained 
the 0.1N HCl dialyzing media.  No such increase was observed, thereby confirming an 
acid-resistant and leak-free seal that prevented cross contamination between wells.   
 
6.4.4. Comparison of additional factors with commercially available dialysis 
systems 
 In addition to dialysis performance, important factors to also consider are the 
costs per sample plate, range of MWCO membranes available, easy integration with 
in-line high-throughput data acquisition systems (e.g., microtiter plate reader), 
minimal creation of waste, and ease of assembling the apparatus.  These factors served 
as additional design criteria for the proposed dialysis system and are compared in 
Table 6-3 with several commercially available systems including those that were 
designed for protein binding assays, but could likely be adapted for equilibrium 
dialysis. 
 A striking distinction between the reported dialysis system and all other systems 
compared in Table 6-3 is the use of a standard 96-well microtiter plate as the sample 
plate from which dialysis occurs.  This feature was designed to facilitate seamless 
integration into a continuous process workflow that may include standard multiwell 
dispensing systems for sample preparation before dialysis as well as high-throughput 
data acquisition systems after dialysis.  Additionally, use of a microtiter sample assay 
plate can potentially reduce the amount of waste generated, especially if the microtiter 
plate can be reused for multiple dialyses, compared to other dialysis systems where the 
sample plate and dialysis membrane are manufactured as one conjoined unit.   
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 Table  6-3.  Comparison between reported dialysis system and several commercially 
available systems 
Type Description Start up cost
Cost per 96 
samples Notes
Spectra/Por®  96 well microdialyzer  (#132326) $1,379
custom made 96 well plate (#132330) $224 
dialysis sheets (MWCO=3.5K) (#132723) $8 
dialysis sheets (MWCO=6-8K) (#132677) $3 
Harvard Apparatus 96-Well DispoDIALYZER *
MWCO =2K (#740901) $317 
MWCO =5K (#740902) $317 
Novagen/EMD Biosciences D-Tube96™ 
Dialyzer (#71712-2) $354 
-  Available in 6-8K and 12-14K MWCO membranes
-  Samples must be transferred for high-throughput data 
   acquisition (e.g., microtire plate reader)
-  New dialysis tubes per sample required for each dialysis
Millipore MultiScreen Filter Plate with Ultracel-
10 Membrane (#MAUF01010) $6 
standard 96-well receiver plate $2 
centrifuge 
Pierce®  Biotech Rapid Equilibrium Dialysis 
(RED) Device
reusable Base Plate (#89811) $320 
RED Device Inserts (#89809) $700 
HTDialysis, LLC 96 - well Micro Equilibrium 
Dialysis block- Complete Set (#1006) ** $2,995 
dialysis strips (MWCO=3.5K) (#1135) $35 
dialysis strips (MWCO=6-8K) (#1103) $30 
Polycarbonate housing, titanium screws and hex 
nuts, gaskets $153
96-well plate $2 
dialysis sheets (MWCO=3.5K) $8 
dialysis sheets (MWCO=6-8K) $3 
-  Available in 3.5K, 6-8K, 12-14K MWCO membranes
-  Samples must be transferred for high-throughput data 
   acquisition (e.g., microtire plate reader)
-  Reusable sample plate
-  Minimal assembly required
-  Centrifuge equipped with a 96-well plate rotor required
-  Available in 10K MWCO membrane only
-  Samples must be transferred for high-throughput data 
   acquisition (e.g., microtire plate reader)
-  New sample plate required for each dialysis
-  No assembly required
-  Available in 1K, 2K, 5K, 10K, 25K MWCO membranes
-  Samples must be transferred for high-throughput data 
   acquisition (e.g., microtire plate reader)
-  New sample plate required for each dialysis
-  No assembly required
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-  Available in 3.5K, 6-8K, 12-14K MWCO membranes
-  Compatible with standard 96 well plate 
   (re-usability optional)
-  Minimal assembly required
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*  Design similar to the one reported by Banker, et al.  (5)
**  Design similar to the one reported by Kariv, et al.  (6)
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-  Available in 8K MWCO membrane only
-  Samples must be transferred for high-throughput data 
   acquisition (e.g., microtire plate reader)
-  Reusable sample plate
-  Minimal assembly required
-  Available in 3.5K, 6-8K, 10K, 12-14K, 25K, 50K MWCO 
   membranes
-  Samples must be transferred for high-throughput data 
   acquisition (e.g., microtire plate reader)
-  Reusable sample plate 
-  Assembly of dialysis apparatus can be cumbersome
 
 An additional enhancement of the reported dialysis system is its economical 
construction compared with the other systems presented in Table 6-3.  The 
Spectra/Por®  96-well microdialyzer, the most similar in design to our apparatus, is 
costlier by ten-fold.  While products such as the MilliPore MultiScreen Filter Plate 
offer an affordable ultrafiltration system, only a 10K MWCO membrane is currently 
available and dialysis requires a centrifuge equipped with 96-well plate rotors.   
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 6.5. CONCLUSIONS 
 As more areas of research embrace the advantages of high-throughput strategies, 
simple yet reliable technology will be critical to fully realize the benefits that such 
strategies can offer.  The reported dialysis system offers researchers an improved high-
throughput approach to purifying high MW product from solutions comprising a 
mixture of low MW by-products and reagents.  Constructed from materials that are 
commercially available, the apparatus can be affordably and easily fabricated in a 
standard machine shop.  The proposed system also provides important enhancements 
over both recently reported and commercially available systems.  In particular, the 
system is 1) readily integrated with in-line automated high-throughput technology 
(e.g., robotic liquid and solid handling systems, 96-well plate readers), 2) resistant to 
acidic environments, 3) creates minimal waste, and 4) easy to assemble.   
 More importantly, the dialysis apparatus and the validation approach described 
herein for a 96-well assay platform provides a readily transferable template upon 
which other multi-well assay platforms can be produced.  With all other components 
of the dialysis apparatus interchangeable, simply modifying the dimensions of the top 
plate and the gasket sheets can enable high-throughput dialysis on a 6-, 24-, and 384-
well plate platform. 
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 APPENDIX   
Drawings of apparatus components 
Drawing of bottom plate 
 
 
 
 
Drawing of top plate 
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Drawing of long spacer bar 
 
 
 
 
 
 
 
Drawing of side spacer bar 
 
 238
  
Drawing of trimmed gasket pieces for long spacer bar 
 
 
 
 
 
 
Drawing of trimmed gasket pieces for short spacer bar 
 
 239
  
Drawing of 96-well gasket 
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 CHAPTER 7 
 
7 A STOCHASTIC MONTE CARLO APPROACH TO 
COMBINATORIAL LIBRARY DESIGN 
 
7.1. ABSTRACT 
The exhaustive screening of large combinatorial libraries continues to be 
resource-limited, thus underscoring the need for strategies to representatively sample 
these vast libraries.  In this study, stochastic Metropolis and parallel tempering Monte 
Carlo algorithms were implemented in silico to sample a 5,008 buffer formulation 
library to locate optimal refolding conditions of a model protein.  In contrast to single-
pass random sampling, Monte Carlo sampling occurs through a round-by-round 
iterative process.  In each progressive round, formulations undergo a proposed change 
according to an assigned step increment scheme.  The proposed formulations are 
accepted with probability exp(βΔE), where ΔE is the difference in refolding yield 
between the original and proposed formulations and β is an empirically determined 
parameter that controls the randomness of the sampling.   The results show that 
Metropolis and parallel tempering Monte Carlo sampling protocols locate 
formulations of higher protein refolding yield more frequently than random sampling.  
The average refolding yields of formulations constructed by Metropolis Monte Carlo 
in a 1,000-formulation library increased in a manner dependent on the β parameter and 
the step increment scheme.   
Following each Monte Carlo simulation, the molecular diversity of 
formulations was quantified within a low-dimensional descriptor space as 
parameterized by the surface tension, critical micelle concentration, and solubility of 
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 formulation excipients.  The diversity of formulations in the final sampling rounds 
constructed by the Monte Carlo methods was either maintained or enhanced relative to 
the initial randomly-generated formulation rounds.  The striking results observed in 
this study were obtained through simple parameterization of a combinatorial library, 
absent any a priori information of how individual excipients influence the complex 
phenomena that underlie protein refolding.  This hybrid experimental-computational 
study demonstrates that stochastic Monte Carlo algorithms offer a dramatic 
improvement over the random sampling of combinatorial libraries that may be too 
arduous to exhaustively search otherwise.   
 
7.2. INTRODUCTION 
 The formulation of molecular chaperones in protein refolding buffers is critical 
for the recovery of active proteins for applications in structural genomics, proteomics, 
and biopharmaceuticals.  Given that refolding conditions for proteins are highly 
specific, combinatorial approaches have been employed to formulate buffers for 
optimal protein refolding. [1-5]  Combinatorial strategies involve creating 
combinations of a prescribed set of components and screening the assembled products 
for desired attributes. [6]  Challenges emerge as the number of components increases, 
leading to a rapid escalation in the number of possible combinations in the final 
combinatorial library.  Despite the development of high-throughput screening 
strategies, the degree to which vast combinatorial libraries may be exhaustively 
investigated continues to be limited by space, time, and financial resources.  
Therefore, methods or alternative approaches that reduce the number of samples per 
screen, while maintaining integrity of results, are desired. 
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  Random sampling of a combinatorial library is arguably the simplest 
alternative to screening each individual constituent of the library.  This approach, 
however, is unsystematic and unreliable because it ignores any a priori knowledge or 
chemical intuition.  Although random sampling does not preclude the identification of 
constituents with optimal characteristics, or “figures of merit”, per se, it is unlikely to 
give consistently dependable results.    
 Stochastic Monte Carlo (MC) methods have been previously proposed as 
potential alternatives to the random sampling of large combinatorial libraries. [7]  
Chemical intuition and a priori knowledge can be inherently incorporated into these 
MC approaches, thereby increasing the probability of identifying higher figure of 
merit constituents relative to random sampling.   
In combinatorial screening experiments, however, a maximal figure of merit 
may be only one of several desired attributes.   For instance, in medicinal chemistry, 
discovering compounds that exhibit high potency against a target is clearly valuable.  
Yet, if subsequent analyses reveal such compounds to possess adverse toxicological 
effects, they may be rendered non-viable for further development.  For this reason,  a 
“molecularly diverse” collection of lead compounds that each possess the desired 
figure of merit, but are also sufficiently dissimilar in chemical or structural 
characteristics, may be desirable to increase the probability of identifying compounds 
that are successful through multiple levels of safety and efficacy screens.    
The previous study that used MC methods to locate compounds with high 
figures of merit also showed that molecular diversity was maintained at sufficient 
levels. [7]  However, this study relied on libraries produced solely through in silico 
simulations rather than through experimentally acquired ex silico approaches.   
The present study first examines the refolding of a denatured model protein to 
its functional conformation in each of 5,008 combinatorially-assembled buffer 
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 formulations.  This library represents an exhaustive collection of formulations 
containing combinations of one, two, or three synthetic molecular chaperones (i.e., 
excipients) per formulation.  With this exhaustive data set in hand, the utility of two 
MC sampling approaches, namely Metropolis MC and parallel tempering MC, was 
explored to locate optimal protein refolding buffer formulations as an alternative to 
exhaustive screening and random sampling.  The results of this hybrid experimental-
computational study are consistent with previously established studies that utilized 
only virtual libraries and provide further validation that Monte Carlo methods offer a 
more systematic and efficient approach toward determining high figure of merit 
(refolding yield) formulations compared to random sampling without compromising 
molecular diversity.   
 
7.3. MATERIALS & METHODS 
7.3.1. Protein refolding combinatorial data set  
A total of 5,008 unique formulation conditions for lysozyme refolding, representing an 
exhaustive screen of combinations of one, two, or three excipients per formulation, 
was generated and used as the reference data set for all sampling simulations.  
Refolding solutions were formulated from 32 possible excipients, comprising 16 
chemical species of two concentrations each (Table 7-1).  Individual formulations 
were constrained to not contain duplicate chemical species.  
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Table  7-1.  Summary of excipients, concentrations, and associated descriptors 
 
Excipient 
Number 
Concentration 
(mg/mL) Excipient Descriptor 
Descriptor 
Metric Reference 
1 0.293 -5.0 
2 2.93 
Methylcellulose Solubility 
-4.9 
[8] 
3 0.029 -5.0 
4 0.293 
Polyethylene 
Glycol (Mw 
3500) 
Solubility 
-5.0 
[9] 
5 0.293 -5.0 
6 2.93 
Dextran Solubility 
-4.9 
[10] 
7 29.3 1.1 
8 58.6 
Glycerin Surface Tension 
1.1 
[10] 
9 29.3 -3.3 
10 58.6 
Sorbitol Surface Tension 
-5.0 
[10] 
11 10.26 -5.0 
12 20.51 
Cyclodextrin Solubility 
-4.9 
[11] 
13 0.029 -0.4 
14 0.293 
Polysorbate 80 CMC 
-0.3 
[12] 
15 0.029 -5.0 
16 0.293 
Polysorbate 20 CMC 
-0.3 
[12] 
17 5.43 1.0 
18 10.81 
CHAPS CMC 
5.0 
[12] 
19 0.19 -0.3 
20 1.9 
Triton X-100 CMC 
0.9 
[12] 
21 12.31 -2.4 
22 46.88 
Urea Solubility 
5.0 
[13] 
23 24.64 -1.1 
24 55.96 
Guanidinium 
chloride Solubility 4.0 
[14] 
25 6.3 1.8 
26 24.91 
Lithium 
Chloride Surface Tension 4.3 
[10] 
27 8.56 2.9 
28 34.22 
Sodium Chloride Surface Tension 
5.0 
[10] 
29 4.16 1.3 
30 32.91 
Sodium Sulfate Surface Tension 
3.4 
[10] 
31 12.77 -4.8 
32 38.3 
L-arginine Solubility 
-4.4 
[13] 
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  Lysozyme refolding yields were quantified following a previously reported 
protocol. [15]  Hen egg white lysozyme (Sigma) was dissolved at 40 mg/mL in 
denaturing buffer (8M guanidinium chloride, 16 mM dithiolthreitol, 1 mM EDTA, 50 
mM Tris-HCl, pH 8.0).  Protein concentration was verified by ultraviolet absorbance 
at 280 nm. [16]  Refolding solutions were generated in tissue culture treated 96-well 
polystyrene plates from stock solutions dispensed into the plates using a Tecan 
RSP150 liquid handling system.  The total volume of each refolding solution was 180 
μL.  Protein refolding was initiated by rapid addition of 20 μL of the denatured 
lysozyme solution followed by immediate aspirating and dispensing to prevent protein 
aggregation.  The 96-well plates were then sealed and incubated at room temperature 
for 48 hours.  Refolding was quenched by addition of 0.5 M iodoacetic acid (20 μL).  
Lysozyme samples were diluted 1:100 in 50 mM Tris-HCl (pH 8.0), and the activity 
for each sample was quantified by measuring the rate of optical density change of a M. 
luteus cell wall suspension.  Assays were performed in triplicate, and the refolding 
yield was quantified relative to native lysozyme activity. 
 
7.3.2. Random library construction  
 For library construction in silico, each excipient in Table 7-1 was randomly 
assigned a unique integer value, and formulations were thus represented as a sequence 
of three integers.  For example, a formulation composed of 2.93 mg/mL 
methylcellulose, 5.43 mg/mL CHAPS, and 12.31 mg/mL urea was represented as (2, 
17, 21).  Formulations with less than three excipients were assigned with zero values 
where appropriate.  Formulations were constructed by random assembly from the 32 
possible stock excipients, where each excipient had equal probability of being in a 
formulation.  The lysozyme refolding yield corresponding to the constructed 
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 formulation was obtained from the protein refolding combinatorial data set described 
above.   
7.3.3. Metropolis Monte Carlo library construction 
 In contrast to libraries generated by single-pass random construction, 
formulation libraries constructed by Metropolis MC simulation proceeded in an 
iterative manner.  For illustrative purposes, a 1,000-formulation library generated from 
50 rounds of 20 formulations each is described here.  A starting set of 20 formulations 
was assembled by random construction as described above.  In each subsequent round 
n (n>1), one excipient, x, in each of the 20 formulations was selected at random with 
equal probability to undergo a proposed move to a new excipient, x’. The integer value 
by which x was changed to x’ was determined by the increment size, k, and the 
increment scheme, namely a fixed step scheme or a fluctuating step scheme.  For a 
given step increment, k, excipients in the fixed step simulations were allowed to move 
to new excipient x’ = x + k or x’ = x - k with equal probability, while for fluctuating 
step simulations, excipients were permitted to move within the range (x - k) ≤ x’ ≤ (x + 
k), where the probability of moving to a specific excipient within this range was 
(1/2k).  Simulations were performed for 1 ≤ k ≤ 16.  Periodic boundary conditions 
were applied to the excipient table such that for x+ k  > 32, then x’ = x + k - 32 or for x 
– k  < 1, then x’ = x - k + 32.  
The lysozyme refolding yield corresponding to the newly proposed 
formulation was obtained from the refolding data set.  The move to the new 
formulation configuration was accepted with the following Metropolis acceptance 
probability: 
Pacc (current→proposed)=min (1, exp [β (Eproposed – Ecurrent) ]) (7-1) 
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 where E represents the protein refolding yield, and β represents a constant-value 
control parameter reflecting a propensity to accept trial moves that would result in a 
decrease in the protein refolding yield.    
For proposed moves that were accepted according to equation 7-1, the new 
formulation configuration was assigned to round n+1; otherwise, the formulation in 
round n+1 remained the same configuration as in round n.  New formulations 
resulting from proposed moves in round n, regardless of whether they were accepted 
to round n+1, are referred to as “accessed” formulations throughout this text.  A 
schematic representation of the Metropolis MC library construction method is 
illustrated in Figure 7-1. 
 
 
 
Accept each proposed 
move with acceptance 
probability =
min[1,exp( βΔE)]
Round n Round n’
Accessed
formulations
Choose one excipient at 
random in each 
formulation and propose 
move
Formulation #1
Formulation #2
Formulation #3
Formulation #1
Formulation #2
Formulation #3
Round n+1
Accepted
formulations
Formulation #1
Formulation #2
Formulation #3
Figure  7-1.  Schematic diagram of the Metropolis Monte Carlo algorithm.  Each 
formulation consists of three individual excipients, as represented by the black circles.  
For a given round n, one excipient in each formulation in the round is chosen at 
random to undergo a change to a new excipient, as represented by the white circle.  
The resulting set of proposed formulations, termed accessed formulations, comprises 
round n’.  The proposed formulations are then accepted or rejected by the Metropolis 
acceptance criterion, which determines the makeup of the accepted formulations for 
round n+1. 
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 For Metropolis MC simulations, the initial round was comprised of m 
randomly constructed formulations; with each successive round of MC moves, the 
algorithm accepted the proposed moves according to the specific acceptance 
probability.  After a finite number of rounds, p, the total number of formulations 
sampled was (m x p).  Libraries of 1,000 total formulations were assembled through 
20x50 or 10x100 sampling experiments. 
 
7.3.4. Parallel Tempering Monte Carlo library construction  
For parallel tempering MC library construction, three Metropolis systems of 
five formulations each were simultaneously simulated for 66 rounds.  The three 
simultaneous Metropolis systems were each performed at different, but constant, β.  
Initial formulations within each of the systems were generated by random 
construction.  Within an individual system, one excipient for every formulation was 
selected to undergo a proposed move.  The excipient undergoing the move was 
selected at random, and the proposed move from excipient x to x’ was subject to either 
the fixed step or fluctuating step schemes as described previously.  The move to the 
new excipient was accepted according to the Metropolis acceptance probability, 
equation 7-1.  Once all formulations within the new round were constructed for the 
three Metropolis systems, two of the three parallel systems, randomly chosen, were 
allowed to swap their current set of formulation configurations.  The probability for 
one of the three systems in the simulation to be chosen to participate in a swapping 
move was 2/3.  The acceptance rule for the parallel tempering exchange was: 
 
Pacc (current → proposed) = min [1, exp(ΔβΔĒ)]  (7-2) 
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 where ΔĒ is the difference in the average refolding yield of the five formulations in 
each system, and Δβ is the difference in β between the two systems undergoing 
exchange.  A diagram of the parallel tempering configuration exchange is shown in 
Figure 7-2.  Libraries of 990 total formulations were assembled in 15x66 sampling 
experiments. 
 
 
β = β2β = β1 β = β3
Swap round n” with 
acceptance probability 
= min [1, exp(ΔβΔĒ)]
β = β2β = β1 β = β3
Round n Round n’ Round n” Round n Round n’ Round n” Round n Round n’ Round n”
Round n+1 Round (n+1)’ Round (n+1)” Round n+1 Round (n+1)’ Round (n+1)”Round n+1 Round (n+1)’ Round (n+1)”
 
Figure  7-2.  Schematic diagram of the parallel tempering Monte Carlo configuration 
exchange.  Three parallel systems, represented in white, grey, and black, are depicted.  
Formulations within each of the parallel systems first undergo Metropolis Monte Carlo 
moves as illustrated in Figure 7-1.  Following each round of Metropolis Monte Carlo, 
two of the three parallel systems participate in a conditional configuration swap. 
 
7.3.5. Data analysis and statistical significance testing 
 Formulation libraries generated by the Metropolis and parallel tempering MC 
sampling algorithms, as described previously, were compared with equally-sized 
libraries generated by random construction.  The key difference was that random 
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 formulations were sampled in a single pass, while the MC libraries were constructed 
in an iterative round-over-round fashion. Regardless of the library construction 
method, the total number of formulations remained constant among comparison 
groups.  Simulated libraries were generated in Fortran and performed in triplicate for 
each condition.  Significance testing between samples was performed via the Student’s 
t-test assuming unknown variances (p<0.05 was considered significant).   
 
7.3.6. Molecular diversity 
Given a set of formulations, a quantitative measure of diversity, D, was defined to be:  
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where i, j, and k correspond to indices designating the descriptor, the excipient, and 
the formulations, respectively, and N is the number of formulations. [7]  Diversity 
values were calculated for each of three independent libraries for each simulation 
condition and compared with values obtained from random library construction.   
To maintain a manageable yet useful number of descriptors for this work, a 
low-dimensional descriptor space was established to quantify the diversity of 
formulations within each library.  Excipients were sorted into one of three distinct 
descriptor categories: the critical micelle concentration (CMC), surface tension, and 
solubility in water.  Cooperative effects among different descriptor categories were not 
taken into account in the diversity measurements.  
 In general, surfactant excipients were assigned to the CMC descriptor, polyols 
and salts were assigned to the surface tension descriptor, and hydrophilic solubilizing 
agents were assigned to the solubility descriptor.   To account for the effects of 
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 excipient concentration in the surface tension and solubility descriptor metrics, the 
magnitude of the metric was made proportional to the appropriate physical 
characteristic multiplied by the concentration.  For scaling purposes, and to ensure that 
each descriptor had an equal weight in the determination of molecular diversity, the 
descriptor metrics were scaled to values between -5 and 5.  A summary of each 
excipient and its corresponding descriptor value is provided in Table 7-1.   
 For CMC descriptors, to account for differences between micelle and uni-
molecular binding, surfactant excipients were scaled according to the difference 
between experimental concentrations and the respective published CMC (i.e., ΔCMC 
= experimental concentration – CMC).  To capture the step-like change in binding 
behavior at the CMC, an additional margin of 10 units was introduced in the descriptor 
scaling.  In instances where the experimental surfactant concentration was below the 
CMC, the descriptor value assigned in that case was (ΔCMC – 5); similarly, in 
instances where the concentration was above the CMC, the descriptor value was 
(ΔCMC + 5).  The resulting value was subsequently rescaled to range from -5 to 5, to 
remain consistent with the convention established for the surface tension and solubility 
descriptors. 
 To illustrate the concept of molecular diversity, Figure 7-3 shows two 
collections of formulations within the three dimensional descriptor space whose axes 
are defined as the critical micelle concentration, surface tension, and solubility.  An 
individual formulation is represented by a single point within the descriptor space and 
its position is specified by the magnitude of each excipient’s respective descriptor.  
The diversity of a collection of formulations is then quantified to be the Euclidean 
distance as defined by equation 7-3.  Formulations represented by the black spheres 
are considered collectively more diverse than those represented by the white spheres.   
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Figure  7-3.  Schematic illustration of the three dimensional diversity space whose 
axes are defined as the critical micelle concentration, surface tension, and solubility. 
Formulations represented by the black spheres are more broadly distributed within 
diversity space compared to the white spheres and are thus considered more 
molecularly diverse. 
 
7.4. RESULTS 
7.4.1. Simulation conditions and parameters 
 Formulation libraries were constructed by Metropolis MC simulation with both 
fixed and fluctuating step schemes to monitor the behavior of the change in refolding 
yield as a function of β, step increment size, and step increment scheme.  Libraries of 
1,000 formulations each were constructed for 1 ≤ β ≤ 100, in 20x50 and 10x100 
experiments (data not shown).  For each value of β, simulations were performed under 
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 the fixed and fluctuating step increment schemes for 1 ≤ k ≤ 16.  The optimal β and 
step increment parameter pair for each simulation was determined to be that which 
resulted in the largest change in refolding yield between the initial and final sampling 
rounds.  Libraries constructed using these optimal parameter pairs were selected for 
further investigation.  These parameter pairs are listed in Table 7-2. 
 
Table  7-2.  Simulation conditions and parameters 
 
Metropolis Monte Carlo 
Formulations x Rounds 20 x 50 10 x 100 
Fixed Step β = 19 k = 12 
β = 15 
k = 13 
Fluctuating Step β = 100 k = 13 
β = 85 
k = 15 
 
Parallel Tempering Monte Carlo 
Formulations x Rounds 15 x 66 
Fixed Step 
k = 13 β1 = 15, β2 = 46, β3 = 89 
Fluctuating Step 
k = 15 β1 = 22, β2 = 66, β3 = 85 
 
Parallel tempering MC simulations consisted of three simultaneous Metropolis 
systems of five formulations each, with each Metropolis system proceeding at a 
different constant β.  These parallel tempering simulations were performed, using both 
the fixed and fluctuating step increment schemes, for 66 rounds of 15 formulations 
each, resulting in 990 total formulations.  To determine the β parameters for use with 
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 the three simultaneous Metropolis systems in parallel tempering, a single system 
within the simulation was held fixed at the optimal β and step increment parameter 
pair as determined in the 10x100 Metropolis simulations described above.  The step 
increment k was kept constant across the three simultaneous systems.  The β values for 
the two remaining systems were selected to achieve a swapping rate between 
neighboring systems of approximately 20% (data not shown). [17]  The parameters for 
the parallel tempering simulations are also summarized in Table 7-2. 
 
7.4.2. Effects of β and number of rounds on refolding yield 
 To determine the effects of the β parameter on the change in refolding yield of 
formulations between the initial and final sampling rounds, simulations were 
conducted at all integer β values of 1-100 as the step increment value, k, was held 
constant at the pre-determined optimum values summarized in Table 7-2.  For each 
step increment scheme, 20x50 and 10x100 libraries were constructed.   
Figure 7-4a shows similar trends in the change in refolding yield for both the 
10x100- and 20x50-constructed libraries generated from the fixed step scheme.  An 
initial steep increase in refolding yield is observed for β < 13, beyond which the yield 
reaches a maximal level, and then trends subtly downward at increasing values of β.  
The rate at which proposed formulations resulting in lower refolding yields are 
accepted is plotted alongside the corresponding β value in Figure 7-4a.  In general, the 
acceptance rate decays as β increases.  The acceptance rate corresponding to the 
maximal improvement in refolding yield is approximately 8% for both 10x100 and 
20x50 sampling experiments.  In contrast, simulations performed under the fluctuating 
step scheme resulted in the average change in refolding yield reaching an asymptotic 
limit beyond β = 15 as shown in Figure 7-4b.  Further, the acceptance rate 
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 corresponding to the maximal change in refolding yield appeared more stringent in the 
fluctuating step simulations than in the fixed step simulations.  For both the 10x100- 
and 20x50-library constructions, the acceptance rate was approximately 1% at β > 15. 
In general, there appears to be no appreciable effect on the change in refolding 
yield due to the number of rounds at all values of β, as suggested by the comparison 
between the 20x50 and 10x100 plots within each step increment scheme.   
 
7.4.3. Effects of step increment size and number of rounds on refolding yield 
To control the sampling movement about the formulation parameter space, moves 
from excipient x to x’ were restricted by the step increment size, k, within either the 
fixed or fluctuating step increment scheme.   The effects of the step increment size on 
the change in refolding yield of formulations between the initial and final sampling 
rounds were evaluated via simulations conducted at 1 ≤ k ≤ 16 for each step increment 
scheme as β was held constant at the values summarized in Table 7-2.  For each step 
increment scheme, 20x50 and 10x100 libraries were constructed.   
In the fixed step scheme simulations, no salient trends were observed between 
the step size and the number of rounds on the average refolding yield (Figure 7-4c).  
The fluctuating step scheme simulations, on the other hand, revealed a steep initial 
approach toward an asymptotic limit as step increment size increased (Figure 7-4d), 
similar to the trend observed with β as shown in Figure 7-4b.  For both fixed and 
fluctuating step schemes, the 20x50 and 10x100 sampling experiments behaved 
comparably.   
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Figure  7-4.  Difference in average protein refolding yield between the initial and final 
formulation rounds for 1,000-formulation Metropolis Monte Carlo sampling 
experiments.  Simulations were conducted in triplicate for each set of parameters.   a)  
Acceptance rates and change in average protein refolding yield as a function of β for 
Metropolis Monte Carlo sampling with a fixed step increment scheme. The step 
increment was held constant at 13 and 12 for 10x100 and 20x50 simulations, 
respectively.  The change in average refolding yield reaches a maximum at an optimal 
value of β corresponding to an acceptance rate of approximately 8%, beyond which 
the change in refolding yield decreases.  b)  Acceptance rate and change in average 
protein refolding yield as a function of β for Metropolis Monte Carlo sampling with a 
fluctuating step increment scheme.  The step increment limit remained constant at 15 
and 13 for the 10x100 and 20x50 simulations, respectively.  The change in refolding 
yield reaches a maximal level at a critical threshold value of β corresponding to an 
approximate acceptance rate of 1%, above which there is no additional improvement 
in the refolding yield.  c)  Difference in protein refolding yield as a function of the step 
increment size for fixed step increment simulations at constant β of 15 and 19 for 
10x100 and 20x50 simulations, respectively.  d)  Difference in protein refolding yield 
as a function of the step increment size for fluctuating step increment simulations at 
constant β of 85 and 100 for 10x100 and 20x50 simulations, respectively. 
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 Figure 7-4 (continued) 
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 Figure 7-4 (continued) 
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7.4.4. Effects of sampling schemes on accessibility to formulations with high 
refolding yields.   
 Figures 7-5a and 7-5b are histograms of formulations accessed by random, 
Metropolis, and parallel tempering sampling protocols.  With regard to the MC 
methods, accessed formulations refer to all proposed formulations during library 
construction, regardless of whether the move was accepted or rejected by the 
Metropolis criterion.  The 1,000-formulation Metropolis MC libraries were generated 
by 20x50 or 10x100 simulations, while 990-formulation parallel tempering libraries 
were constructed by 15x66 experiments.  For both Metropolis and parallel tempering 
MC simulations conducted under the fixed step increment scheme, formulations with 
higher refolding yields were accessed more frequently than with random sampling, as 
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 shown by the rightward shift in the formulation distributions, with no apparent 
dependence on the number of sampling rounds employed.  
The distributions of accessed formulations under fluctuating step increment 
Metropolis and parallel tempering simulations show a similar behavior to the fixed 
step simulations, in that formulations with higher refolding yields are accessed more 
frequently than with random sampling.  However, the increased frequency appears to 
occur to a greater extent than the fixed step scheme protocols.   
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Figure  7-5.  Distribution of formulations accessed by Metropolis and parallel 
tempering (PT) Monte Carlo sampling at their respective optimized parameter pairs 
under a) fixed step increment schemes and b) fluctuating step increment schemes.  
The data are from 1,000 formulation libraries for Metropolis Monte Carlo and 990-
formulation libraries for parallel tempering.  The shifts in the histograms indicate that 
Metropolis Monte Carlo and parallel tempering sampling methods access high 
refolding yield formulations more frequently than random sampling. 
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 Figure 7-5 (continued) 
Fluctuating Step Increment Scheme
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7.4.5. Effects of sampling schemes on acceptance of formulations with high 
refolding yields 
 Figure 7-6 shows the average refolding yields of unique formulations resulting 
from proposed moves that were accepted by the Metropolis criterion.  Here, the term 
“unique” is used to describe non-repeating formulations when multiple copies of the 
same formulation appear in a sampling library.  In general, there is a propensity for 
higher refolding yield formulations to remain in the library and propagate throughout 
the rounds, thereby biasing the arithmetic average of a particular MC formulation 
library.  To account for this situation, only contributions from unique, non-repeating 
formulations were recognized.  
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Figure  7-6.  Comparison of average refolding yields of unique, accepted formulations 
for random, Metropolis Monte Carlo, and parallel tempering Monte Carlo sampling.  
In all cases, Metropolis and parallel tempering Monte Carlo sampling methods with 
either fixed or fluctuating step increment schemes result in increases in the average 
refolding yield of formulations relative to random sampling.   In addition, the average 
refolding yields of formulations constructed with fluctuating step increment schemes 
are higher than formulations constructed by corresponding simulations using fixed 
step increment schemes.  Data for random and Metropolis Monte Carlo libraries are 
based on 1,000 formulations; parallel tempering libraries contain 990 formulations.  
Simulations were performed in triplicate, and error bars represent +/- one standard 
deviation.  Asterisks (*) denote statistical significance (p < 0.05) compared to random 
sampling, and daggers (†) denote statistical significance (p < 0.05) between fixed and 
fluctuating step schemes within libraries constructed with the same number of 
formulations per round. 
 
All Metropolis and parallel tempering MC sampling methods generated 
formulations with greater refolding yields compared to those obtained from random 
sampling.  For both Metropolis and parallel tempering MC, the fluctuating step 
scheme produced libraries with statistically greater refolding yields compared to its 
fixed step scheme counterpart.  For instance, a 10x100 Metropolis library employing 
the fluctuating step scheme resulted in formulations with a larger aggregated refolding 
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 yield average than a 10x100 Metropolis library that employed the fixed step scheme.  
In both fluctuating and fixed step scheme Metropolis simulations, the number of 
formulation rounds had no significant effect on the average refolding yield.   
 
7.4.6. Molecular diversity.   
 Molecular diversity values were calculated for formulations in the initial and 
final rounds (containing 10, 15, or 20 formulations each) of 1,000-formulation 
libraries constructed by Metropolis and parallel tempering MC algorithms with fixed 
and fluctuating step schemes (Figure 7-7).  As indicated previously, initial formulation 
rounds were randomly generated, and thus the diversity of the initial round was 
deemed an appropriate baseline reference.  All libraries generated by Metropolis and 
parallel tempering sampling approaches resulted in no significant change in the 
molecular diversity between formulations in the initial (random) round and 
formulations in the final sampling round. 
The molecular diversity was also determined for the ten highest yield 
formulations within each formulation library, as these high-performing formulations 
are likely candidates for subsequent screening.  Figure 7-8 shows that, in all cases, the 
diversity of the ten highest yield formulations generated by MC sampling were 
comparable to those generated by random sampling.  When compared to the 
exhaustive screen of the complete 5,008-formulation library, two MC sampling 
methods resulted in sustained levels of diversity among the ten highest yield 
formulations – the10x100 Metropolis fluctuating step scheme and the parallel 
tempering fluctuating step scheme.   
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Figure  7-7.  Comparison of molecular diversity of formulations of the initial (random) 
and final rounds of Metropolis Monte Carlo sampling for 1,000-formulation 
experiments (10x100 and 20x50) and parallel tempering Monte Carlo sampling for 
990-formulation experiments.  Three separate initial rounds generated from random 
construction, containing 10, 15, or 20 formulations each, are plotted alongside the 
simulation data for comparison.  In all cases, the level of molecular diversity is 
maintained from the initial to the final round of formulations.  Simulations were 
performed in triplicate, error bars represent +/- standard deviation.   
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Figure  7-8.  Molecular diversity comparison of the ten highest refolding yield 
formulations within each of the exhaustive, random, Metropolis Monte Carlo, and 
parallel tempering Monte Carlo libraries.  Compared to the exhaustive screen, the 
molecular diversity was maintained for the 10x100 Metropolis fluctuating step scheme 
and the parallel tempering fluctuating step scheme simulations.  Relative to random 
sampling, all sampling methods resulted in no significant change in molecular 
diversity.  Simulations were conducted in triplicate.  The asterisks (*) denote statistical 
significance (p < 0.05) compared with formulations derived from the exhaustive 
screen. 
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 7.5. DISCUSSION 
Protein expression and folding is important for a range of applications in 
structural genomics, proteomics, and biopharmaceuticals.  Prokaryotes such as E. coli 
are often used to express high quantities of foreign proteins, however the aggregation 
of misfolded proteins into inclusion bodies reduces the recovery yield and complicates 
the purification process.  To recover functional proteins from inclusion bodies, the 
proteins are first solubilized in a denatured form using concentrated chaotropic agents 
(primarily urea or guanidinium chloride).  The denaturing agents are then replaced 
with a refolding buffer whose composition will dictate the yield of functional protein 
recovery.  The formulation of these refolding buffers is notoriously fastidious, so a 
universal refolding buffer is not available and protein recovery yields from inclusion 
bodies are typically low. 
To improve recovery yields, a number of high-throughput approaches have 
been described where the refolding buffers are formulated in a combinatorial fashion, 
thereby allowing for a large number of refolding conditions to be simultaneously 
evaluated with the hope of identifying formulations of suitable compositions. [1-5]  
The current high-throughput refolding literature presents data for tens or hundreds of 
different refolding conditions whereas a full combinatorial analysis of refolding 
conditions requires upwards of thousands of samples.  This numerical challenge is not 
restricted to protein refolding but is pervasive in combinatorial experimentation in 
general.  Given the large number of samples necessary to fully map a meaningful 
refolding parameter space, there is a great need for alternative strategies to exhaustive 
screening.   
 Two stochastic Monte Carlo sampling approaches, Metropolis and parallel 
tempering, have emerged as viable alternatives to both exhaustive screening and 
random sampling of combinatorial libraries. [7]  Although the traditional roots of the 
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 MC sampling method began with molecular simulations of thermonuclear reactions, it 
quickly became a general optimization algorithm in a variety of diverse applications. 
[18, 19]   One of the earlier extensions of the method was developed by Metropolis et 
al. to determine the equilibrium properties of systems comprised of individual 
particles interacting in a two-dimensional space. [20]  Such properties were calculated 
based on a series of simulated particle displacements and their corresponding changes 
in energy.  Displacements that resulted in a reduction of the calculated energy of the 
system reflected a thermodynamically consistent event, and were therefore allowed.  
In contrast, displacements that resulted in an increase in the energy were allowed 
conditionally based on a probability that was biased by the Boltzmann factor, exp(-
E/kT).  Simulated adjustments in the spatial positioning of individual particles and the 
calculation of a corresponding change in energy create, in essence, the traversal along 
an energy landscape that exists in configuration space.  Since particle configurations 
resulting in an increase in energy were only allowed occasionally, whereas those 
resulting in a reduction in energy were always allowed, the simulation was designed to 
trend toward the lowest free energy state of the system without becoming trapped in 
local minima.    
Parallel tempering is an extension of the Metropolis MC method that is shown 
to be particularly adept at traversing rugged energy landscapes. [21-23]  The parallel 
tempering scheme simulates replicas of systems, with each system at a different 
constant β, where β replaces 1/kT in the Boltzmann factor.  Systems at lower β sample 
the configuration space more comprehensively, while systems at higher β tend to 
sample the space more locally.  Parallel tempering MC facilitates improved sampling 
by allowing the configurations of one system at, say, β1 to exchange with the 
configurations of another system at, say, β2 (Figure 7-2).  Thus, a system at lower β 
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 which undergoes configuration exchange with a system at higher β theoretically 
allows for representative sampling of many local regions of the configuration space.   
There are clear analogies between sampling particle configuration space for a 
free energy minimum and searching composition space for formulations with a 
maximum figure of merit. [7]     In both instances, MC is used to optimize a particular 
attribute of the system, the only difference being a sign change in the exponential 
factor of the acceptance probability (i.e., exp(-βΔE) versus exp(βΔE)). 
It is also important to recognize, however, distinctions with regard to the 
concept of step size used in conventional molecular simulations and the concept of 
step size employed here in the formulation parameter space.  In the former application, 
particle physics and statistical thermodynamics enable the energy landscape to be a 
function of the physical particle configurations, and a step change in particle 
configuration represents the physical displacement between atoms.  In the latter 
application, on the other hand, excipients are unable to be organized in a chemically 
and physically relevant manner due to the absence of any information regarding how 
multiple excipients together affect the complex interactions governing protein 
refolding.  Given this limitation, excipients were arbitrarily assigned to unique integer 
values and the step size is not directly related to a physical or chemical distance. 
This work is an experimental validation of two MC approaches, Metropolis 
and parallel tempering, toward identifying high protein refolding buffer formulations 
with greater efficiency than exhaustive screening and random sampling.  A key 
advantage to MC library construction lies in its iterative approach to creating 
formulations compared to random library construction, which occurs in a single pass 
without incorporating any a priori knowledge gleaned from previous formulation 
cycles.  This iterative approach to sampling formulations, where one excipient in each 
formulation of a given round is conditionally incremented according to a specified 
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 step scheme, is how the formulation parameter space is sampled and the figure of 
merit landscape is traversed.  Thus, the degree to which the Metropolis MC algorithms 
may improve sampling efficiency is greatly dependent on the factors that determine 
the probability and increment by which excipients are changed from one round to the 
next.  In this study, the modeling parameters β, step increment size, and step 
increment scheme were examined to determine their effects on the sampling 
efficiency.  
Figures 7-4a and 7-4b show that the change in refolding yield from the initial 
to the final formulation round generally increases with increasing β.   The figure of 
merit enhancement as a function of β resembles a parabolic behavior under the fixed 
step scheme and resembles an asymptotic behavior under the fluctuating step scheme.  
For both 20x50 and 10x100 libraries constructed under the fixed step scheme, the 
change in refolding yield reaches a maximal level at some optimal value of β 
corresponding to an acceptance rate of approximately 8%, beyond which the change in 
refolding yield decreases.  In contrast, for libraries constructed with the fluctuating 
step scheme, the change in refolding yield reaches a maximal level at a critical 
threshold value of β corresponding to an acceptance rate of approximately 1%, above 
which there is no additional improvement in refolding yield.  For both step schemes, 
the initial increase in the change in refolding yield as β increases is consistent with the 
Metropolis acceptance criterion: at higher values of β, moves to formulations of lower 
refolding yields are accepted with less frequency and formulations with higher 
refolding yields tend to survive the repeated sampling; lower values of β result in 
accepting moves less discriminately and tend to mimic random sampling.   
The observed contrast between the two step schemes with regard to the 
behavior in the figure of merit enhancement as a function of β may be attributed to 
differences in the step schemes’ ability to access formulations within the parameter 
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 space.  Moves proposed under the fixed step scheme are only able to access 
formulations that fall a constant step-distance away from the original formulation, 
while moves proposed with the fluctuating step scheme simulations may access all 
formulations within a step-distance perimeter.  Sampling the parameter space under 
fixed step increment conditions are, therefore, more tightly restricted than sampling 
under the fluctuating step increment.  In the fixed step scheme, restrictions on 
formulation accessibility are combined with the more stringent acceptance criteria 
imposed by higher values of β to cause formulations to eventually become trapped in 
local maxima over repeated rounds of sampling, thus leading to a reduction in the 
change in figure of merit beyond the optimal value of β.  Fluctuating step scheme 
sampling prevents the reduction in the figure of merit at higher β that might otherwise 
occur because formulations can escape local maxima over rounds of repeated 
sampling, despite high β, due to increased access to proposed formulations.  This 
situation of escaping local maxima likens the purported goals of parallel tempering 
sampling where β values are swapped between parallel systems to improve the 
thoroughness of the sampling in order to escape local maxima. 
Another important factor to consider in MC-based simulations is the step size 
at which proposed moves are incremented.  In molecular simulations, if the step size is 
too small, all moves tend to be accepted; if the step size is too large, moves tend to be 
frequently rejected. [24]  Strategies have been developed to adjust the step size to 
optimize the performance of molecular simulations.  In the same vein, similar efforts 
were taken in this study to examine the effects of step increment sizes on the sampling 
efficiency.   
Figures 7-4c and 7-4d chart the change in refolding yield at all possible step 
increment sizes (1 ≤ k ≤ 16) while β was held constant.  No trends beyond stochastic 
fluctuations are readily apparent for the fixed step scheme, as expected, since the 
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 formulation parameter space was not parameterized with any meaningful 
physicochemical distance in mind.  Interestingly, for the fluctuating step scheme, the 
average change in refolding yield increases steeply at step increments less than four 
and maintains the maximal change in refolding yield at larger step increments.  This 
initial upward trend may be related to the sampling thoroughness afforded at differing 
values of k operating within the fluctuating step scheme, similar to the effects 
described previously with β.  The observed sub-maximal enhancement in refolding 
yields at low values of k may be due to sampling within a more local region, thus 
increasing the possibility of becoming trapped in local maxima.  The improved 
performance at larger step increments may be because higher values of k allow for a 
mixture of both large and small traversals across the refolding yield landscape.   
Given the arbitrary organization of the formulation parameter space, it is 
unclear whether the dependence of the figure of merit on step size seen with the 
fluctuating step scheme is an inherent attribute to the sampling scheme, or rather an 
unintended result due to stochastic fluctuation.  To further explore the combined 
effects of the step increment scheme and step size on sampling efficiency, 
formulations may need to be organized within a more structured physicochemical 
parameter space.  Possibilities toward this effort include defining the distance along 
the landscape in binary terms, where changes in excipient concentration represent 
“short” distances and changes in chemical species represent “long” distances.  
Alternatively, the distance may also be defined in proportion to the number of 
chemical species changed with each proposed move such that changing three 
excipients represents a relatively “long” distance when compared with changing only 
one of the three excipients in a particular formulation. 
In both the β and step increment studies (Figures 7-4a – 7-4d), increasing the 
number of sampling rounds by two-fold while keeping the library size constant did not 
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 result in any meaningful increase in the average change in protein refolding yields.  
This is surprising since each of ten formulations undergoes 100 proposed moves in the 
10x100 sampling experiments, while each of 20 formulations undergoes only half the 
number of proposed moves.  Chen and Deem have previously observed a significant 
effect of the number of sampling rounds on figure of merit, however the figure of 
merit enhancement was realized with a 10-fold increase in the number of sampling 
rounds. [7]  A more comprehensive evaluation on the effects of the number of rounds 
may require experiments with larger data sets that allow for more sampling rounds. 
Based on a series of precursory simulations where 10x100 and 20x50 libraries 
were constructed at 1 ≤ β ≤ 100 and 1≤ k ≤ 16, the parameter pairs that resulted in the 
largest change in refolding yield between the initial and final rounds for each 
simulation condition were determined and are summarized in Table 7-2.  These 
optimal parameter pairs were subsequently used to evaluate the performance of the 
various MC sampling algorithms relative to random sampling.  Figures 7-5a and 7-5b 
suggest that Metropolis and parallel tempering MC methods, under both fixed and 
fluctuating step increment schemes, afford greater access to high refolding yield 
formulations than with random sampling, as indicated by the shifts in the distribution 
of accessed formulations toward higher refolding yields.  In the fixed step increment 
simulations, this shift is more subtle with little discernible difference in the 
distribution of accessed formulations beyond 80% refolding yield among the 
Metropolis and parallel tempering sampling approaches compared to random 
sampling.  Under fluctuating step increment moves, the trend toward higher refolding 
yields is particularly evident for formulations with refolding yield ≥ 90%.   
 In practice, the appeal of using MC sampling methods lies not only in the 
formulations accessed, but by those actually accepted by the Metropolis criterion to 
subsequent sampling rounds.  Figure 7-6 shows the refolding yield data of accepted, 
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 unique formulations in aggregate.  The results demonstrate that MC sampling methods 
generate formulations with greater refolding yields, on average, than those obtained by 
random sampling.   Moreover, Metropolis and parallel tempering simulations adopting 
the fluctuating step scheme with optimized parameters generate the greatest 
enhancements in refolding yield compared to those employing a fixed step scheme 
with optimized parameters.  Note that the observed enhancements in refolding yields 
as generated by the sampling schemes are not attributable to top performing 
formulations that remain in the library and propagate throughout the rounds as a result 
of high values of β.  Rather, the average refolding yields reported reflect the yields of 
only unique, non-repeating formulations.     
 Although the results suggest MC algorithms to be capable of locating 
formulations with high protein refolding yields more efficiently than by random 
sampling, refolding yield may not be the only figure of merit to consider.  Subsequent 
screening (e.g., toxicology, stability, manufacturability) of these formulations are 
often necessary to fully evaluate their safety and efficacy profiles.  One means of 
estimating how successful a collection of formulations will be in subsequent screens is 
by assessing the degree of similarity or dissimilarity (e.g., structurally, chemically, or 
conformationally) among individual formulations within a collection.  The utility of 
quantifying this degree of similarity, often referred to as the molecular diversity, is 
based on the assumption that similar formulations share similar activity, while 
dissimilar formulations share dissimilar activity. [25]  If a set of formulations with 
high protein refolding capabilities can be efficiently assembled, for instance via MC 
sampling algorithms, and is deemed to be molecularly diverse, then it is likely that at 
least some of the formulations within the collection will pass subsequent analyses that 
do not rely on refolding as the exclusive figure of merit.   
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  Borrowing from a strategy typically used in small-molecule drug discovery 
applications, the diversity of the refolding formulations was quantified within a 
framework defined by three components:  diversity metrics, diversity space, and 
diversity sampling. [26]  Diversity metrics are used to translate the physicochemical 
characteristics of a set of compounds into a geometrical distance in order to quantify 
its diversity within some predefined chemical or structural space.  Diversity space is a 
relevant chemical and structural space within which the diversity of a set of 
compounds is assessed.  The boundaries and units of measure within this parameter 
space are defined by “molecular descriptors” that are used to numerically represent 
each compound within the diversity space.  Diversity sampling refers to algorithms 
developed to identify a maximally diverse and representative subset of compounds 
from a typically much larger compound collection.  Although algorithms specifically 
designed to maximize molecular diversity have been presented in the literature, the 
MC schemes employed in this study do not explicitly consider diversity optimization 
as part of the sampling procedure. [27]  Table 7-3 summarizes the specific diversity 
components that were chosen to analyze the molecular diversity of the MC- and 
randomly-generated formulation libraries.   
 
Table  7-3.  Parameters Adopted for Molecular Diversity Analysis 
 
 Specific Parameters 
Diversity Metric Euclidean distance-based method  [7] 
Diversity Space 
Molecular Descriptors: 
1) Surface tension 
2) CMC 
3) Solubility 
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 There are no universally accepted set of molecular descriptors and those that 
are selected to parameterize the diversity space are often very application specific. 
[28]  A collection of over 1800 different descriptors and their respective definitions 
have been compiled, demonstrating the vast assortment of descriptors that have been 
proposed for various applications in the past and more significantly, the absence of an 
absolute set of descriptors to quantify molecular diversity. [29]  Additionally, the 
number of descriptors needed to uniquely describe each compound in a complex and 
large combinatorial library can easily become very large and unruly.   
To maintain a manageable yet useful number of descriptors for the present 
work, three molecular descriptors - surface tension, critical micelle concentration 
(CMC), and solubility - were chosen to characterize the formulations within each 
library.  Although each excipient may conceivably be allocated to more than one 
molecular descriptor category, only one descriptor was assigned to each excipient 
based upon what is believed to be the single predominant physical characteristic 
contributing to the protein refolding process.  Cooperative effects between excipients 
were not accounted for in the diversity measurements.    
The positive refolding effect of preferential hydration on denatured proteins is 
a widely accepted mechanism for protein stabilization and has been well documented 
in the literature. [30]  Excipients that induce this phenomenon do so, by modifying the 
surface tension of water and consequently the interaction at the water-protein 
interface.  Polyol and salt excipients were categorized within the surface tension 
descriptor to account for this important contribution to protein refolding.  Refolding 
can also be facilitated with surfactants within the refolding buffer due to their 
amphiphilic nature that can bind to exposed hydrophobic regions of folding 
intermediates, thereby suppressing aggregation and maintaining protein solubility 
within the solvent. [30, 31]  This binding interaction is dependent on the concentration 
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 of the surfactant within the bulk solvent, although it is unclear whether detergents 
provide optimal protein refolding assistance at concentrations above or below the 
CMC.  The literature suggests that the extent of binding, and thus the folding effects of 
detergent on the protein, exhibits a step-like change in binding behavior at the CMC. 
[30, 32]  As such, the specific molecular descriptor value for surfactant excipients 
were assigned accordingly to capture this marked change in binding behavior at the 
CMC.  (See Materials and Methods).    Hydrogen bonding and hydrophobic effects 
play critical roles in stabilizing the three-dimensional conformation of folded proteins. 
[30]  To capture these effects, solubility in water was chosen as a relative indicator of 
the hydrophilic or hydrophobic nature of selected excipients.    
 It is important to acknowledge that diversity is meaningful only with respect to 
the specified molecular descriptors, since every given set of descriptors generates a 
unique descriptor space within which the formulations are distributed.  Moreover, the 
molecular diversity value alone is meaningless; its significance is limited to 
comparison with another set of formulations whose diversity is quantified with the 
same set of descriptors.  Figure 7-3 illustrates a comparison between two collections 
of formulations.  The collection represented by the black spheres is more broadly 
distributed within diversity space compared to the white spheres and are thus 
considered more molecularly diverse.   
Based on the diversity analysis shown in Figure 7-7, all simulation schemes 
maintained a statistically comparable level of diversity amongst the formulations in 
the final sampling round when compared with the initial formulations generated by 
random sampling.  These diversity results, in conjunction with the results shown in 
Figures 7-5 and 7-6, highlight the capacity of MC schemes to locate more 
formulations with high refolding yields, compared to random sampling, without 
compromising molecular diversity.  What may be of more practical interest is the 
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 diversity of a set of high-performing formulations as they are the likely candidates for 
subsequent screening (Figure 7-8).  Compared to the ten highest-yielding formulations 
generated by random sampling, all MC sampling methods arrived at formulations 
whose molecular diversity measurements were statistically comparable in diversity.  
When compared with the top performing formulations derived from the exhaustive 
screen, libraries generated by two out of the six MC sampling conditions resulted in 
formulations with statistically comparable levels of diversity.  Despite the reduction in 
molecular diversity observed for the other four sampling conditions, MC simulations 
often located at least four of the ten highest refolding yield formulations from the 
exhaustive screen while only requiring the sampling of 20% of the total number of 
samples (data not shown).  This illustrates the potential compromise in molecular 
diversity and figure of merit that may exist between sampling only a fraction of a 
combinatorial library over exhaustively screening each constituent.   
Two distinct situations are envisioned for experimenters who wish to 
implement these MC algorithms for sampling combinatorial libraries: first in instances 
where the figure of merit must be computationally estimated with an appropriate 
quantitative model, and second in instances where the figure of merit must be 
evaluated experimentally with each iterative round of library construction.   
In the situation where the figure of merit is to be computationally estimated, 
appropriate metrics that can capture the characteristics of each library constituent’s 
influence on the figure of merit need to be developed.  The molecular descriptors used 
in the diversity analysis here are examples of such metrics.  These metrics are then 
used as input variables in a quantitative model, which can predict the figure of merit of 
each library constituent.  A similar concept has been demonstrated to predict protein 
adsorption on biomaterials in a combinatorial polymer library. [33-35] 
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 When a quantitative model or a comprehensive data set is unavailable, the 
figure of merit for each library constituent may be evaluated experimentally with each 
iterative round of library construction.  A sufficient starting set of samples, round 1, 
must first be obtained by random sampling from the parameter space.  These samples 
must then be quantitatively evaluated for a figure of merit.  The MC moves may then 
commence, resulting in a set of proposed new samples, collectively denoted as round 
1’, each of which must be synthesized and once again evaluated for the figure of merit.  
Once the figures of merit for both the original configuration and its corresponding 
proposed configuration have been evaluated, the appropriate acceptance probability 
criterion is applied.  If the proposed move is accepted, the new sample in round 1’ 
advances to round 2.  Otherwise, the original sample from round 1 remains in round 2.  
The proposed moves and the subsequent synthesis and evaluation then proceed in this 
order in a loop wise fashion.  At the conclusion of the sampling experiments, the total 
number of samples to be generated has not decreased compared to a randomly 
sampled library of equal size.  Rather, the total number of samples is the same, but 
those with high figures of merit may be identified with greater efficiency using this 
proposed combination of traditional experimental methods coupled to computational 
decision-making algorithms. 
 
7.6. CONCLUSIONS 
In light of the imposing technical and financial challenges associated with 
high-throughput synthesis and screening, much attention has been directed at 
developing alternative strategies to efficiently and effectively cover the chemical 
parameter space without having to rely on exhaustive screening.  Using an 
experimentally-acquired, exhaustive data set of protein refolding yields for a 
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 combinatorial library of lysozyme refolding buffer formulations, this study illustrates 
that both Metropolis and parallel tempering MC algorithms can effectively sample the 
formulation parameter space, thereby affording access to high yielding formulations 
and ultimately a more efficient way to locate top performing formulations when 
compared to random sampling.     
The results demonstrate that the change in average refolding yields is 
dependent upon the step increment scheme and the value of the Metropolis β 
parameter and the step increment size operating within the scheme.  These tunable 
parameters are critical to the MC sampling schemes and afford experimenters the 
flexibility to tailor the use of such approaches in an application-specific manner.  In 
addition to the protein refolding yield figure of merit, the effects of the sampling 
schemes on molecular diversity have been considered.  Molecular diversity, as 
parameterized by surface tension, critical micelle concentration, and solubility, does 
not appear to diminish as formulations are sampled throughout the Metropolis or 
parallel tempering MC rounds compared with formulations generated by random 
sampling.   
 The results presented herein compellingly illustrate the versatility of MC 
methods in  sampling combinatorial libraries.  More highly resolved landscapes, by 
way of physiochemical parameterization, plus the availability of larger data sets may 
further illuminate the full range of capabilities of Monte Carlo-based strategies for 
applications beyond traditional molecular simulations.  
 279
 REFERENCES 
 
[1] Wang, T., John, S., Archuleta, S., and Jonsson, C.B. Rapid, high-throughput 
purification of hiv-1 integrase using microtiter plate technology. Protein Expr. 
Purif. 33(2):  232-237 (2004). 
[2]  Voziyan, P., Johnston, M., Chao, A., Bomhoff, G., and Fisher, M. Designing a 
high throughput refolding array using a combination of the groel chaperonin and 
osmolytes. J. Struct. Funct. Genomics 6(2-3):  183-188 (2005). 
[3]  Vincentelli, R., Canaan, S., Campanacci, V., Valencia, C., Maurin, D., Frassinetti, 
F., Scappucini-Calvo, L., Bourne, Y., Cambillau, C., and Bignon, C. High-
throughput automated refolding screening of inclusion bodies. Protein Sci. 
13(10):  2782-2792 (2004). 
[4]  Lin, L., Seehra, J., and Stahl, M.L. High-throughput identification of refolding 
conditions for lxr beta without a functional assay. Protein Expr. Purif. 47(2):  
355-366 (2006). 
[5]  Cowieson, N.P., Wensley, B., Listwan, P., Hume, D.A., Kobe, B., and Martin, J.L. 
An automatable screen for the rapid identification of proteins amenable to 
refolding. Proteomics 6(6):  1750-1757 (2006). 
[6]  Geysen, H.M., Schoenen, F., Wagner, D., and Wagner, R. Combinatorial 
compound libraries for drug discovery: An ongoing challenge. Nat. Rev. Drug 
Discovery 2(3):  222-230 (2003). 
[7] Chen, L.G. and Deem, M.W. Monte carlo methods for small molecule high-
throughput experimentation. J. Chem. Inf. Comput. Sci. 41(4):  950-957 (2001). 
[8]  Ott, E., Cellulose and cellulose derivatives. 1943, New York: Interscience 
Publishers. 1176. 
[9] Larsson, C., Widell, S., and Kjellbom, P. Preparation of high-purity plasma-
membranes. Methods Enzymol. 148:  558-568 (1987). 
 280
 [10] Weast, R.C., Astle, M.J., and Beyer, W.H., Chemical rubber company handbook 
of chemistry and physics. 1988, Boca Raton: CRC Press. 
[11] Connors, K.A. The stability of cyclodextrin complexes in solution. Chemical 
Reviews 97(5):  1325-1357 (1997). 
[12]  Helenius, A., D.R., M., Fries, E., and Tanford, C. Properties of detergents. 
Methods Enzymol. 56:  734-749 (1979). 
[13]  www.sigmaaldrich.com 
[14] Macdonald, R.J., Swift, G.H., Przybyla, A.E., and Chirgwin, J.M. Isolation of rna 
using guanidinium salts. Methods Enzymol. 152:  219-227 (1987). 
[15] Hevehan, D.L. and Clark, E.D. Oxidative renaturation of lysozyme at high 
concentrations. Biotechnol. Bioeng. 54(3):  221-230 (1997). 
[16]  Wetlaufer, D.B., Johnson, E.R., and Clauss, L.M., Lysozyme, ed. E.F. Osserman, 
R.E. Canfield, and S. Beychok. 1974, New York: Academic. 
[17]  Rathore, N., Chopra, M., and De Pablo, J.J. Optimal allocation of replicas in 
parallel tempering simulations. J. Chem. Phys. 122(2):  - (2005). 
[18]  Frenkel, D. and Smit, B., Understanding molecular simulation: From algorithms 
to applications. 2002, San Diego: Academic Press. 638. 
[19] Metropolis, N. The beginning of the monte carlo method. Los Alamos Science 
Special Issue:  125-130 (1987). 
[20] Metropolis, N., Rosenbluth, A.W., Rosenbluth, M.N., Teller, A.H., and Teller, E. 
Equation of state calculations by fast computing machines. J. Chem. Phys. 21(6):  
1087-1092 (1953). 
[21] Earl, D.J. and Deem, M.W. Parallel tempering: Theory, applications, and new 
perspectives. Phys. Chem. Chem. Phys. 7(23):  3910-3916 (2005). 
 281
 [22] Geyer, C.J. Markov chain monte carlo maximum likelihood. in Computing 
Science and Statistics: Proceedings of the 23rd Symposium on the Interface. 
American Statistical Association. 1991. New York. 
[23] Swendsen, R.H. and Wang, J.S. Replica monte-carlo simulation of spin-glasses. 
Phys. Rev. Lett. 57(21):  2607-2609 (1986). 
[24] Miller, M.A., Amon, L.M., and Reinhardt, W.P. Should one adjust the maximum 
step size in a metropolis monte carlo simulation? Chem. Phys. Lett. 331(2-4):  
278-284 (2000). 
[25] Gorse, A.D. Diversity in medicinal chemistry space. Curr. Top. Med. Chem. 6(1):  
3-18 (2006). 
[26]  Agrafiotis, D.K., Lobanov, V., Rassokhin, D., and Izrailev, S., The measurement 
of molecular diversity, in Virtual screening for bioactive molecules, H.J. Bohn 
and G. Schneider, Editors. 2000, Wiley-VCH: Weinheim, Germany. p. 265-300. 
[27] Agrafiotis, D.K. Stochastic algorithms for maximizing molecular diversity. J. 
Chem. Inf. Comput. Sci. 37(5):  841-851 (1997). 
[28] Glen, R.C. and Adams, S.E. Similarity metrics and descriptor spaces - which 
combinations to choose? QSAR Comb. Sci. 25(12):  1133-1142 (2006). 
[29] Todeschini, R. and Consonni, V., Handbook of molecular descriptors. 2000, 
Weinheim, Germany: Wiley-VCH. 667. 
[30] Wang, W. Instability, stabilization, and formulation of liquid protein 
pharmaceuticals. Int. J. Pharm. 185(2):  129-188 (1999). 
[31] Clark, E.D., Schwarz, E., and Rudolph, R. Inhibition of aggregation side reactions 
during in vitro protein folding. Amyloid, Prions, and Other Protein Aggregates 
309:  217-236 (1999). 
[32] Ruckenstein, E. and Nagarajan, R. Critical micelle concentration - transition point 
for micellar size distribution. J. Phys. Chem. 79(24):  2622-2626 (1975). 
 282
 [33] Smith, J.R., Kholodovych, V., Knight, D., Kohn, J., and Welsh, W.J. Predicting 
fibrinogen adsorption to polymeric surfaces in silico: A combined method 
approach. Polymer 46(12):  4296-4306 (2005). 
[34] Smith, J.R., Knight, D., Kohn, J., Rasheed, K., Weber, N., Kholodovych, V., and 
Welsh, W.J. Using surrogate modeling in the prediction of fibrinogen adsorption 
onto polymer surfaces. J. Chem. Inf. Comput. Sci. 44(3):  1088-1097 (2004). 
[35] Smith, J.R., Seyda, A., Weber, N., Knight, D., Abramson, S., and Kohn, J. 
Integration of combinatorial synthesis, rapid screening, and computational 
modeling in biomaterials development. Macromol. Rapid Commun. 25(1):  127-
140 (2004). 
 
 
 
 283
